| Year |
Citation |
Score |
| 2024 |
Dissanayaka DMS, Jayasena V, Rainey-Smith SR, Martins RN, Fernando WMADB. The Role of Diet and Gut Microbiota in Alzheimer's Disease. Nutrients. 16. PMID 38337696 DOI: 10.3390/nu16030412 |
0.411 |
|
| 2023 |
Ramezani M, Fernando M, Eslick S, Asih PR, Shadfar S, Bandara EMS, Hillebrandt H, Meghwar S, Shahriari M, Chatterjee P, Thota R, Dias CB, Garg ML, Martins RN. Ketone bodies mediate alterations in brain energy metabolism and biomarkers of Alzheimer's disease. Frontiers in Neuroscience. 17: 1297984. PMID 38033541 DOI: 10.3389/fnins.2023.1297984 |
0.356 |
|
| 2023 |
Slee MG, Rainey-Smith SR, Villemagne VL, Doecke JD, Sohrabi HR, Taddei K, Ames D, Dore V, Maruff P, Laws SM, Masters CL, Rowe CC, Martins RN, Erickson KI, Brown BM. Physical activity and brain amyloid beta: A longitudinal analysis of cognitively unimpaired older adults. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 37984813 DOI: 10.1002/alz.13556 |
0.417 |
|
| 2023 |
Fernando MG, Silva R, Fernando WMADB, de Silva HA, Wickremasinghe AR, Dissanayake AS, Sohrabi HR, Martins RN, Williams SS. Effect of Virgin Coconut Oil Supplementation on Cognition of Individuals with Mild-to-Moderate Alzheimer's Disease in Sri Lanka (VCO-AD Study): A Randomized Placebo-Controlled Trial. Journal of Alzheimer's Disease : Jad. PMID 37980665 DOI: 10.3233/JAD-230670 |
0.333 |
|
| 2023 |
Naismith SL, Michaelian JC, Santos C, Mehrani I, Robertson J, Wallis K, Lin X, Ward SA, Martins R, Masters CL, Breakspear M, Ahern S, Fripp J, Schofield PR, Sachdev PS, et al. Tackling Dementia Together via The Australian Dementia Network (ADNeT): A Summary of Initiatives, Progress and Plans. Journal of Alzheimer's Disease : Jad. PMID 37927266 DOI: 10.3233/JAD-230854 |
0.387 |
|
| 2023 |
Shirzadi Z, Schultz SA, Yau WW, Joseph-Mathurin N, Fitzpatrick CD, Levin R, Kantarci K, Preboske GM, Jack CR, Farlow MR, Hassenstab J, Jucker M, Morris JC, Xiong C, Karch CM, ... ... Martins RN, et al. Etiology of White Matter Hyperintensities in Autosomal Dominant and Sporadic Alzheimer Disease. Jama Neurology. PMID 37843849 DOI: 10.1001/jamaneurol.2023.3618 |
0.329 |
|
| 2023 |
Xia Y, Maruff P, Doré V, Bourgeat P, Laws SM, Fowler C, Rainey-Smith SR, Martins RN, Villemagne VL, Rowe CC, Masters CL, Coulson EJ, Fripp J. Longitudinal trajectories of basal forebrain volume in normal aging and Alzheimer's disease. Neurobiology of Aging. 132: 120-130. PMID 37801885 DOI: 10.1016/j.neurobiolaging.2023.09.002 |
0.723 |
|
| 2023 |
Yuan J, Pedrini S, Thota R, Doecke J, Chatterjee P, Sohrabi HR, Teunissen CE, Verberk IMW, Stoops E, Vanderstichele H, Meloni BP, Mitchell C, Rainey-Smith S, Goozee K, Tai ACP, ... ... Martins RN, et al. Elevated plasma sclerostin is associated with high brain amyloid-β load in cognitively normal older adults. Npj Aging. 9: 17. PMID 37666862 DOI: 10.1038/s41514-023-00114-4 |
0.387 |
|
| 2023 |
Johnson ECB, Bian S, Haque RU, Carter EK, Watson CM, Gordon BA, Ping L, Duong DM, Epstein MP, McDade E, Barthélemy NR, Karch CM, Xiong C, Cruchaga C, Perrin RJ, ... ... Martins R, et al. Cerebrospinal fluid proteomics define the natural history of autosomal dominant Alzheimer's disease. Nature Medicine. PMID 37550416 DOI: 10.1038/s41591-023-02476-4 |
0.382 |
|
| 2023 |
McKay NS, Gordon BA, Hornbeck RC, Dincer A, Flores S, Keefe SJ, Joseph-Mathurin N, Jack CR, Koeppe R, Millar PR, Ances BM, Chen CD, Daniels A, Hobbs DA, Jackson K, ... ... Martins R, et al. Positron emission tomography and magnetic resonance imaging methods and datasets within the Dominantly Inherited Alzheimer Network (DIAN). Nature Neuroscience. PMID 37429916 DOI: 10.1038/s41593-023-01359-8 |
0.453 |
|
| 2023 |
Schultz SA, Shirzadi Z, Schultz AP, Liu L, Fitzpatrick CD, McDade E, Barthelemy NR, Renton A, Esposito B, Joseph-Mathurin N, Cruchaga C, Chen CD, Goate A, Allegri RF, Benzinger TLS, ... ... Martins RN, et al. Location of pathogenic variants in PSEN1 impacts progression of cognitive, clinical, and neurodegenerative measures in autosomal-dominant Alzheimer's disease. Aging Cell. e13871. PMID 37291760 DOI: 10.1111/acel.13871 |
0.355 |
|
| 2023 |
Chatterjee P, Doré V, Pedrini S, Krishnadas N, Thota R, Bourgeat P, Ikonomovic MD, Rainey-Smith SR, Burnham SC, Fowler C, Taddei K, Mulligan R, Ames D, Masters CL, Fripp J, ... ... Martins RN, et al. Plasma Glial Fibrillary Acidic Protein Is Associated with 18F-SMBT-1 PET: Two Putative Astrocyte Reactivity Biomarkers for Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 36776057 DOI: 10.3233/JAD-220908 |
0.451 |
|
| 2023 |
Sewell KR, Rainey-Smith SR, Peiffer J, Sohrabi HR, Taddei K, Ames D, Maruff P, Masters CL, Rowe CC, Martins RN, Erickson KI, Brown BM. The relationship between objective physical activity and change in cognitive function. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 36656659 DOI: 10.1002/alz.12950 |
0.343 |
|
| 2022 |
Chatterjee P, Vermunt L, Gordon BA, Pedrini S, Boonkamp L, Armstrong NJ, Xiong C, Singh AK, Li Y, Sohrabi HR, Taddei K, Molloy M, Benzinger TLS, Morris JC, Karch C, ... ... Martins RN, et al. Plasma glial fibrillary acidic protein in autosomal dominant Alzheimer's disease: Associations with Aβ-PET, neurodegeneration, and cognition. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 36576155 DOI: 10.1002/alz.12879 |
0.504 |
|
| 2022 |
Chatterjee P, Pedrini S, Doecke JD, Thota R, Villemagne VL, Doré V, Singh AK, Wang P, Rainey-Smith S, Fowler C, Taddei K, Sohrabi HR, Molloy MP, Ames D, Maruff P, ... ... Martins RN, et al. Plasma Aβ42/40 ratio, p-tau181, GFAP, and NfL across the Alzheimer's disease continuum: A cross-sectional and longitudinal study in the AIBL cohort. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 36574591 DOI: 10.1002/alz.12724 |
0.502 |
|
| 2022 |
Dhiman K, Villemagne VL, Fowler C, Bourgeat P, Li QX, Collins S, Rowe CC, Masters CL, Ames D, Blennow K, Zetterberg H, Martins RN, Gupta V. Cerebrospinal fluid levels of fatty acid-binding protein 3 are associated with likelihood of amyloidopathy in cognitively healthy individuals. Alzheimer's & Dementia (Amsterdam, Netherlands). 14: e12377. PMID 36479019 DOI: 10.1002/dad2.12377 |
0.438 |
|
| 2022 |
Fowler CJ, Stoops E, Rainey-Smith SR, Vanmechelen E, Vanbrabant J, Dewit N, Mauroo K, Maruff P, Rowe CC, Fripp J, Li QX, Bourgeat P, Collins SJ, Martins RN, Masters CL, et al. Plasma p-tau181/Aβ ratio predicts Aβ-PET status and correlates with CSF-p-tau181/Aβ and future cognitive decline. Alzheimer's & Dementia (Amsterdam, Netherlands). 14: e12375. PMID 36447478 DOI: 10.1002/dad2.12375 |
0.49 |
|
| 2022 |
Huang X, Li Y, Fowler C, Doecke JD, Lim YY, Drysdale C, Zhang V, Park K, Trounson B, Pertile K, Rumble R, Pickering JW, Rissman RA, Sarsoza F, Abdel-Latif S, ... ... Martins R, et al. Leukocyte surface biomarkers implicate deficits of innate immunity in sporadic Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 36349985 DOI: 10.1002/alz.12813 |
0.475 |
|
| 2022 |
Tarawneh HY, Jayakody DMP, Sohrabi HR, Martins RN, Mulders WHAM. Understanding the Relationship Between Age-Related Hearing Loss and Alzheimer's Disease: A Narrative Review. Journal of Alzheimer's Disease Reports. 6: 539-556. PMID 36275417 DOI: 10.3233/ADR-220035 |
0.375 |
|
| 2022 |
Sewell KR, Rainey-Smith SR, Villemagne VL, Peiffer J, Sohrabi HR, Taddei K, Ames D, Doré V, Maruff P, Laws SM, Masters CL, Rowe CC, Martins RN, Erickson KI, Brown BM. The interaction between physical activity and sleep on cognitive function and brain beta-amyloid in older adults. Behavioural Brain Research. 437: 114108. PMID 36100010 DOI: 10.1016/j.bbr.2022.114108 |
0.465 |
|
| 2022 |
Pedrini S, Doecke JD, Hone E, Wang P, Thota R, Bush AI, Rowe CC, Dore V, Villemagne VL, Ames D, Rainey-Smith S, Verdile G, Sohrabi HR, Raida MR, Taddei K, ... ... Martins RN, et al. Plasma high-density lipoprotein cargo is altered in Alzheimer's disease and is associated with regional brain volume. Journal of Neurochemistry. PMID 36000528 DOI: 10.1111/jnc.15681 |
0.711 |
|
| 2022 |
Cespedes M, Jacobs KR, Maruff P, Rembach A, Fowler CJ, Trounson B, Pertile KK, Rumble RL, Rainey-Smithe SR, Rowe CC, Villemagne VL, Bourgeat P, Lim CK, Chatterjee P, Martins RN, et al. Systemic perturbations of the kynurenine pathway precede progression to dementia independently of amyloid-β. Neurobiology of Disease. 171: 105783. PMID 35675895 DOI: 10.1016/j.nbd.2022.105783 |
0.51 |
|
| 2022 |
Cadby G, Giles C, Melton PE, Huynh K, Mellett NA, Duong T, Nguyen A, Cinel M, Smith A, Olshansky G, Wang T, Brozynska M, Inouye M, McCarthy NS, Ariff A, ... ... Martins RN, et al. Comprehensive genetic analysis of the human lipidome identifies loci associated with lipid homeostasis with links to coronary artery disease. Nature Communications. 13: 3124. PMID 35668104 DOI: 10.1038/s41467-022-30875-7 |
0.463 |
|
| 2022 |
Dhiman K, Villemagne VL, Fowler C, Bourgeat P, Li QX, Collins S, Bush AI, Rowe CC, Masters CL, Ames D, Blennow K, Zetterberg H, Martins RN, Gupta V. Cerebrospinal Fluid Neurofilament Light Predicts Risk of Dementia Onset in Cognitively Healthy Individuals and Rate of Cognitive Decline in Mild Cognitive Impairment: A Prospective Longitudinal Study. Biomedicines. 10. PMID 35625782 DOI: 10.3390/biomedicines10051045 |
0.588 |
|
| 2022 |
Vöglein J, Franzmeier N, Morris JC, Dieterich M, McDade E, Simons M, Preische O, Hofmann A, Hassenstab J, Benzinger TL, Fagan A, Noble JM, Berman SB, Graff-Radford NR, Ghetti B, ... ... Martins R, et al. Patterns and implications of neurological examination findings in autosomal dominant Alzheimer disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 35609137 DOI: 10.1002/alz.12684 |
0.427 |
|
| 2022 |
Morris JC, Weiner M, Xiong C, Beckett L, Coble D, Saito N, Aisen PS, Allegri R, Benzinger TLS, Berman SB, Cairns NJ, Carrillo MC, Chui HC, Chhatwal JP, Cruchaga C, ... ... Martins R, et al. Autosomal dominant and sporadic late onset Alzheimer disease share a common in vivo pathophysiology. Brain : a Journal of Neurology. PMID 35580594 DOI: 10.1093/brain/awac181 |
0.53 |
|
| 2022 |
Pedrini S, Chatterjee P, Nakamura A, Tegg M, Hone E, Rainey-Smith SR, Rowe CC, Dore V, Villemagne VL, Ames D, Kaneko N, Gardener SL, Taddei K, Fernando B, Martins I, ... ... Martins RN, et al. The Association Between Alzheimer's Disease-Related Markers and Physical Activity in Cognitively Normal Older Adults. Frontiers in Aging Neuroscience. 14: 771214. PMID 35418852 DOI: 10.3389/fnagi.2022.771214 |
0.516 |
|
| 2022 |
Doré V, Doecke JD, Saad ZS, Triana-Baltzer G, Slemmon R, Krishnadas N, Bourgeat P, Huang K, Burnham S, Fowler C, Rainey-Smith SR, Bush AI, Ward L, Robertson J, Martins RN, et al. Plasma p217+tau versus NAV4694 amyloid and MK6240 tau PET across the Alzheimer's continuum. Alzheimer's & Dementia (Amsterdam, Netherlands). 14: e12307. PMID 35415202 DOI: 10.1002/dad2.12307 |
0.535 |
|
| 2022 |
Woodfield A, Porter T, Gilani I, Noordin S, Li QX, Collins S, Martins RN, Maruff P, Masters CL, Rowe CC, Villemagne VL, Dore V, Newsholme P, Laws SM, Verdile G. Insulin resistance, cognition and Alzheimer's disease biomarkers: Evidence that CSF Aβ42 moderates the association between insulin resistance and increased CSF tau levels. Neurobiology of Aging. 114: 38-48. PMID 35381406 DOI: 10.1016/j.neurobiolaging.2022.03.004 |
0.699 |
|
| 2022 |
Dharmaraj GL, Arigo FD, Young KA, Martins R, Mancera RL, Bharadwaj P. Novel Amylin Analogues Reduce Amyloid-β Cross-Seeding Aggregation and Neurotoxicity. Journal of Alzheimer's Disease : Jad. PMID 35275530 DOI: 10.3233/JAD-215339 |
0.33 |
|
| 2022 |
Jayatunga DPW, Hone E, Fernando WMADB, Garg ML, Verdile G, Martins RN. Mitoprotective Effects of a Synergistic Nutraceutical Combination: Basis for a Prevention Strategy Against Alzheimer's Disease. Frontiers in Aging Neuroscience. 13: 781468. PMID 35264941 DOI: 10.3389/fnagi.2021.781468 |
0.646 |
|
| 2022 |
Jayatunga DPW, Hone E, Fernando WMADB, Garg ML, Verdile G, Martins RN. A Synergistic Combination of DHA, Luteolin, and Urolithin A Against Alzheimer's Disease. Frontiers in Aging Neuroscience. 14: 780602. PMID 35250535 DOI: 10.3389/fnagi.2022.780602 |
0.633 |
|
| 2022 |
Rosenich E, Bransby L, Yassi N, Fripp J, Laws SM, Martins RN, Fowler C, Rainey-Smith SR, Rowe CC, Masters CL, Maruff P, Lim YY. Differential Effects of APOE and Modifiable Risk Factors on Hippocampal Volume Loss and Memory Decline in AB- and AB+ Older Adults. Neurology. PMID 35169009 DOI: 10.1212/WNL.0000000000200118 |
0.425 |
|
| 2022 |
Guévremont D, Tsui H, Knight R, Fowler CJ, Masters CL, Martins RN, Abraham WC, Tate WP, Cutfield NJ, Williams JM. Plasma microRNA vary in association with the progression of Alzheimer's disease. Alzheimer's & Dementia (Amsterdam, Netherlands). 14: e12251. PMID 35141392 DOI: 10.1002/dad2.12251 |
0.465 |
|
| 2022 |
Laffoon SB, Doecke JD, Roberts AM, Vance JA, Reeves BD, Pertile KK, Rumble RL, Fowler CJ, Trounson B, Ames D, Martins R, Bush AI, Masters CL, Grieco PA, Dratz EA, et al. Analysis of plasma proteins using 2D gels and novel fluorescent probes: in search of blood based biomarkers for Alzheimer's disease. Proteome Science. 20: 2. PMID 35081972 DOI: 10.1186/s12953-021-00185-9 |
0.554 |
|
| 2022 |
Wang T, Huynh K, Giles C, Mellett NA, Duong T, Nguyen A, Lim WLF, Smith AA, Olshansky G, Cadby G, Hung J, Hui J, Beilby J, Watts GF, Chatterjee P, ... ... Martins RN, et al. APOE ε2 resilience for Alzheimer's disease is mediated by plasma lipid species: Analysis of three independent cohort studies. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 35077012 DOI: 10.1002/alz.12538 |
0.569 |
|
| 2022 |
Chhatwal JP, Schultz SA, McDade E, Schultz AP, Liu L, Hanseeuw BJ, Joseph-Mathurin N, Feldman R, Fitzpatrick CD, Sparks KP, Levin J, Berman SB, Renton AE, Esposito BT, Fernandez MV, ... ... Martins R, et al. Variant-dependent heterogeneity in amyloid β burden in autosomal dominant Alzheimer's disease: cross-sectional and longitudinal analyses of an observational study. The Lancet. Neurology. 21: 140-152. PMID 35065037 DOI: 10.1016/S1474-4422(21)00375-6 |
0.495 |
|
| 2021 |
Li Y, Schindler SE, Bollinger JG, Ovod V, Mawuenyega KG, Weiner MW, Leslie SM, Masters CL, Fowler CJ, Trojanowski JQ, Korecka M, Martins RN, Janelidze S, Hansson O, Bateman RJ. Validation of Plasma Amyloid-β 42/40 for Detecting Alzheimer Disease Amyloid Plaques. Neurology. PMID 34906975 DOI: 10.1212/WNL.0000000000013211 |
0.496 |
|
| 2021 |
Gardener SL, Rainey-Smith SR, Villemagne VL, Fripp J, Doré V, Bourgeat P, Taddei K, Fowler C, Masters CL, Maruff P, Rowe CC, Ames D, Martins RN. Higher Coffee Consumption Is Associated With Slower Cognitive Decline and Less Cerebral Aβ-Amyloid Accumulation Over 126 Months: Data From the Australian Imaging, Biomarkers, and Lifestyle Study. Frontiers in Aging Neuroscience. 13: 744872. PMID 34867277 DOI: 10.3389/fnagi.2021.744872 |
0.519 |
|
| 2021 |
Buckles VD, Xiong C, Bateman RJ, Hassenstab J, Allegri R, Berman SB, Chhatwal JP, Danek A, Fagan AM, Ghetti B, Goate A, Graff-Radford N, Jucker M, Levin J, Marcus DS, ... ... Martins R, et al. Different rates of cognitive decline in autosomal dominant and late-onset Alzheimer disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 34854530 DOI: 10.1002/alz.12505 |
0.432 |
|
| 2021 |
Jayatunga DPW, Hone E, Khaira H, Lunelli T, Singh H, Guillemin GJ, Fernando B, Garg ML, Verdile G, Martins RN. Therapeutic Potential of Mitophagy-Inducing Microflora Metabolite, Urolithin A for Alzheimer's Disease. Nutrients. 13. PMID 34836000 DOI: 10.3390/nu13113744 |
0.64 |
|
| 2021 |
Rezaee N, Fernando WMADB, Hone E, Sohrabi HR, Johnson SK, Gunzburg S, Martins RN. Potential of Sorghum Polyphenols to Prevent and Treat Alzheimer's Disease: A Review Article. Frontiers in Aging Neuroscience. 13: 729949. PMID 34690742 DOI: 10.3389/fnagi.2021.729949 |
0.359 |
|
| 2021 |
Tarawneh HY, Mulders WHAM, Sohrabi HR, Martins RN, Jayakody DMP. Investigating Auditory Electrophysiological Measures of Participants with Mild Cognitive Impairment and Alzheimer's Disease: A Systematic Review and Meta-Analysis of Event-Related Potential Studies. Journal of Alzheimer's Disease : Jad. 84: 419-448. PMID 34569950 DOI: 10.3233/JAD-210556 |
0.356 |
|
| 2021 |
Chatterjee P, Pedrini S, Ashton NJ, Tegg M, Goozee K, Singh AK, Karikari TK, Simrén J, Vanmechelen E, Armstrong NJ, Hone E, Asih PR, Taddei K, Doré V, Villemagne VL, ... ... Martins RN, et al. Diagnostic and prognostic plasma biomarkers for preclinical Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 34494715 DOI: 10.1002/alz.12447 |
0.468 |
|
| 2021 |
Fowler C, Rainey-Smith SR, Bird S, Bomke J, Bourgeat P, Brown BM, Burnham SC, Bush AI, Chadunow C, Collins S, Doecke J, Doré V, Ellis KA, Evered L, Fazlollahi A, ... ... Martins RN, et al. Fifteen Years of the Australian Imaging, Biomarkers and Lifestyle (AIBL) Study: Progress and Observations from 2,359 Older Adults Spanning the Spectrum from Cognitive Normality to Alzheimer's Disease. Journal of Alzheimer's Disease Reports. 5: 443-468. PMID 34368630 DOI: 10.3233/ADR-210005 |
0.638 |
|
| 2021 |
Fagan AM, Henson RL, Li Y, Boerwinkle AH, Xiong C, Bateman RJ, Goate A, Ances BM, Doran E, Christian BT, Lai F, Rosas HD, Schupf N, Krinsky-McHale S, Silverman W, ... ... Martins RN, et al. Comparison of CSF biomarkers in Down syndrome and autosomal dominant Alzheimer's disease: a cross-sectional study. The Lancet. Neurology. 20: 615-626. PMID 34302786 DOI: 10.1016/S1474-4422(21)00139-3 |
0.462 |
|
| 2021 |
Keret O, Staffaroni AM, Ringman JM, Cobigo Y, Goh SM, Wolf A, Allen IE, Salloway S, Chhatwal J, Brickman AM, Reyes-Dumeyer D, Bateman RJ, Benzinger TLS, Morris JC, Ances BM, ... ... Martins RN, et al. Pattern and degree of individual brain atrophy predicts dementia onset in dominantly inherited Alzheimer's disease. Alzheimer's & Dementia (Amsterdam, Netherlands). 13: e12197. PMID 34258377 DOI: 10.1002/dad2.12197 |
0.451 |
|
| 2021 |
Gardener SL, Weinborn M, Sohrabi HR, Doecke JD, Bourgeat P, Rainey-Smith SR, Shen KK, Fripp J, Taddei K, Maruff P, Salvado O, Savage G, Ames D, Masters CL, Rowe CC, ... Martins RN, et al. Longitudinal Trajectories in Cortical Thickness and Volume Atrophy: Superior Cognitive Performance Does Not Protect Against Brain Atrophy in Older Adults. Journal of Alzheimer's Disease : Jad. 81: 1039-1052. PMID 33935071 DOI: 10.3233/JAD-201243 |
0.38 |
|
| 2021 |
Doecke JD, Francois C, Fowler CJ, Stoops E, Bourgeat P, Rainey-Smith SR, Li QX, Masters CL, Martins RN, Villemagne VL, Collins SJ, Vanderstichele HM. Core Alzheimer's disease cerebrospinal fluid biomarker assays are not affected by aspiration or gravity drip extraction methods. Alzheimer's Research & Therapy. 13: 79. PMID 33863377 DOI: 10.1186/s13195-021-00812-9 |
0.363 |
|
| 2021 |
Chatterjee P, Tegg M, Pedrini S, Fagan AM, Xiong C, Singh AK, Taddei K, Gardener S, Masters CL, Schofield PR, Multhaup G, Benzinger TLS, Morris JC, Bateman RJ, Greenberg SM, ... ... Martins RN, et al. Plasma Amyloid-Beta Levels in a Pre-Symptomatic Dutch-Type Hereditary Cerebral Amyloid Angiopathy Pedigree: A Cross-Sectional and Longitudinal Investigation. International Journal of Molecular Sciences. 22. PMID 33805778 DOI: 10.3390/ijms22062931 |
0.768 |
|
| 2021 |
Fernandez S, Burnham SC, Milicic L, Savage G, Maruff P, Peretti M, Sohrabi HR, Lim YY, Weinborn M, Ames D, Masters CL, Martins RN, Rainey-Smith S, Rowe CC, Salvado O, et al. Is Associated with Amyloid-β and ε4-Related Cognitive Decline in Cognitively Normal Adults. Journal of Alzheimer's Disease Reports. 5: 111-120. PMID 33782664 DOI: 10.3233/ADR-200246 |
0.647 |
|
| 2021 |
Ewers M, Luan Y, Frontzkowski L, Neitzel J, Rubinski A, Dichgans M, Hassenstab J, Gordon BA, Chhatwal JP, Levin J, Schofield P, Benzinger TLS, Morris JC, Goate A, Karch CM, ... ... Martins RN, et al. Segregation of functional networks is associated with cognitive resilience in Alzheimer's disease. Brain : a Journal of Neurology. PMID 33725114 DOI: 10.1093/brain/awab112 |
0.361 |
|
| 2021 |
Moussavi Nik SH, Porter T, Newman M, Bartlett B, Khan I, Sabale M, Eccles M, Woodfield A, Groth D, Dore V, Villemagne VL, Masters CL, Martins RN, Laws SM, Lardelli M, et al. Relevance of a Truncated PRESENILIN 2 Transcript to Alzheimer's Disease and Neurodegeneration. Journal of Alzheimer's Disease : Jad. PMID 33720885 DOI: 10.3233/JAD-201133 |
0.734 |
|
| 2021 |
Tan S, Porter T, Bucks RS, Weinborn M, Milicic L, Brown A, Rainey-Smith SR, Taddei K, Ames D, Masters CL, Maruff P, Savage G, Rowe CC, Villemagne VL, Brown B, ... ... Martins RN, et al. Androgen receptor CAG repeat length as a moderator of the relationship between free testosterone levels and cognition. Hormones and Behavior. 131: 104966. PMID 33714752 DOI: 10.1016/j.yhbeh.2021.104966 |
0.395 |
|
| 2021 |
Chatterjee P, Pedrini S, Stoops E, Goozee K, Villemagne VL, Asih PR, Verberk IMW, Dave P, Taddei K, Sohrabi HR, Zetterberg H, Blennow K, Teunissen CE, Vanderstichele HM, Martins RN. Plasma glial fibrillary acidic protein is elevated in cognitively normal older adults at risk of Alzheimer's disease. Translational Psychiatry. 11: 27. PMID 33431793 DOI: 10.1038/s41398-020-01137-1 |
0.381 |
|
| 2020 |
Chatterjee P, Fagan AM, Xiong C, McKay M, Bhatnagar A, Wu Y, Singh AK, Taddei K, Martins I, Gardener SL, Molloy MP, Multhaup G, Masters CL, Schofield PR, Benzinger TLS, ... ... Martins RN, et al. Presymptomatic Dutch-Type Hereditary Cerebral Amyloid Angiopathy-Related Blood Metabolite Alterations. Journal of Alzheimer's Disease : Jad. PMID 33361604 DOI: 10.3233/JAD-201267 |
0.756 |
|
| 2020 |
Jayatunga DPW, Hone E, Bharadwaj P, Garg M, Verdile G, Guillemin GJ, Martins RN. Targeting Mitophagy in Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 33285629 DOI: 10.3233/JAD-191258 |
0.607 |
|
| 2020 |
van der Kall LM, Truong T, Burnham SC, Doré V, Mulligan RS, Bozinovski S, Lamb F, Bourgeat P, Fripp J, Schultz S, Lim YY, Laws SM, Ames D, Fowler C, Rainey-Smith SR, ... Martins RN, et al. Association of β-amyloid level, clinical progression and longitudinal cognitive change in normal older individuals. Neurology. PMID 33184233 DOI: 10.1212/WNL.0000000000011222 |
0.451 |
|
| 2020 |
Huynh K, Lim WLF, Giles C, Jayawardana KS, Salim A, Mellett NA, Smith AAT, Olshansky G, Drew BG, Chatterjee P, Martins I, Laws SM, Bush AI, Rowe CC, Villemagne VL, ... ... Martins RN, et al. Concordant peripheral lipidome signatures in two large clinical studies of Alzheimer's disease. Nature Communications. 11: 5698. PMID 33173055 DOI: 10.1038/s41467-020-19473-7 |
0.557 |
|
| 2020 |
Xia Y, Yassi N, Raniga P, Bourgeat P, Desmond P, Doecke J, Ames D, Laws SM, Fowler C, Rainey-Smith SR, Martins R, Maruff P, Villemagne VL, Masters CL, Rowe CC, et al. Comorbidity of Cerebrovascular and Alzheimer's Disease in Aging. Journal of Alzheimer's Disease : Jad. PMID 32986666 DOI: 10.3233/JAD-200419 |
0.502 |
|
| 2020 |
Krishnan S, Shrestha Y, Jayatunga DPW, Rea S, Martins R, Bharadwaj P. Activate or Inhibit? Implications of Autophagy Modulation as a Therapeutic Strategy for Alzheimer's Disease. International Journal of Molecular Sciences. 21. PMID 32937909 DOI: 10.3390/Ijms21186739 |
0.429 |
|
| 2020 |
Siddiqui MS, Francois M, Rainey-Smith S, Martins R, Masters CL, Ames D, Rowe CC, Macaulay LS, Fenech MF, Leifert WR. Evaluation of GammaH2AX in Buccal Cells as a Molecular Biomarker of DNA Damage in Alzheimer's Disease in the AIBL Study of Ageing. Life (Basel, Switzerland). 10. PMID 32781776 DOI: 10.3390/Life10080141 |
0.538 |
|
| 2020 |
Bradfield NI, Ellis KA, Savage G, Maruff P, Burnham S, Darby D, Lautenschlager NT, Martins RN, Masters CL, Rainey-Smith SR, Robertson J, Rowe C, Woodward M, Ames D. Aggregation of Abnormal Memory Scores and Risk of Incident Alzheimer's Disease Dementia: A Measure of Objective Memory Impairment in Amnestic Mild Cognitive Impairment. Journal of the International Neuropsychological Society : Jins. 1-12. PMID 32772959 DOI: 10.1017/S135561772000079X |
0.449 |
|
| 2020 |
Burnham SC, Laws SM, Budgeon CA, Doré V, Porter T, Bourgeat P, Buckley RF, Murray K, Ellis KA, Turlach BA, Salvado O, Ames D, Martins RN, Rentz D, Masters CL, et al. Impact of APOE-ε4 carriage on the onset and rates of neocortical Aβ-amyloid deposition. Neurobiology of Aging. 95: 46-55. PMID 32750666 DOI: 10.1016/J.Neurobiolaging.2020.06.001 |
0.481 |
|
| 2020 |
Pedrini S, Hone E, Gupta VB, James I, Teimouri E, Bush AI, Rowe CC, Villemagne VL, Ames D, Masters CL, Rainey-Smith S, Verdile G, Sohrabi HR, Raida MR, Wenk MR, ... ... Martins RN, et al. Plasma High Density Lipoprotein Small Subclass is Reduced in Alzheimer's Disease Patients and Correlates with Cognitive Performance. Journal of Alzheimer's Disease : Jad. PMID 32741823 DOI: 10.3233/Jad-200291 |
0.71 |
|
| 2020 |
Kivipelto M, Mangialasche F, Snyder HM, Allegri R, Andrieu S, Arai H, Baker L, Belleville S, Brodaty H, Brucki SM, Calandri I, Caramelli P, Chen C, Chertkow H, Chew E, ... ... Martins R, et al. World-Wide FINGERS Network: A global approach to risk reduction and prevention of dementia. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 32627328 DOI: 10.1002/Alz.12123 |
0.353 |
|
| 2020 |
Bharadwaj P, Solomon T, Sahoo BR, Ignasiak K, Gaskin S, Rowles J, Verdile G, Howard MJ, Bond CS, Ramamoorthy A, Martins RN, Newsholme P. Amylin and beta amyloid proteins interact to form amorphous heterocomplexes with enhanced toxicity in neuronal cells. Scientific Reports. 10: 10356. PMID 32587390 DOI: 10.1038/S41598-020-66602-9 |
0.631 |
|
| 2020 |
Ashraf A, Ashton NJ, Chatterjee P, Goozee K, Shen K, Fripp J, Ames D, Rowe C, Masters CL, Villemagne V, Hye A, Martins RN, So PW. Plasma transferrin and hemopexin are associated with altered Aβ uptake and cognitive decline in Alzheimer's disease pathology. Alzheimer's Research & Therapy. 12: 72. PMID 32517787 DOI: 10.1186/S13195-020-00634-1 |
0.514 |
|
| 2020 |
Lim WLF, Huynh K, Chatterjee P, Martins I, Jayawardana KS, Giles C, Mellett NA, Laws SM, Bush AI, Rowe CC, Villemagne VL, Ames D, Drew BG, Masters CL, Meikle PJ, ... Martins RN, et al. Relationships Between Plasma Lipids Species, Gender, Risk Factors, and Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 32474467 DOI: 10.3233/Jad-191304 |
0.583 |
|
| 2020 |
Lim B, Li QX, Rowe C, Dhiman K, Gupta VB, Masters CL, Doecke JD, Martins RN, Collins S, Diamandis EP. Decreased cerebrospinal fluid neuronal pentraxin receptor is associated with PET-Aβ load and cerebrospinal fluid Aβ in a pilot study of Alzheimer's disease. Neuroscience Letters. 135078. PMID 32450185 DOI: 10.1016/J.Neulet.2020.135078 |
0.498 |
|
| 2020 |
Bharadwaj P, Martins R. A rapid absorbance-based growth assay to screen the toxicity of oligomer Aβ and protect against cell death in yeast. Neural Regeneration Research. 15: 1931-1936. PMID 32246642 DOI: 10.4103/1673-5374.280318 |
0.382 |
|
| 2020 |
Doecke JD, Ward L, Burnham SC, Villemagne VL, Li QX, Collins S, Fowler CJ, Manuilova E, Widmann M, Rainey-Smith SR, Martins RN, Masters CL. Elecsys CSF biomarker immunoassays demonstrate concordance with amyloid-PET imaging. Alzheimer's Research & Therapy. 12: 36. PMID 32234072 DOI: 10.1186/s13195-020-00595-5 |
0.458 |
|
| 2020 |
Dhiman K, Gupta VB, Villemagne VL, Eratne D, Graham PL, Fowler C, Bourgeat P, Li QX, Collins S, Bush AI, Rowe CC, Masters CL, Ames D, Hone E, Blennow K, ... ... Martins RN, et al. Cerebrospinal fluid neurofilament light concentration predicts brain atrophy and cognition in Alzheimer's disease. Alzheimer's & Dementia (Amsterdam, Netherlands). 12: e12005. PMID 32211500 DOI: 10.1002/Dad2.12005 |
0.621 |
|
| 2020 |
Barthélemy NR, Li Y, Joseph-Mathurin N, Gordon BA, Hassenstab J, Benzinger TLS, Buckles V, Fagan AM, Perrin RJ, Goate AM, Morris JC, Karch CM, Xiong C, Allegri R, Mendez PC, ... ... Martins RN, et al. A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer's disease. Nature Medicine. 26: 398-407. PMID 32161412 DOI: 10.1038/S41591-020-0781-Z |
0.456 |
|
| 2020 |
Arnold M, Nho K, Kueider-Paisley A, Massaro T, Huynh K, Brauner B, MahmoudianDehkordi S, Louie G, Moseley MA, Thompson JW, John-Williams LS, Tenenbaum JD, Blach C, Chang R, Brinton RD, ... ... Martins R, et al. Sex and APOE ε4 genotype modify the Alzheimer's disease serum metabolome. Nature Communications. 11: 1148. PMID 32123170 DOI: 10.1038/S41467-020-14959-W |
0.412 |
|
| 2020 |
Lai MMY, Ames DJ, Cox KL, Ellis KA, Sharman MJR, Hepworth G, Desmond P, Cyarto EV, Szoeke C, Martins R, Masters CL, Lautenschlager NT. Association between Cognitive Function and Clustered Cardiovascular Risk of Metabolic Syndrome in Older Adults at Risk of Cognitive Decline. The Journal of Nutrition, Health & Aging. 24: 300-304. PMID 32115611 DOI: 10.1007/S12603-020-1333-4 |
0.318 |
|
| 2020 |
Teimouri E, Rainey-Smith SR, Bharadwaj P, Verdile G, Martins RN. Amla Therapy as a Potential Modulator of Alzheimer's Disease Risk Factors and Physiological Change. Journal of Alzheimer's Disease : Jad. PMID 32083581 DOI: 10.3233/Jad-191033 |
0.633 |
|
| 2020 |
Bharadwaj P, Martins RN. PRKAG2 Gene Expression Is Elevated and its Protein Levels Are Associated with Increased Amyloid-β Accumulation in the Alzheimer's Disease Brain. Journal of Alzheimer's Disease : Jad. PMID 32039845 DOI: 10.3233/JAD-190948 |
0.335 |
|
| 2020 |
Brini S, Sohrabi HR, Hebert JJ, Forrest MRL, Laine M, Hämäläinen H, Karrasch M, Peiffer JJ, Martins RN, Fairchild TJ. Bilingualism Is Associated with a Delayed Onset of Dementia but Not with a Lower Risk of Developing it: a Systematic Review with Meta-Analyses. Neuropsychology Review. PMID 32036490 DOI: 10.1007/S11065-020-09426-8 |
0.31 |
|
| 2020 |
Lai MMY, Sharman MJ, Ames DJ, Ellis KA, Cox KL, Hepworth G, Desmond P, Cyarto EV, Martins RN, Masters CL, Lautenschlager NT. Relationship of Established Cardiovascular Risk Factors and Peripheral Biomarkers on Cognitive Function in Adults at Risk of Cognitive Deterioration. Journal of Alzheimer's Disease : Jad. PMID 32007955 DOI: 10.3233/JAD-190953 |
0.37 |
|
| 2020 |
Fernando WMADB, Martins IJ, Morici M, Bharadwaj P, Rainey-Smith SR, Lim WLF, Martins RN. Sodium Butyrate Reduces Brain Amyloid-β Levels and Improves Cognitive Memory Performance in an Alzheimer's Disease Transgenic Mouse Model at an Early Disease Stage. Journal of Alzheimer's Disease : Jad. PMID 31958090 DOI: 10.3233/JAD-190120 |
0.39 |
|
| 2020 |
Chatterjee P, Fernando M, Fenando B, Dias CB, Shah T, Silva R, Williams S, Pedrini S, Hillebrandt H, Goozee K, Barin E, Sohrabi HR, Garg M, Cunnane S, Martins RN. Potential of coconut oil and medium chain triglycerides in the prevention and treatment of Alzheimer's disease. Mechanisms of Ageing and Development. 111209. PMID 31953123 DOI: 10.1016/j.mad.2020.111209 |
0.32 |
|
| 2020 |
Aschenbrenner AJ, James BD, McDade E, Wang G, Lim YY, Benzinger TLS, Cruchaga C, Goate A, Xiong C, Perrin R, Buckles V, Allegri R, Berman SB, Chhatwal JP, Fagan A, ... ... Martins RN, et al. Awareness of genetic risk in the Dominantly Inherited Alzheimer Network (DIAN). Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 16: 219-228. PMID 31914221 DOI: 10.1002/Alz.12010 |
0.376 |
|
| 2019 |
Yassi N, Hilal S, Xia Y, Lim YY, Watson R, Kuijf H, Fowler C, Yates P, Maruff P, Martins R, Ames D, Chen C, Rowe C, Villemagne V, Salvado O, et al. Influence of Comorbidity of Cerebrovascular Disease and Amyloid-β on Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 31884485 DOI: 10.3233/Jad-191028 |
0.536 |
|
| 2019 |
Hata S, Omori C, Kimura A, Saito H, Kimura N, Gupta V, Pedrini S, Hone E, Chatterjee P, Taddei K, Kasuga K, Ikeuchi T, Waragai M, Nishimura M, Hu A, ... ... Martins RN, et al. Decrease in p3-Alcβ37 and p3-Alcβ40, products of Alcadein β generated by γ-secretase cleavages, in aged monkeys and patients with Alzheimer's disease. Alzheimer's & Dementia (New York, N. Y.). 5: 740-750. PMID 31754625 DOI: 10.1016/J.Trci.2019.09.015 |
0.438 |
|
| 2019 |
Vacher M, Porter T, Villemagne VL, Milicic L, Peretti M, Fowler C, Martins R, Rainey-Smith S, Ames D, Masters CL, Rowe CC, Doecke JD, Laws SM. Validation of a priori candidate Alzheimer's disease SNPs with brain amyloid-beta deposition. Scientific Reports. 9: 17069. PMID 31745181 DOI: 10.1038/S41598-019-53604-5 |
0.577 |
|
| 2019 |
Burnham SC, Coloma PM, Li QX, Collins S, Savage G, Laws S, Doecke J, Maruff P, Martins RN, Ames D, Rowe CC, Masters CL, Villemagne VL. Application of the NIA-AA Research Framework: Towards a Biological Definition of Alzheimer's Disease Using Cerebrospinal Fluid Biomarkers in the AIBL Study. The Journal of Prevention of Alzheimer's Disease. 6: 248-255. PMID 31686097 DOI: 10.14283/jpad.2019.25 |
0.483 |
|
| 2019 |
Chatterjee P, Zetterberg H, Goozee K, Lim CK, Jacobs KR, Ashton NJ, Hye A, Pedrini S, Sohrabi HR, Shah T, Asih PR, Dave P, Shen K, Taddei K, Lovejoy DB, ... ... Martins RN, et al. Plasma neurofilament light chain and amyloid-β are associated with the kynurenine pathway metabolites in preclinical Alzheimer's disease. Journal of Neuroinflammation. 16: 186. PMID 31601232 DOI: 10.1186/s12974-019-1567-4 |
0.36 |
|
| 2019 |
Mputhia Z, Hone E, Tripathi T, Sargeant T, Martins R, Bharadwaj P. Autophagy Modulation as a Treatment of Amyloid Diseases. Molecules (Basel, Switzerland). 24. PMID 31527516 DOI: 10.3390/Molecules24183372 |
0.425 |
|
| 2019 |
Chatterjee P, Elmi M, Goozee K, Shah T, Sohrabi HR, Dias CB, Pedrini S, Shen K, Asih PR, Dave P, Taddei K, Vanderstichele H, Zetterberg H, Blennow K, Martins RN. Ultrasensitive Detection of Plasma Amyloid-β as a Biomarker for Cognitively Normal Elderly Individuals at Risk of Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 31424403 DOI: 10.3233/JAD-190533 |
0.388 |
|
| 2019 |
Schultz A, Kloet RW, Sohrabi HR, van der Weerd L, van Rooden S, Wermer MJH, Grand Moursel L, Yaqub M, van Berckel BNM, Chatterjee P, Gardener SL, Taddei K, Fagan AM, Benzinger TL, Morris JC, ... ... Martins R, et al. Amyloid Imaging of Dutch-type Hereditary Cerebral Amyloid Angiopathy Carriers. Annals of Neurology. PMID 31361916 DOI: 10.1002/Ana.25560 |
0.366 |
|
| 2019 |
Tripathi T, Kalita P, Martins R, Bharadwaj P. Autophagy Promotes Memory Formation. Acs Chemical Neuroscience. PMID 31244056 DOI: 10.1021/Acschemneuro.9B00317 |
0.354 |
|
| 2019 |
Porter T, Burnham SC, Milicic L, Savage G, Maruff P, Sohrabi HR, Peretti M, Lim YY, Weinborn M, Ames D, Masters CL, Martins RN, Rainey-Smith S, Rowe CC, Salvado O, et al. val158met is not associated with Aβ-amyloid and ε4 related cognitive decline in cognitively normal older adults. Ibro Reports. 6: 147-152. PMID 31080907 DOI: 10.1016/J.Ibror.2019.05.001 |
0.683 |
|
| 2019 |
Jacobs KR, Lim CK, Blennow K, Zetterberg H, Chatterjee P, Martins RN, Brew BJ, Guillemin GJ, Lovejoy DB. Correlation between plasma and CSF concentrations of kynurenine pathway metabolites in Alzheimer's disease and relationship to amyloid-β and tau. Neurobiology of Aging. 80: 11-20. PMID 31055163 DOI: 10.1016/j.neurobiolaging.2019.03.015 |
0.324 |
|
| 2019 |
Ashton NJ, Nevado-Holgado AJ, Barber IS, Lynham S, Gupta V, Chatterjee P, Goozee K, Hone E, Pedrini S, Blennow K, Schöll M, Zetterberg H, Ellis KA, Bush AI, Rowe CC, ... ... Martins R, et al. A plasma protein classifier for predicting amyloid burden for preclinical Alzheimer's disease. Science Advances. 5: eaau7220. PMID 30775436 DOI: 10.1126/Sciadv.Aau7220 |
0.605 |
|
| 2019 |
Dhiman K, Blennow K, Zetterberg H, Martins RN, Gupta VB. Cerebrospinal fluid biomarkers for understanding multiple aspects of Alzheimer's disease pathogenesis. Cellular and Molecular Life Sciences : Cmls. PMID 30770953 DOI: 10.1007/s00018-019-03040-5 |
0.351 |
|
| 2019 |
Porter T, Burnham SC, Milicic L, Savage G, Maruff P, Lim YY, Ames D, Masters CL, Martins RN, Rainey-Smith S, Rowe CC, Salvado O, Groth D, Verdile G, Villemagne VL, et al. Klotho allele status is not associated with Aβ and APOE ε4-related cognitive decline in preclinical Alzheimer's disease. Neurobiology of Aging. 76: 162-165. PMID 30716541 DOI: 10.1016/J.Neurobiolaging.2018.12.014 |
0.712 |
|
| 2019 |
Preische O, Schultz SA, Apel A, Kuhle J, Kaeser SA, Barro C, Gräber S, Kuder-Buletta E, LaFougere C, Laske C, Vöglein J, Levin J, Masters CL, Martins R, Schofield PR, et al. Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer's disease. Nature Medicine. PMID 30664784 DOI: 10.1038/S41591-018-0304-3 |
0.525 |
|
| 2019 |
Jayatunga DP, Gupta VB, Hone E, Verdile G, Garg ML, Martins RN. P1-098: OPTIMAL CONCENTRATIONS OF LUTEOLIN AND DHA TO EXHIBIT SYNERGISTIC EFFECTS AGAINST Aβ1-42
-INDUCED NEUROTOXICITY Alzheimer's & Dementia. 15: P271-P272. DOI: 10.1016/J.Jalz.2019.06.653 |
0.548 |
|
| 2019 |
Martins RN, Chatterjee P, Masters CL, Zetterberg H, Blennow K, Nakamura A, Yanagisawa K. PATIENT-RELATED PRE-ANALYTICAL FACTORS INFLUENCING PLASMA AMYLOID BETA CONCENTRATIONS Alzheimer's & Dementia. 15: P185. DOI: 10.1016/J.Jalz.2019.06.4386 |
0.341 |
|
| 2018 |
Porter T, Burnham SC, Savage G, Lim YY, Maruff P, Milicic L, Peretti M, Ames D, Masters CL, Martins RN, Rainey-Smith S, Rowe CC, Salvado O, Taddei K, Groth D, et al. A Polygenic Risk Score Derived From Episodic Memory Weighted Genetic Variants Is Associated With Cognitive Decline in Preclinical Alzheimer's Disease. Frontiers in Aging Neuroscience. 10: 423. PMID 30620773 DOI: 10.3389/Fnagi.2018.00423 |
0.672 |
|
| 2018 |
Rainey-Smith SR, Gu Y, Gardener SL, Doecke JD, Villemagne VL, Brown BM, Taddei K, Laws SM, Sohrabi HR, Weinborn M, Ames D, Fowler C, Macaulay SL, Maruff P, Masters CL, ... ... Martins RN, et al. Mediterranean diet adherence and rate of cerebral Aβ-amyloid accumulation: Data from the Australian Imaging, Biomarkers and Lifestyle Study of Ageing. Translational Psychiatry. 8: 238. PMID 30375373 DOI: 10.1038/S41398-018-0293-5 |
0.519 |
|
| 2018 |
Müller S, Preische O, Sohrabi HR, Gräber S, Jucker M, Ringman JM, Martins RN, McDade E, Schofield PR, Ghetti B, Rossor M, Fox NN, Graff-Radford NR, Levin J, Danek A, et al. Relationship between physical activity, cognition, and Alzheimer pathology in autosomal dominant Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 30266303 DOI: 10.1016/J.Jalz.2018.06.3059 |
0.503 |
|
| 2018 |
Khan I, Krishnaswamy S, Sabale M, Groth D, Wijaya L, Morici M, Berger I, Schaffitzel C, Fraser PE, Martins RN, Verdile G. Efficient production of a mature and functional gamma secretase protease. Scientific Reports. 8: 12834. PMID 30150752 DOI: 10.1038/S41598-018-30788-W |
0.589 |
|
| 2018 |
Chatterjee P, Goozee K, Lim CK, James I, Shen K, Jacobs KR, Sohrabi HR, Shah T, Asih PR, Dave P, ManYan C, Taddei K, Lovejoy DB, Chung R, Guillemin GJ, ... Martins RN, et al. Alterations in serum kynurenine pathway metabolites in individuals with high neocortical amyloid-β load: A pilot study. Scientific Reports. 8: 8008. PMID 29789640 DOI: 10.1038/s41598-018-25968-7 |
0.348 |
|
| 2018 |
Weinborn M, Bucks RS, Sohrabi HR, Rainey-Smith SR, Brown BM, Gardener SL, Gozt A, Christensen D, Savage G, Laws SM, Taddei K, Maruff P, Robertson JS, Ellis KA, Ames D, ... ... Martins RN, et al. Trajectories of irregular word reading ability as a proxy for premorbid intelligence in Alzheimer's disease, mild cognitive impairment, and healthy aging: A longitudinal study. Psychological Assessment. PMID 29781669 DOI: 10.1037/pas0000565 |
0.483 |
|
| 2018 |
Brown BM, Rainey-Smith SR, Dore V, Peiffer JJ, Burnham SC, Laws SM, Taddei K, Ames D, Masters CL, Rowe CC, Martins RN, Villemagne VL. Self-Reported Physical Activity is Associated with Tau Burden Measured by Positron Emission Tomography. Journal of Alzheimer's Disease : Jad. PMID 29758940 DOI: 10.3233/JAD-170998 |
0.419 |
|
| 2018 |
Lee S, Zimmerman ME, Narkhede A, Nasrabady SE, Tosto G, Meier IB, Benzinger TLS, Marcus DS, Fagan AM, Fox NC, Cairns NJ, Holtzman DM, Buckles V, Ghetti B, McDade E, ... Martins RN, et al. White matter hyperintensities and the mediating role of cerebral amyloid angiopathy in dominantly-inherited Alzheimer's disease. Plos One. 13: e0195838. PMID 29742105 DOI: 10.1371/Journal.Pone.0195838 |
0.482 |
|
| 2018 |
Martins RN, Villemagne V, Sohrabi HR, Chatterjee P, Shah TM, Verdile G, Fraser P, Taddei K, Gupta VB, Rainey-Smith SR, Hone E, Pedrini S, Lim WL, Martins I, Frost S, et al. Alzheimer's Disease: A Journey from Amyloid Peptides and Oxidative Stress, to Biomarker Technologies and Disease Prevention Strategies-Gains from AIBL and DIAN Cohort Studies. Journal of Alzheimer's Disease : Jad. 62: 965-992. PMID 29562546 DOI: 10.3233/Jad-171145 |
0.74 |
|
| 2018 |
Bradfield NI, Ellis KA, Savage G, Maruff P, Burnham S, Darby D, Lautenschlager NT, Martins RN, Masters CL, Rainey-Smith SR, Robertson J, Rowe C, Woodward M, Ames D. Baseline Amnestic Severity Predicts Progression From Amnestic Mild Cognitive Impairment to Alzheimer Disease Dementia at 3 Years. Alzheimer Disease and Associated Disorders. PMID 29561277 DOI: 10.1097/WAD.0000000000000252 |
0.502 |
|
| 2018 |
Chhatwal JP, Schultz AP, Johnson KA, Hedden T, Jaimes S, Benzinger TLS, Jack C, Ances BM, Ringman JM, Marcus DS, Ghetti B, Farlow MR, Danek A, Levin J, Yakushev I, ... ... Martins RN, et al. Preferential degradation of cognitive networks differentiates Alzheimer's disease from ageing. Brain : a Journal of Neurology. PMID 29522171 DOI: 10.1093/Brain/Awy053 |
0.46 |
|
| 2018 |
Rainey-Smith SR, Mazzucchelli GN, Villemagne VL, Brown BM, Porter T, Weinborn M, Bucks RS, Milicic L, Sohrabi HR, Taddei K, Ames D, Maruff P, Masters CL, Rowe CC, Salvado O, ... Martins RN, et al. Genetic variation in Aquaporin-4 moderates the relationship between sleep and brain Aβ-amyloid burden. Translational Psychiatry. 8: 47. PMID 29479071 DOI: 10.1038/s41398-018-0094-x |
0.373 |
|
| 2018 |
Nakamura A, Kaneko N, Villemagne VL, Kato T, Doecke J, Doré V, Fowler C, Li QX, Martins R, Rowe C, Tomita T, Matsuzaki K, Ishii K, Ishii K, Arahata Y, et al. High performance plasma amyloid-β biomarkers for Alzheimer's disease. Nature. 554: 249-254. PMID 29420472 DOI: 10.1038/Nature25456 |
0.463 |
|
| 2018 |
Porter T, Burnham SC, Doré V, Savage G, Bourgeat P, Begemann K, Milicic L, Ames D, Bush AI, Maruff P, Masters CL, Rowe CC, Rainey-Smith S, Martins RN, Groth D, et al. KIBRA is associated with accelerated cognitive decline and hippocampal atrophy in APOE ε4-positive cognitively normal adults with high Aβ-amyloid burden. Scientific Reports. 8: 2034. PMID 29391469 DOI: 10.1038/S41598-018-20513-Y |
0.728 |
|
| 2018 |
Fernando WMADB, Rainey-Smith SR, Gardener SL, Villemagne VL, Burnham SC, Macaulay SL, Brown BM, Gupta VB, Sohrabi HR, Weinborn M, Taddei K, Laws SM, Goozee K, Ames D, Fowler C, ... ... Martins RN, et al. Associations of Dietary Protein and Fiber Intake with Brain and Blood Amyloid-β. Journal of Alzheimer's Disease : Jad. 61: 1589-1598. PMID 29376865 DOI: 10.3233/JAD-170742 |
0.453 |
|
| 2018 |
Lim YY, Kalinowski P, Pietrzak RH, Laws SM, Burnham SC, Ames D, Villemagne VL, Fowler CJ, Rainey-Smith SR, Martins RN, Rowe CC, Masters CL, Maruff PT. Association of β-Amyloid and Apolipoprotein E ε4 With Memory Decline in Preclinical Alzheimer Disease. Jama Neurology. PMID 29356823 DOI: 10.1001/jamaneurol.2017.4325 |
0.486 |
|
| 2018 |
Perin S, Harrington KD, Lim YY, Ellis K, Ames D, Pietrzak RH, Schembri A, Rainey-Smith S, Salvado O, Laws SM, Martins RN, Villemagne VL, Rowe CC, Masters CL, Maruff P, et al. Amyloid burden and incident depressive symptoms in preclinical Alzheimer's disease. Journal of Affective Disorders. 229: 269-274. PMID 29329059 DOI: 10.1016/j.jad.2017.12.101 |
0.474 |
|
| 2017 |
Pietrzak RH, Laws SM, Lim YY, Bender SJ, Porter T, Doecke J, Ames D, Fowler C, Masters CL, Milicic L, Rainey-Smith S, Villemagne VL, Rowe CC, Martins RN, Maruff P, et al. Plasma Cortisol, Brain Amyloid-β, and Cognitive Decline in Preclinical Alzheimer's Disease: A 6-Year Prospective Cohort Study. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. 2: 45-52. PMID 29560886 DOI: 10.1016/j.bpsc.2016.08.006 |
0.528 |
|
| 2017 |
Doecke JD, Rembach A, Villemagne VL, Varghese S, Rainey-Smith S, Sarros S, Evered LA, Fowler CJ, Pertile KK, Rumble RL, Trounson B, Taddei K, Laws SM, Macaulay SL, Bush AI, ... ... Martins R, et al. Concordance Between Cerebrospinal Fluid Biomarkers with Alzheimer's Disease Pathology Between Three Independent Assay Platforms. Journal of Alzheimer's Disease : Jad. PMID 29171991 DOI: 10.3233/Jad-170128 |
0.643 |
|
| 2017 |
Pedrini S, Gupta VB, Hone E, Doecke J, O'Bryant S, James I, Bush AI, Rowe CC, Villemagne VL, Ames D, Masters CL, Martins RN. A blood-based biomarker panel indicates IL-10 and IL-12/23p40 are jointly associated as predictors of β-amyloid load in an AD cohort. Scientific Reports. 7: 14057. PMID 29070909 DOI: 10.1038/S41598-017-14020-9 |
0.621 |
|
| 2017 |
Mirzaei M, Gupta VB, Chick JM, Greco TM, Wu Y, Chitranshi N, Wall RV, Hone E, Deng L, Dheer Y, Abbasi M, Rezaeian M, Braidy N, You Y, Salekdeh GH, ... ... Martins R, et al. Age-related neurodegenerative disease associated pathways identified in retinal and vitreous proteome from human glaucoma eyes. Scientific Reports. 7: 12685. PMID 28978942 DOI: 10.1038/S41598-017-12858-7 |
0.347 |
|
| 2017 |
Brini S, Sohrabi HR, Peiffer JJ, Karrasch M, Hämäläinen H, Martins RN, Fairchild TJ. Physical Activity in Preventing Alzheimer's Disease and Cognitive Decline: A Narrative Review. Sports Medicine (Auckland, N.Z.). PMID 28940148 DOI: 10.1007/s40279-017-0787-y |
0.357 |
|
| 2017 |
Frost S, Robinson L, Rowe CC, Ames D, Masters CL, Taddei K, Rainey-Smith SR, Martins RN, Kanagasingam Y. Evaluation of Cholinergic Deficiency in Preclinical Alzheimer's Disease Using Pupillometry. Journal of Ophthalmology. 2017: 7935406. PMID 28894607 DOI: 10.1155/2017/7935406 |
0.495 |
|
| 2017 |
Laws SM, Gaskin S, Woodfield A, Srikanth V, Bruce D, Fraser PE, Porter T, Newsholme P, Wijesekara N, Burnham S, Doré V, Li QX, Maruff P, Masters CL, Rainey-Smith S, ... ... Martins RN, et al. Insulin resistance is associated with reductions in specific cognitive domains and increases in CSF tau in cognitively normal adults. Scientific Reports. 7: 9766. PMID 28852028 DOI: 10.1016/J.Jalz.2017.06.2000 |
0.7 |
|
| 2017 |
Harrington KD, Lim YY, Ames D, Hassenstab J, Laws SM, Martins RN, Rainey-Smith S, Robertson J, Rowe CC, Salvado O, Doré V, Villemagne VL, Snyder PJ, Masters CL, Maruff P. Amyloid β-associated cognitive decline in the absence of clinical disease progression and systemic illness. Alzheimer's & Dementia (Amsterdam, Netherlands). 8: 156-164. PMID 28761926 DOI: 10.1016/J.Dadm.2017.05.006 |
0.45 |
|
| 2017 |
Kinnunen KM, Cash DM, Poole T, Frost C, Benzinger TLS, Ahsan RL, Leung KK, Cardoso MJ, Modat M, Malone IB, Morris JC, Bateman RJ, Marcus DS, Goate A, Salloway S, ... ... Martins RN, et al. Presymptomatic atrophy in autosomal dominant Alzheimer's disease: A serial MRI study. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 28738187 DOI: 10.1016/J.Jalz.2017.06.2268 |
0.44 |
|
| 2017 |
Holmes SE, Esterlis I, Mazure CM, Lim YY, Ames D, Rainey-Smith S, Fowler C, Ellis K, Martins RN, Salvado O, Doré V, Villemagne VL, Rowe CC, Laws SM, Masters CL, et al. Trajectories of depressive and anxiety symptoms in older adults: a 6-year prospective cohort study. International Journal of Geriatric Psychiatry. PMID 28736899 DOI: 10.1002/Gps.4761 |
0.31 |
|
| 2017 |
Lim YY, Rainey-Smith S, Lim Y, Laws SM, Gupta V, Porter T, Bourgeat P, Ames D, Fowler C, Salvado O, Villemagne VL, Rowe CC, Masters CL, Zhou XF, Martins RN, et al. BDNF Val66Met in preclinical Alzheimer's disease is associated with short-term changes in episodic memory and hippocampal volume but not serum mBDNF. International Psychogeriatrics. 1-10. PMID 28720165 DOI: 10.1017/S1041610217001284 |
0.453 |
|
| 2017 |
Goozee K, Chatterjee P, James I, Shen K, Sohrabi HR, Asih PR, Dave P, ManYan C, Taddei K, Ayton SJ, Garg ML, Kwok JB, Bush AI, Chung R, Magnussen JS, ... Martins RN, et al. Elevated plasma ferritin in elderly individuals with high neocortical amyloid-β load. Molecular Psychiatry. PMID 28696433 DOI: 10.1038/Mp.2017.146 |
0.538 |
|
| 2017 |
Asih PR, Tegg ML, Sohrabi H, Carruthers M, Gandy SE, Saad F, Verdile G, Ittner LM, Martins RN. Multiple Mechanisms Linking Type 2 Diabetes and Alzheimer's Disease: Testosterone as a Modifier. Journal of Alzheimer's Disease : Jad. PMID 28655134 DOI: 10.3233/Jad-161259 |
0.654 |
|
| 2017 |
Binosha FWMAD, Somaratne G, Williams S, Goozee KG, Singh H, Martins RN. Diabetes and Alzheimer's Disease: Can Tea Phytochemicals Play a Role in Prevention? Journal of Alzheimer's Disease : Jad. PMID 28582855 DOI: 10.3233/Jad-161200 |
0.391 |
|
| 2017 |
Lim YY, Williamson R, Laws SM, Villemagne VL, Bourgeat P, Fowler C, Rainey-Smith S, Salvado O, Martins RN, Rowe CC, Masters CL, Maruff P. Effect of APOE Genotype on Amyloid Deposition, Brain Volume, and Memory in Cognitively Normal Older Individuals. Journal of Alzheimer's Disease : Jad. PMID 28550258 DOI: 10.3233/JAD-170072 |
0.519 |
|
| 2017 |
Gupta VB, Hone E, Pedrini S, Doecke J, O'Bryant S, James I, Bush AI, Rowe CC, Villemagne VL, Ames D, Masters CL, Martins RN. Altered levels of blood proteins in Alzheimer's disease longitudinal study: Results from Australian Imaging Biomarkers Lifestyle Study of Ageing cohort. Alzheimer's & Dementia (Amsterdam, Netherlands). 8: 60-72. PMID 28508031 DOI: 10.1016/J.Dadm.2017.04.003 |
0.616 |
|
| 2017 |
Brown BM, Sohrabi HR, Taddei K, Gardener SL, Rainey-Smith SR, Peiffer JJ, Xiong C, Fagan AM, Benzinger T, Buckles V, Erickson KI, Clarnette R, Shah T, Masters CL, Weiner M, ... ... Martins RN, et al. Habitual exercise levels are associated with cerebral amyloid load in presymptomatic autosomal dominant Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 28501451 DOI: 10.1016/J.Jalz.2017.03.008 |
0.47 |
|
| 2017 |
Müller S, Preische O, Sohrabi HR, Gräber S, Jucker M, Dietzsch J, Ringman JM, Martins RN, McDade E, Schofield PR, Ghetti B, Rossor M, Graff-Radford NR, Levin J, Galasko D, et al. Decreased body mass index in the preclinical stage of autosomal dominant Alzheimer's disease. Scientific Reports. 7: 1225. PMID 28450713 DOI: 10.1038/S41598-017-01327-W |
0.395 |
|
| 2017 |
Gardener SL, Rainey-Smith SR, Sohrabi HR, Weinborn M, Verdile G, Fernando WM, Lim YY, Harrington K, Burnham S, Taddei K, Masters CL, Macaulay SL, Rowe CC, Ames D, Maruff P, ... Martins RN, et al. Increased Carbohydrate Intake is Associated with Poorer Performance in Verbal Memory and Attention in an APOE Genotype-Dependent Manner. Journal of Alzheimer's Disease : Jad. PMID 28387666 DOI: 10.3233/Jad-161158 |
0.685 |
|
| 2017 |
Goozee K, Chatterjee P, James I, Shen K, Sohrabi HR, Asih PR, Dave P, Ball B, ManYan C, Taddei K, Chung R, Garg ML, Martins RN. Alterations in erythrocyte fatty acid composition in preclinical Alzheimer's disease. Scientific Reports. 7: 676. PMID 28386119 DOI: 10.1038/s41598-017-00751-2 |
0.331 |
|
| 2017 |
Frost S, Bhuiyan A, Offerman D, Doecke JD, Macaulay SL, Sohrabi HR, Ames D, Masters C, Martins RN, Kanagasingam Y, Aibl Research Group. Modulation of Retinal Arteriolar Central Reflection by APOE genotype. Current Alzheimer Research. PMID 28290247 DOI: 10.2174/1567205014666170309115016 |
0.43 |
|
| 2017 |
Golzan SM, Goozee K, Georgevsky D, Avolio A, Chatterjee P, Shen K, Gupta V, Chung R, Savage G, Orr CF, Martins RN, Graham SL. Retinal vascular and structural changes are associated with amyloid burden in the elderly: ophthalmic biomarkers of preclinical Alzheimer's disease. Alzheimer's Research & Therapy. 9: 13. PMID 28253913 DOI: 10.1186/s13195-017-0239-9 |
0.339 |
|
| 2017 |
Hollands S, Lim YY, Laws SM, Villemagne VL, Pietrzak RH, Harrington K, Porter T, Snyder P, Ames D, Fowler C, Rainey-Smith SR, Martins RN, Salvado O, Robertson J, Rowe CC, et al. APOEɛ4 Genotype, Amyloid, and Clinical Disease Progression in Cognitively Normal Older Adults. Journal of Alzheimer's Disease : Jad. PMID 28234254 DOI: 10.3233/Jad-161019 |
0.515 |
|
| 2017 |
Cardoso BR, Hare DJ, Bush AI, Li QX, Fowler CJ, Masters CL, Martins RN, Ganio K, Lothian A, Mukherjee S, Kapp EA, Roberts BR. Selenium Levels in Serum, Red Blood Cells, and Cerebrospinal Fluid of Alzheimer's Disease Patients: A Report from the Australian Imaging, Biomarker & Lifestyle Flagship Study of Ageing (AIBL). Journal of Alzheimer's Disease : Jad. PMID 28222503 DOI: 10.3233/Jad-160622 |
0.719 |
|
| 2017 |
Peters KE, Davis WA, Taddei K, Martins RN, Masters CL, Davis TM, Bruce DG. Plasma Amyloid-β Peptides in Type 2 Diabetes: A Matched Case-Control Study. Journal of Alzheimer's Disease : Jad. PMID 28106562 DOI: 10.3233/Jad-161050 |
0.397 |
|
| 2017 |
Shah TM, Gupta SM, Chatterjee P, Campbell M, Martins RN. Beta-amyloid sequelae in the eye: a critical review on its diagnostic significance and clinical relevance in Alzheimer's disease. Molecular Psychiatry. PMID 28093567 DOI: 10.1038/Mp.2016.251 |
0.482 |
|
| 2017 |
Shah TM, Weinborn M, Verdile G, Sohrabi HR, Martins RN. Enhancing Cognitive Functioning in Healthly Older Adults: a Systematic Review of the Clinical Significance of Commercially Available Computerized Cognitive Training in Preventing Cognitive Decline. Neuropsychology Review. PMID 28092015 DOI: 10.1007/S11065-016-9338-9 |
0.576 |
|
| 2017 |
Hanseeuw BJ, McDade E, Schultz AP, Martins RN, Schofield PR, Masters CL, Graff-Radford NR, Salloway S, Danek A, Levin J, Buckles V, Goate AM, Benzinger TL, Morris JC, Bateman RJ, et al. GENOTYPIC VARIANCE MAY EXPLAIN THE BALANCE OF EARLY CORTICAL VERSUS STRIATAL AMYLOID DEPOSITION IN AUTOSOMAL DOMINANT AD Alzheimer's & Dementia. 13: P187-P188. DOI: 10.1016/J.Jalz.2017.07.043 |
0.439 |
|
| 2017 |
Ashton NJ, Narvardo-Holgado AJ, Lynham S, Ward M, Gupta VB, Chatterjee P, Goozee K, Hone E, Pedrini S, Bush AI, Rowe CC, Villemagne VLL, Ames D, Masters CL, Aarsland D, ... ... Martins R, et al. A mass spectrometry-based discovery and replication of a multi-analyte classifier for neocortical amyloid pathology Alzheimers & Dementia. 13: 1033. DOI: 10.1016/J.Jalz.2017.06.1456 |
0.553 |
|
| 2016 |
O'Bryant SE, Mielke MM, Rissman RA, Lista S, Vanderstichele H, Zetterberg H, Lewczuk P, Posner H, Hall J, Johnson L, Fong YL, Luthman J, Jeromin A, Batrla-Utermann R, Villarreal A, ... ... Martins R, et al. Blood-based biomarkers in Alzheimer disease: Current state of the science and a novel collaborative paradigm for advancing from discovery to clinic. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 27870940 DOI: 10.1016/J.Jalz.2016.09.014 |
0.398 |
|
| 2016 |
Tang M, Ryman DC, McDade E, Jasielec MS, Buckles VD, Cairns NJ, Fagan AM, Goate A, Marcus DS, Xiong C, Allegri RF, Chhatwal JP, Danek A, Farlow MR, Fox NC, ... ... Martins RN, et al. Neurological manifestations of autosomal dominant familial Alzheimer's disease: a comparison of the published literature with the Dominantly Inherited Alzheimer Network observational study (DIAN-OBS). The Lancet. Neurology. PMID 27777020 DOI: 10.1016/S1474-4422(16)30229-0 |
0.408 |
|
| 2016 |
Holmes SE, Esterlis I, Mazure CM, Lim YY, Ames D, Rainey-Smith S, Martins RN, Salvado O, Dore V, Villemagne VL, Rowe CC, Laws SM, Masters CL, Maruff P, Pietrzak RH, et al. β-Amyloid, APOE and BDNF Genotype, and Depressive and Anxiety Symptoms in Cognitively Normal Older Women and Men. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. PMID 27742526 DOI: 10.1016/J.Jagp.2016.08.007 |
0.368 |
|
| 2016 |
Buckley R, Saling M, Ellis K, Rowe C, Maruff P, Macaulay LS, Martins R, Masters C, Savage G, Rainey-Smith S, Rembach A, Ames D. Corrigendum: Corrigendum to 'Self and informant memory concerns align in healthy memory complainers and in early stages of mild cognitive impairment but separate with increasing cognitive impairment'. Age and Ageing. 45: 742. PMID 27646269 DOI: 10.1093/Ageing/Afw117 |
0.354 |
|
| 2016 |
Lim YY, Villemagne VL, Laws SM, Pietrzak RH, Ames D, Fowler C, Rainey-Smith S, Snyder PJ, Bourgeat P, Martins RN, Salvado O, Rowe CC, Masters CL, Maruff P. Performance on the Cogstate Brief Battery Is Related to Amyloid Levels and Hippocampal Volume in Very Mild Dementia. Journal of Molecular Neuroscience : Mn. PMID 27586003 DOI: 10.1007/s12031-016-0822-8 |
0.509 |
|
| 2016 |
Cerin E, Rainey-Smith SR, Ames D, Lautenschlager NT, Macaulay SL, Fowler C, Robertson JS, Rowe CC, Maruff P, Martins RN, Masters CL, Ellis KA. Associations of neighborhood environment with brain imaging outcomes in the AIBL cohort. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 27546307 DOI: 10.1016/j.jalz.2016.06.2364 |
0.351 |
|
| 2016 |
Burnham SC, Rowe CC, Baker D, Bush AI, Doecke JD, Faux NG, Laws SM, Martins RN, Maruff P, Macaulay SL, Rainey-Smith S, Savage G, Ames D, Masters CL, Wilson W, et al. Predicting Alzheimer disease from a blood-based biomarker profile: A 54-month follow-up. Neurology. PMID 27534714 DOI: 10.1212/Wnl.0000000000003094 |
0.599 |
|
| 2016 |
Burnham SC, Bourgeat P, Doré V, Savage G, Brown B, Laws S, Maruff P, Salvado O, Ames D, Martins RN, Masters CL, Rowe CC, Villemagne VL. Clinical and cognitive trajectories in cognitively healthy elderly individuals with suspected non-Alzheimer's disease pathophysiology (SNAP) or Alzheimer's disease pathology: a longitudinal study. The Lancet. Neurology. PMID 27450471 DOI: 10.1016/S1474-4422(16)30125-9 |
0.508 |
|
| 2016 |
Muenchhoff J, Poljak A, Thalamuthu A, Gupta VB, Chatterjee P, Raftery M, Masters CL, Morris JC, Bateman RJ, Fagan AM, Martins RN, Sachdev PS. Changes in the plasma proteome at asymptomatic and symptomatic stages of autosomal dominant Alzheimer's disease. Scientific Reports. 6: 29078. PMID 27381087 DOI: 10.1038/Srep29078 |
0.425 |
|
| 2016 |
Frost S, Guymer R, Aung KZ, Macaulay SL, Sohrabi HR, Bourgeat P, Salvado O, Rowe CC, Ames D, Masters CL, Martins RN, Kanagasingam Y, Group AT. Alzheimer`s disease and the early signs of age-related macular degeneration. Current Alzheimer Research. PMID 27335042 DOI: 10.2174/1567205013666160603003800 |
0.501 |
|
| 2016 |
Gupta V, Gupta VB, Chitranshi N, Gangoda S, Vander Wall R, Abbasi M, Golzan M, Dheer Y, Shah T, Avolio A, Chung R, Martins R, Graham S. One protein, multiple pathologies: multifaceted involvement of amyloid β in neurodegenerative disorders of the brain and retina. Cellular and Molecular Life Sciences : Cmls. PMID 27333888 DOI: 10.1007/S00018-016-2295-X |
0.453 |
|
| 2016 |
Gupta VB, Doecke JD, Hone E, Pedrini S, Laws SM, Thambisetty M, Bush AI, Rowe CC, Villemagne VL, Ames D, Masters CL, Macaulay SL, Rembach A, Rainey-Smith SR, Martins RN, et al. Plasma apolipoprotein J as a potential biomarker for Alzheimer's disease: Australian Imaging, Biomarkers and Lifestyle study of aging. Alzheimer's & Dementia (Amsterdam, Netherlands). 3: 18-26. PMID 27239546 DOI: 10.1016/J.Dadm.2015.12.001 |
0.622 |
|
| 2016 |
Lim YY, Snyder PJ, Pietrzak RH, Ukiqi A, Villemagne VL, Ames D, Salvado O, Bourgeat P, Martins RN, Masters CL, Rowe CC, Maruff P. Sensitivity of composite scores to amyloid burden in preclinical Alzheimer's disease: Introducing the Z-scores of Attention, Verbal fluency, and Episodic memory for Nondemented older adults composite score. Alzheimer's & Dementia (Amsterdam, Netherlands). 2: 19-26. PMID 27239532 DOI: 10.1016/j.dadm.2015.11.003 |
0.482 |
|
| 2016 |
Harrington KD, Gould E, Lim YY, Ames D, Pietrzak RH, Rembach A, Rainey-Smith S, Martins RN, Salvado O, Villemagne VL, Rowe CC, Masters CL, Maruff P. Amyloid burden and incident depressive symptoms in cognitively normal older adults. International Journal of Geriatric Psychiatry. PMID 27114112 DOI: 10.1002/gps.4489 |
0.439 |
|
| 2016 |
Brown BM, Rainey-Smith SR, Villemagne VL, Weinborn M, Bucks RS, Sohrabi HR, Laws SM, Taddei K, Macaulay SL, Ames D, Fowler C, Maruff P, Masters CL, Rowe CC, Martins RN, et al. The Relationship between Sleep Quality and Brain Amyloid Burden. Sleep. PMID 27091528 |
0.353 |
|
| 2016 |
Warrier S, Marimuthu R, Sekhar S, Bhuvanalakshmi G, Arfuso F, Das AK, Bhonde R, Martins R, Dharmarajan A. sFRP-mediated Wnt sequestration as a potential therapeutic target for Alzheimer's disease. The International Journal of Biochemistry & Cell Biology. PMID 27063405 DOI: 10.1016/J.Biocel.2016.04.002 |
0.437 |
|
| 2016 |
Gardener SL, Sohrabi HR, Shen KK, Rainey-Smith SR, Weinborn M, Bates KA, Shah T, Foster JK, Lenzo N, Salvado O, Laske C, Laws SM, Taddei K, Verdile G, Martins RN. Cerebral Glucose Metabolism is Associated with Verbal but not Visual Memory Performance in Community-Dwelling Older Adults. Journal of Alzheimer's Disease : Jad. PMID 27031482 DOI: 10.3233/Jad-151084 |
0.542 |
|
| 2016 |
Lim YY, Laws SM, Villemagne VL, Pietrzak RH, Porter T, Ames D, Fowler C, Rainey-Smith S, Snyder PJ, Martins RN, Salvado O, Bourgeat P, Rowe CC, Masters CL, Maruff P. Aβ-related memory decline in APOE ε4 noncarriers: Implications for Alzheimer disease. Neurology. PMID 27029632 DOI: 10.1212/Wnl.0000000000002604 |
0.495 |
|
| 2016 |
O'Bryant SE, Lista S, Rissman RA, Edwards M, Zhang F, Hall J, Zetterberg H, Lovestone S, Gupta V, Graff-Radford N, Martins R, Jeromin A, Waring S, Oh E, King M, et al. Comparing biological markers of Alzheimer's disease across blood fraction and platforms: Comparing apples to oranges. Alzheimer's & Dementia (Amsterdam, Netherlands). 3: 27-34. PMID 27019866 DOI: 10.1016/J.Dadm.2015.12.003 |
0.343 |
|
| 2016 |
Lee S, Viqar F, Zimmerman ME, Narkhede A, Tosto G, Benzinger TL, Marcus DS, Fagan AM, Goate A, Fox NC, Cairns NJ, Holtzman DM, Buckles V, Ghetti B, McDade E, ... Martins RN, et al. White matter hyperintensities are a core feature of Alzheimer's disease: Evidence from the Dominantly Inherited Alzheimer Network. Annals of Neurology. PMID 27016429 DOI: 10.1002/ana.24647 |
0.478 |
|
| 2016 |
François M, Fenech MF, Thomas P, Hor M, Rembach A, Martins RN, Rainey-Smith SR, Masters CL, Ames D, Rowe CC, Lance Macaulay S, Hill AF, Leifert WR, The Australian Imaging Biomarkers And Lifestyle Study Research Group. High content, multi-parameter analyses in buccal cells to identify Alzheimer's disease. Current Alzheimer Research. PMID 26975368 DOI: 10.2174/1567205013666160315112151 |
0.504 |
|
| 2016 |
Hare DJ, Faux NG, Roberts BR, Volitakis I, Martins RN, Bush AI. Lead and manganese levels in serum and erythrocytes in Alzheimer's disease and mild cognitive impairment: results from the Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing. Metallomics : Integrated Biometal Science. PMID 26962965 DOI: 10.1039/C6Mt00019C |
0.562 |
|
| 2016 |
Bird SM, Sohrabi HR, Sutton TA, Weinborn M, Rainey-Smith SR, Brown B, Patterson L, Taddei K, Gupta V, Carruthers M, Lenzo N, Knuckey N, Bucks RS, Verdile G, Martins RN. Cerebral amyloid-β accumulation and deposition following traumatic brain injury-A narrative review and meta-analysis of animal studies. Neuroscience and Biobehavioral Reviews. PMID 26899257 DOI: 10.1016/J.Neubiorev.2016.01.004 |
0.621 |
|
| 2016 |
Buckley RF, Maruff P, Ames D, Bourgeat P, Martins RN, Masters CL, Rainey-Smith S, Lautenschlager N, Rowe CC, Savage G, Villemagne VL, Ellis KA. Subjective memory decline predicts greater rates of clinical progression in preclinical Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 26852195 DOI: 10.1016/j.jalz.2015.12.013 |
0.425 |
|
| 2016 |
Chatterjee P, Lim WL, Shui G, Gupta VB, James I, Fagan AM, Xiong C, Sohrabi HR, Taddei K, Brown BM, Benzinger T, Masters C, Snowden SG, Wenk MR, Bateman RJ, ... ... Martins RN, et al. Plasma Phospholipid and Sphingolipid Alterations in Presenilin1 Mutation Carriers: A Pilot Study. Journal of Alzheimer's Disease : Jad. PMID 26836186 DOI: 10.3233/Jad-150948 |
0.438 |
|
| 2016 |
Porter T, Bharadwaj P, Groth D, Paxman A, Laws SM, Martins RN, Verdile G. The Effects of Latrepirdine on Amyloid-β Aggregation and Toxicity. Journal of Alzheimer's Disease : Jad. PMID 26836170 DOI: 10.3233/Jad-150790 |
0.62 |
|
| 2016 |
Brown BM, Rainey-Smith SR, Villemagne VL, Weinborn M, Bucks RS, Sohrabi HR, Laws SM, Taddei K, Macaulay SL, Ames D, Fowler C, Maruff P, Masters CL, Rowe CC, Martins RN. The relationship between sleep quality and brain amyloid burden Sleep. 39: 1063-1068. DOI: 10.5665/sleep.5756 |
0.34 |
|
| 2016 |
Gupta V, Hone E, Pedrini S, Martins RN. P3-150: Blood Biomarkers for Alzheimer's Disease Correlate With Pet Amyloid in AIBL Longitudnal Study of Aging Alzheimer's & Dementia. 12: P876-P876. DOI: 10.1016/j.jalz.2016.06.1810 |
0.324 |
|
| 2016 |
Gupta VB, Doecke JD, Hone E, Pedrini S, Laws SM, Thambisetty M, Bush AI, Rowe CC, Villemagne VL, Ames D, Masters CL, Macaulay SL, Rembach A, Rainey-Smith SR, Martins RN. Plasma apolipoprotein J as a potential biomarker for Alzheimer's disease: Australian Imaging, Biomarkers and Lifestyle study of aging Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring. 3: 18-26. DOI: 10.1016/j.dadm.2015.12.001 |
0.572 |
|
| 2015 |
Kerestes R, Phal PM, Steward C, Moffat BA, Salinas S, Cox KL, Ellis KA, Cyarto EV, Ames D, Martins RN, Masters CL, Rowe CC, Sharman MJ, Salvado O, Szoeke C, et al. Alterations in dorsal and ventral posterior cingulate connectivity in APOE ε4 carriers at risk of Alzheimer's disease. Bjpsych Open. 1: 139-148. PMID 27703739 DOI: 10.1192/bjpo.bp.115.001339 |
0.379 |
|
| 2015 |
Verdile G, Keane KN, Cruzat VF, Medic S, Sabale M, Rowles J, Wijesekara N, Martins RN, Fraser PE, Newsholme P. Inflammation and Oxidative Stress: The Molecular Connectivity between Insulin Resistance, Obesity, and Alzheimer's Disease. Mediators of Inflammation. 2015: 105828. PMID 26693205 DOI: 10.1155/2015/105828 |
0.615 |
|
| 2015 |
Goozee KG, Shah TM, Sohrabi HR, Rainey-Smith SR, Brown B, Verdile G, Martins RN. Examining the potential clinical value of curcumin in the prevention and diagnosis of Alzheimer's disease. The British Journal of Nutrition. 1-17. PMID 26652155 DOI: 10.1017/S0007114515004687 |
0.712 |
|
| 2015 |
Zwan MD, Villemagne VL, Doré V, Buckley R, Bourgeat P, Veljanoski R, Salvado O, Williams R, Margison L, Rembach A, Macaulay SL, Martins R, Ames D, van der Flier WM, Ellis KA, et al. Subjective Memory Complaints in APOEɛ4 Carriers are Associated with High Amyloid-β Burden. Journal of Alzheimer's Disease : Jad. PMID 26639956 DOI: 10.3233/Jad-150446 |
0.57 |
|
| 2015 |
Rembach A, Evered LA, Li QX, Nash T, Vidaurre L, Fowler CJ, Pertile KK, Rumble RL, Trounson BO, Maher S, Mooney F, Farrow M, Taddei K, Rainey-Smith S, Laws SM, ... ... Martins RN, et al. Alzheimer's disease cerebrospinal fluid biomarkers are not influenced by gravity drip or aspiration extraction methodology. Alzheimer's Research & Therapy. 7: 71. PMID 26581886 DOI: 10.1186/s13195-015-0157-7 |
0.423 |
|
| 2015 |
Wahjoepramono EJ, Asih PR, Aniwiyanti V, Taddei K, Dhaliwal SS, Fuller SJ, Foster J, Carruthers M, Verdile G, Sohrabi HR, Martins RN. The Effects of Testosterone Supplementation on Cognitive Functioning in Older Men. Cns & Neurological Disorders Drug Targets. PMID 26553159 DOI: 10.2174/1871527315666151110125704 |
0.571 |
|
| 2015 |
Barr RK, Verdile G, Wijaya LK, Morici M, Taddei K, Gupta VB, Pedrini S, Jin L, Nicolazzo JA, Knock E, Fraser PE, Martins RN. Validation and Characterisation of a Novel Peptide that Binds Monomeric and Aggregated Beta-amyloid and Inhibits the Formation of Neurotoxic Oligomers. The Journal of Biological Chemistry. PMID 26538562 DOI: 10.1074/Jbc.M115.679993 |
0.622 |
|
| 2015 |
Buckley R, Saling M, Ellis K, Rowe C, Maruff P, Macaulay LS, Martins R, Masters C, Savage G, Rainey-Smith S, Rembach A, Ames D. Self and informant memory concerns align in healthy memory complainers and in early stages of mild cognitive impairment but separate with increasing cognitive impairment. Age and Ageing. 44: 1012-9. PMID 26452663 DOI: 10.1093/Ageing/Afv136 |
0.346 |
|
| 2015 |
Thai C, Lim YY, Villemagne VL, Laws SM, Ames D, Ellis KA, Rainey-Smith SR, Martins RN, Masters CL, Rowe CC, Maruff P. Amyloid-Related Memory Decline in Preclinical Alzheimer's Disease Is Dependent on APOE ε4 and Is Detectable over 18-Months. Plos One. 10: e0139082. PMID 26430784 DOI: 10.1371/journal.pone.0139082 |
0.436 |
|
| 2015 |
Burnham SC, Raghavan N, Wilson W, Baker D, Ropacki MT, Novak G, Ames D, Ellis K, Martins RN, Maruff P, Masters CL, Romano G, Rowe CC, Savage G, Macaulay SL, et al. Novel Statistically-Derived Composite Measures for Assessing the Efficacy of Disease-Modifying Therapies in Prodromal Alzheimer's Disease Trials: An AIBL Study. Journal of Alzheimer's Disease : Jad. 46: 1079-89. PMID 26402634 DOI: 10.3233/JAD-143015 |
0.44 |
|
| 2015 |
Leifert WR, Nguyen T, Rembach A, Martins R, Rainey-Smith S, Masters CL, Ames D, Rowe CC, Macaulay SL, François M, Fenech MF. Buccal Cell Cytokeratin 14 Correlates with Multiple Blood Biomarkers of Alzheimer's Disease Risk. Journal of Alzheimer's Disease : Jad. 48: 443-52. PMID 26402008 DOI: 10.3233/Jad-150330 |
0.571 |
|
| 2015 |
Li QX, Villemagne VL, Doecke JD, Rembach A, Sarros S, Varghese S, McGlade A, Laughton KM, Pertile KK, Fowler CJ, Rumble RL, Trounson BO, Taddei K, Rainey-Smith SR, Laws SM, ... ... Martins RN, et al. Alzheimer's Disease Normative Cerebrospinal Fluid Biomarkers Validated in PET Amyloid-β Characterized Subjects from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study. Journal of Alzheimer's Disease : Jad. 48: 175-87. PMID 26401938 DOI: 10.3233/JAD-150247 |
0.488 |
|
| 2015 |
Wang F, Gordon BA, Ryman DC, Ma S, Xiong C, Hassenstab J, Goate A, Fagan AM, Cairns NJ, Marcus DS, McDade E, Ringman JM, Graff-Radford NR, Ghetti B, Farlow MR, ... ... Martins RN, et al. Cerebral amyloidosis associated with cognitive decline in autosomal dominant Alzheimer disease. Neurology. PMID 26245925 DOI: 10.1212/Wnl.0000000000001903 |
0.455 |
|
| 2015 |
Verdile G, Asih PR, Barron AM, Wahjoepramono EJ, Ittner LM, Martins RN. The impact of luteinizing hormone and testosterone on beta amyloid (Aβ) accumulation: Animal and human clinical studies. Hormones and Behavior. PMID 26122291 DOI: 10.1016/J.Yhbeh.2015.05.020 |
0.661 |
|
| 2015 |
Xu H, Gupta VB, Martins IJ, Martins RN, Fowler CJ, Bush AI, Finkelstein DI, Adlard PA. Zinc affects the proteolytic stability of Apolipoprotein E in an isoform-dependent way. Neurobiology of Disease. PMID 26117305 DOI: 10.1016/J.Nbd.2015.06.016 |
0.515 |
|
| 2015 |
Albrecht MA, Szoeke C, Maruff P, Savage G, Lautenschlager NT, Ellis KA, Taddei K, Martins R, Masters CL, Ames D, Foster JK. Longitudinal cognitive decline in the AIBL cohort: The role of APOE ε4 status. Neuropsychologia. 75: 411-419. PMID 26102189 DOI: 10.1016/J.Neuropsychologia.2015.06.008 |
0.452 |
|
| 2015 |
Verdile G, Fuller SJ, Martins RN. The role of type 2 diabetes in neurodegeneration. Neurobiology of Disease. PMID 25926349 DOI: 10.1016/J.Nbd.2015.04.008 |
0.623 |
|
| 2015 |
Laske C, Sohrabi HR, Jasielec MS, Müller S, Koehler NK, Gräber S, Förster S, Drzezga A, Mueller-Sarnowski F, Danek A, Jucker M, Bateman RJ, Buckles V, Saykin AJ, Martins RN, et al. Diagnostic Value of Subjective Memory Complaints Assessed with a Single Item in Dominantly Inherited Alzheimer's Disease: Results of the DIAN Study. Biomed Research International. 2015: 828120. PMID 25922840 DOI: 10.1155/2015/828120 |
0.381 |
|
| 2015 |
Asih PR, Wahjoepramono EJ, Aniwiyanti V, Wijaya LK, de Ruyck K, Taddei K, Fuller SJ, Sohrabi H, Dhaliwal SS, Verdile G, Carruthers M, Martins RN. Testosterone replacement therapy in older male subjective memory complainers: double-blind randomized crossover placebo-controlled clinical trial of physiological assessment and safety. Cns & Neurological Disorders Drug Targets. 14: 576-86. PMID 25921747 DOI: 10.2174/1871527314666150429112112 |
0.591 |
|
| 2015 |
Gupta VB, Wilson AC, Burnham S, Hone E, Pedrini S, Laws SM, Lim WL, Rembach A, Rainey-Smith S, Ames D, Cobiac L, Macaulay SL, Masters CL, Rowe CC, Bush AI, ... Martins RN, et al. Follow-up plasma apolipoprotein E levels in the Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing (AIBL) cohort. Alzheimer's Research & Therapy. 7: 16. PMID 25859282 DOI: 10.1186/S13195-015-0105-6 |
0.616 |
|
| 2015 |
Sutton TA, Sohrabi HR, Rainey-Smith SR, Bird SM, Weinborn M, Martins RN. The role of APOE-ɛ4 and beta amyloid in the differential rate of recovery from ECT: a review. Translational Psychiatry. 5: e539. PMID 25826114 DOI: 10.1038/tp.2015.39 |
0.302 |
|
| 2015 |
Moussavi Nik SH, Newman M, Wilson L, Ebrahimie E, Wells S, Musgrave I, Verdile G, Martins RN, Lardelli M. Alzheimer's disease-related peptide PS2V plays ancient, conserved roles in suppression of the unfolded protein response under hypoxia and stimulation of γ-secretase activity. Human Molecular Genetics. 24: 3662-78. PMID 25814654 DOI: 10.1093/Hmg/Ddv110 |
0.646 |
|
| 2015 |
Leifert WR, Tuli JF, Francois M, Nguyen T, Rembach A, Rumble RL, Rainey-Smith S, Martins R, Fenech MF. Buccal cell cytokeratin 14 identifies mild cognitive impairment and Alzheimer' s disease in the AIBL study of aging. Current Alzheimer Research. 12: 233-41. PMID 25731627 DOI: 10.2174/1567205012666150302154650 |
0.47 |
|
| 2015 |
Buckley RF, Ellis KA, Ames D, Rowe CC, Lautenschlager NT, Maruff P, Villemagne VL, Macaulay SL, Szoeke C, Martins RN, Masters CL, Savage G, Rainey-Smith SR, Rembach A, Saling MM, et al. Phenomenological characterization of memory complaints in preclinical and prodromal Alzheimer's disease. Neuropsychology. 29: 571-81. PMID 25664464 DOI: 10.1037/Neu0000156 |
0.48 |
|
| 2015 |
Chatterjee P, Gupta VB, Fagan AM, Jasielec MS, Xiong C, Sohrabi HR, Dhaliwal S, Taddei K, Bourgeat P, Brown BM, Benzinger T, Bateman RJ, Morris JC, Martins RN. Decreased platelet APP isoform ratios in autosomal dominant Alzheimer's disease: baseline data from a DIAN cohort subset. Current Alzheimer Research. 12: 157-64. PMID 25654503 DOI: 10.2174/1567205012666150204125732 |
0.303 |
|
| 2015 |
Pietrzak RH, Lim YY, Neumeister A, Ames D, Ellis KA, Harrington K, Lautenschlager NT, Restrepo C, Martins RN, Masters CL, Villemagne VL, Rowe CC, Maruff P. Amyloid-β, anxiety, and cognitive decline in preclinical Alzheimer disease: a multicenter, prospective cohort study. Jama Psychiatry. 72: 284-91. PMID 25629787 DOI: 10.1001/jamapsychiatry.2014.2476 |
0.501 |
|
| 2015 |
Rembach A, Stingo FC, Peterson C, Vannucci M, Do KA, Wilson WJ, Macaulay SL, Ryan TM, Martins RN, Ames D, Masters CL, Doecke JD. Bayesian graphical network analyses reveal complex biological interactions specific to Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 44: 917-25. PMID 25613103 DOI: 10.3233/Jad-141497 |
0.525 |
|
| 2015 |
Pietrzak RH, Lim YY, Ames D, Harrington K, Restrepo C, Martins RN, Rembach A, Laws SM, Masters CL, Villemagne VL, Rowe CC, Maruff P. Trajectories of memory decline in preclinical Alzheimer's disease: results from the Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing. Neurobiology of Aging. 36: 1231-8. PMID 25585532 DOI: 10.1016/j.neurobiolaging.2014.12.015 |
0.376 |
|
| 2015 |
Lim YY, Villemagne VL, Pietrzak RH, Ames D, Ellis KA, Harrington K, Snyder PJ, Martins RN, Masters CL, Rowe CC, Maruff P. APOE ε4 moderates amyloid-related memory decline in preclinical Alzheimer's disease. Neurobiology of Aging. 36: 1239-44. PMID 25559335 DOI: 10.1016/j.neurobiolaging.2014.12.008 |
0.501 |
|
| 2015 |
Lim YY, Pietrzak RH, Bourgeat P, Ames D, Ellis KA, Rembach A, Harrington K, Salvado O, Martins RN, Snyder PJ, Masters CL, Rowe CC, Villemagne VL, Maruff P. Relationships between performance on the Cogstate Brief Battery, neurodegeneration, and Aβ accumulation in cognitively normal older adults and adults with MCI. Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists. 30: 49-58. PMID 25467942 DOI: 10.1093/arclin/acu068 |
0.507 |
|
| 2015 |
Laske C, Sohrabi HR, Frost SM, López-de-Ipiña K, Garrard P, Buscema M, Dauwels J, Soekadar SR, Mueller S, Linnemann C, Bridenbaugh SA, Kanagasingam Y, Martins RN, O'Bryant SE. Innovative diagnostic tools for early detection of Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 11: 561-78. PMID 25443858 DOI: 10.1016/J.Jalz.2014.06.004 |
0.319 |
|
| 2015 |
O'Bryant SE, Gupta V, Henriksen K, Edwards M, Jeromin A, Lista S, Bazenet C, Soares H, Lovestone S, Hampel H, Montine T, Blennow K, Foroud T, Carrillo M, Graff-Radford N, ... ... Martins R, et al. Guidelines for the standardization of preanalytic variables for blood-based biomarker studies in Alzheimer's disease research. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 11: 549-60. PMID 25282381 DOI: 10.1016/J.Jalz.2014.08.099 |
0.393 |
|
| 2015 |
Bourgeat P, Villemagne VL, Dore V, Brown B, Macaulay SL, Martins R, Masters CL, Ames D, Ellis K, Rowe CC, Salvado O, Fripp J. Comparison of MR-less PiB SUVR quantification methods. Neurobiology of Aging. 36: S159-66. PMID 25257985 DOI: 10.1016/J.Neurobiolaging.2014.04.033 |
0.392 |
|
| 2015 |
Hollands S, Lim YY, Buckley R, Pietrzak RH, Snyder PJ, Ames D, Ellis KA, Harrington K, Lautenschlager N, Martins RN, Masters CL, Villemagne VL, Rowe CC, Maruff P. Amyloid-β related memory decline is not associated with subjective or informant rated cognitive impairment in healthy adults. Journal of Alzheimer's Disease : Jad. 43: 677-86. PMID 25114076 DOI: 10.3233/JAD-140678 |
0.478 |
|
| 2015 |
Gardener SL, Rainey-Smith SR, Barnes MB, Sohrabi HR, Weinborn M, Lim YY, Harrington K, Taddei K, Gu Y, Rembach A, Szoeke C, Ellis KA, Masters CL, Macaulay SL, Rowe CC, ... ... Martins RN, et al. Dietary patterns and cognitive decline in an Australian study of ageing. Molecular Psychiatry. 20: 860-6. PMID 25070537 DOI: 10.1038/Mp.2014.79 |
0.377 |
|
| 2015 |
Burnham SC, Raghavan N, Wilson W, Baker D, Ropacki MT, Novak G, Ames D, Ellis K, Martins RN, Maruff P, Masters CL, Romano G, Rowe CC, Savage G, Macaulay SL, et al. Novel Statistically-Derived Composite Measures for Assessing the Efficacy of Disease-Modifying Therapies in Prodromal Alzheimer's Disease Trials: An AIBL Study Journal of Alzheimer's Disease. 46: 1079-1089. DOI: 10.3233/JAD-143015 |
0.394 |
|
| 2014 |
Johnson P, Vandewater L, Wilson W, Maruff P, Savage G, Graham P, Macaulay LS, Ellis KA, Szoeke C, Martins RN, Rowe CC, Masters CL, Ames D, Zhang P. Genetic algorithm with logistic regression for prediction of progression to Alzheimer's disease. Bmc Bioinformatics. 15: S11. PMID 25521394 DOI: 10.1186/1471-2105-15-S16-S11 |
0.427 |
|
| 2014 |
Shah T, Verdile G, Sohrabi H, Campbell A, Putland E, Cheetham C, Dhaliwal S, Weinborn M, Maruff P, Darby D, Martins RN. A combination of physical activity and computerized brain training improves verbal memory and increases cerebral glucose metabolism in the elderly. Translational Psychiatry. 4: e487. PMID 25463973 DOI: 10.1038/Tp.2014.122 |
0.577 |
|
| 2014 |
Asih PR, Chatterjee P, Verdile G, Gupta VB, Trengove RD, Martins RN. Clearing the amyloid in Alzheimer's: progress towards earlier diagnosis and effective treatments - an update for clinicians. Neurodegenerative Disease Management. 4: 363-78. PMID 25405650 DOI: 10.2217/Nmt.14.29 |
0.674 |
|
| 2014 |
Moussavi Nik SH, Newman M, Ganesan S, Chen M, Martins R, Verdile G, Lardelli M. Hypoxia alters expression of zebrafish microtubule-associated protein tau (mapta, maptb) gene transcripts. Bmc Research Notes. 7: 767. PMID 25359609 DOI: 10.1186/1756-0500-7-767 |
0.617 |
|
| 2014 |
Cheng L, Doecke JD, Sharples RA, Villemagne VL, Fowler CJ, Rembach A, Martins RN, Rowe CC, Macaulay SL, Masters CL, Hill AF. Prognostic serum miRNA biomarkers associated with Alzheimer's disease shows concordance with neuropsychological and neuroimaging assessment. Molecular Psychiatry. PMID 25349172 DOI: 10.1038/mp.2014.127 |
0.419 |
|
| 2014 |
Lim YY, Villemagne VL, Laws SM, Pietrzak RH, Snyder PJ, Ames D, Ellis KA, Harrington K, Rembach A, Martins RN, Rowe CC, Masters CL, Maruff P. APOE and BDNF polymorphisms moderate amyloid β-related cognitive decline in preclinical Alzheimer's disease. Molecular Psychiatry. PMID 25288138 DOI: 10.1038/mp.2014.123 |
0.517 |
|
| 2014 |
Martins R, Carruthers M. Testosterone as the missing link between pesticides, Alzheimer disease, and Parkinson disease. Jama Neurology. 71: 1189-90. PMID 25200541 DOI: 10.1001/Jamaneurol.2014.795 |
0.385 |
|
| 2014 |
Brown BM, Bourgeat P, Peiffer JJ, Burnham S, Laws SM, Rainey-Smith SR, Bartrés-Faz D, Villemagne VL, Taddei K, Rembach A, Bush A, Ellis KA, Macaulay SL, Rowe CC, Ames D, ... ... Martins RN, et al. Influence of BDNF Val66Met on the relationship between physical activity and brain volume. Neurology. 83: 1345-52. PMID 25186863 DOI: 10.1212/Wnl.0000000000000867 |
0.451 |
|
| 2014 |
Thomas JB, Brier MR, Bateman RJ, Snyder AZ, Benzinger TL, Xiong C, Raichle M, Holtzman DM, Sperling RA, Mayeux R, Ghetti B, Ringman JM, Salloway S, McDade E, Rossor MN, ... ... Martins RN, et al. Functional connectivity in autosomal dominant and late-onset Alzheimer disease. Jama Neurology. 71: 1111-22. PMID 25069482 DOI: 10.1001/Jamaneurol.2014.1654 |
0.436 |
|
| 2014 |
Buckley RF, Saling MM, Irish M, Ames D, Rowe CC, Villemagne VL, Lautenschlager NT, Maruff P, Macaulay SL, Martins RN, Szoeke C, Masters CL, Rainey-Smith SR, Rembach A, Savage G, et al. Autobiographical narratives relate to Alzheimer's disease biomarkers in older adults. International Psychogeriatrics / Ipa. 26: 1737-46. PMID 24969443 DOI: 10.1017/S1041610214001136 |
0.496 |
|
| 2014 |
François M, Leifert W, Martins R, Thomas P, Fenech M. Biomarkers of Alzheimer's disease risk in peripheral tissues; focus on buccal cells. Current Alzheimer Research. 11: 519-31. PMID 24938500 DOI: 10.2174/1567205011666140618103827 |
0.47 |
|
| 2014 |
Ryman DC, Acosta-Baena N, Aisen PS, Bird T, Danek A, Fox NC, Goate A, Frommelt P, Ghetti B, Langbaum JB, Lopera F, Martins R, Masters CL, Mayeux RP, McDade E, et al. Symptom onset in autosomal dominant Alzheimer disease: a systematic review and meta-analysis. Neurology. 83: 253-60. PMID 24928124 DOI: 10.1212/Wnl.0000000000000596 |
0.434 |
|
| 2014 |
Rembach A, Watt AD, Wilson WJ, Rainey-Smith S, Ellis KA, Rowe CC, Villemagne VL, Macaulay SL, Bush AI, Martins RN, Ames D, Masters CL, Doecke JD. An increased neutrophil-lymphocyte ratio in Alzheimer's disease is a function of age and is weakly correlated with neocortical amyloid accumulation. Journal of Neuroimmunology. 273: 65-71. PMID 24907904 DOI: 10.1016/J.Jneuroim.2014.05.005 |
0.622 |
|
| 2014 |
Lim WL, Martins IJ, Martins RN. The involvement of lipids in Alzheimer's disease. Journal of Genetics and Genomics = Yi Chuan Xue Bao. 41: 261-74. PMID 24894353 DOI: 10.1016/j.jgg.2014.04.003 |
0.344 |
|
| 2014 |
Rembach A, Hare DJ, Doecke JD, Burnham SC, Volitakis I, Fowler CJ, Cherny RA, McLean C, Grimm R, Martins R, Ames D, Masters CL, Bush AI, Roberts BR. Decreased serum zinc is an effect of ageing and not Alzheimer's disease. Metallomics : Integrated Biometal Science. 6: 1216-9. PMID 24676028 DOI: 10.1039/C4Mt00060A |
0.655 |
|
| 2014 |
Yates PA, Desmond PM, Phal PM, Steward C, Szoeke C, Salvado O, Ellis KA, Martins RN, Masters CL, Ames D, Villemagne VL, Rowe CC. Incidence of cerebral microbleeds in preclinical Alzheimer disease. Neurology. 82: 1266-73. PMID 24623839 DOI: 10.1212/Wnl.0000000000000285 |
0.492 |
|
| 2014 |
François M, Leifert W, Hecker J, Faunt J, Martins R, Thomas P, Fenech M. Altered cytological parameters in buccal cells from individuals with mild cognitive impairment and Alzheimer's disease. Cytometry. Part a : the Journal of the International Society For Analytical Cytology. 85: 698-708. PMID 24616437 DOI: 10.1002/Cyto.A.22453 |
0.441 |
|
| 2014 |
Fagan AM, Xiong C, Jasielec MS, Bateman RJ, Goate AM, Benzinger TL, Ghetti B, Martins RN, Masters CL, Mayeux R, Ringman JM, Rossor MN, Salloway S, Schofield PR, Sperling RA, et al. Longitudinal change in CSF biomarkers in autosomal-dominant Alzheimer's disease. Science Translational Medicine. 6: 226ra30. PMID 24598588 DOI: 10.1126/Scitranslmed.3007901 |
0.519 |
|
| 2014 |
Lim YY, Maruff P, Pietrzak RH, Ellis KA, Darby D, Ames D, Harrington K, Martins RN, Masters CL, Szoeke C, Savage G, Villemagne VL, Rowe CC. Aβ and cognitive change: examining the preclinical and prodromal stages of Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 10: 743-751.e1. PMID 24589436 DOI: 10.1016/j.jalz.2013.11.005 |
0.513 |
|
| 2014 |
Pietrzak RH, Scott JC, Neumeister A, Lim YY, Ames D, Ellis KA, Harrington K, Lautenschlager NT, Szoeke C, Martins RN, Masters CL, Villemagne VL, Rowe CC, Maruff P. Anxiety symptoms, cerebral amyloid burden and memory decline in healthy older adults without dementia: 3-year prospective cohort study. The British Journal of Psychiatry : the Journal of Mental Science. 204: 400-1. PMID 24526746 DOI: 10.1192/Bjp.Bp.113.134239 |
0.396 |
|
| 2014 |
Buckley RF, Saling MM, Irish M, Ames D, Rowe CC, Lautenschlager NT, Maruff P, Macaulay SL, Martins RN, Masters CL, Rainey-Smith SR, Rembach A, Savage G, Szoeke C, Ellis KA. Personal memory function in mild cognitive impairment and subjective memory complaints: results from the Australian Imaging, Biomarkers, and Lifestyle (AIBL) Study of Ageing. Journal of Alzheimer's Disease : Jad. 40: 551-61. PMID 24496075 DOI: 10.3233/Jad-131820 |
0.355 |
|
| 2014 |
Lim YY, Villemagne VL, Laws SM, Ames D, Pietrzak RH, Ellis KA, Harrington K, Bourgeat P, Bush AI, Martins RN, Masters CL, Rowe CC, Maruff P. Effect of BDNF Val66Met on memory decline and hippocampal atrophy in prodromal Alzheimer's disease: a preliminary study. Plos One. 9: e86498. PMID 24475133 DOI: 10.1371/Journal.Pone.0086498 |
0.593 |
|
| 2014 |
Faux NG, Rembach A, Wiley J, Ellis KA, Ames D, Fowler CJ, Martins RN, Pertile KK, Rumble RL, Trounson B, Masters CL, Bush AI. An anemia of Alzheimer's disease. Molecular Psychiatry. 19: 1227-34. PMID 24419041 DOI: 10.1038/Mp.2013.178 |
0.627 |
|
| 2014 |
Bates K, Vink R, Martins R, Harvey A. Aging, cortical injury and Alzheimer's disease-like pathology in the guinea pig brain. Neurobiology of Aging. 35: 1345-51. PMID 24360504 DOI: 10.1016/J.Neurobiolaging.2013.11.020 |
0.469 |
|
| 2014 |
Rembach A, Watt AD, Wilson WJ, Villemagne VL, Burnham SC, Ellis KA, Maruff P, Ames D, Rowe CC, Macaulay SL, Bush AI, Martins RN, Masters CL, Doecke JD. Plasma amyloid-β levels are significantly associated with a transition toward Alzheimer's disease as measured by cognitive decline and change in neocortical amyloid burden. Journal of Alzheimer's Disease : Jad. 40: 95-104. PMID 24334723 DOI: 10.3233/Jad-131802 |
0.604 |
|
| 2014 |
Ellis KA, Szoeke C, Bush AI, Darby D, Graham PL, Lautenschlager NT, Macaulay SL, Martins RN, Maruff P, Masters CL, McBride SJ, Pike KE, Rainey-Smith SR, Rembach A, Robertson J, et al. Rates of diagnostic transition and cognitive change at 18-month follow-up among 1,112 participants in the Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing (AIBL). International Psychogeriatrics / Ipa. 26: 543-54. PMID 24252258 DOI: 10.1017/S1041610213001956 |
0.604 |
|
| 2014 |
Moore EM, Ames D, Mander AG, Carne RP, Brodaty H, Woodward MC, Boundy K, Ellis KA, Bush AI, Faux NG, Martins RN, Masters CL, Rowe CC, Szoeke C, Watters DA. Among vitamin B12 deficient older people, high folate levels are associated with worse cognitive function: combined data from three cohorts. Journal of Alzheimer's Disease : Jad. 39: 661-8. PMID 24246419 DOI: 10.3233/Jad-131265 |
0.528 |
|
| 2014 |
Kanyenda LJ, Verdile G, Martins R, Meloni BP, Chieng J, Mastaglia F, Laws SM, Anderton RS, Boulos S. Is cholesterol and amyloid-β stress induced CD147 expression a protective response? Evidence that extracellular cyclophilin a mediated neuroprotection is reliant on CD147. Journal of Alzheimer's Disease : Jad. 39: 545-56. PMID 24217276 DOI: 10.3233/Jad-131442 |
0.591 |
|
| 2014 |
Lim YY, Maruff P, Pietrzak RH, Ames D, Ellis KA, Harrington K, Lautenschlager NT, Szoeke C, Martins RN, Masters CL, Villemagne VL, Rowe CC. Effect of amyloid on memory and non-memory decline from preclinical to clinical Alzheimer's disease. Brain : a Journal of Neurology. 137: 221-31. PMID 24176981 DOI: 10.1093/brain/awt286 |
0.491 |
|
| 2014 |
Newman M, Wilson L, Verdile G, Lim A, Khan I, Moussavi Nik SH, Pursglove S, Chapman G, Martins RN, Lardelli M. Differential, dominant activation and inhibition of Notch signalling and APP cleavage by truncations of PSEN1 in human disease. Human Molecular Genetics. 23: 602-17. PMID 24101600 DOI: 10.1093/Hmg/Ddt448 |
0.623 |
|
| 2014 |
Burnham SC, Faux NG, Wilson W, Laws SM, Ames D, Bedo J, Bush AI, Doecke JD, Ellis KA, Head R, Jones G, Kiiveri H, Martins RN, Rembach A, Rowe CC, et al. A blood-based predictor for neocortical Aβ burden in Alzheimer's disease: results from the AIBL study. Molecular Psychiatry. 19: 519-26. PMID 23628985 DOI: 10.1038/Mp.2013.40 |
0.574 |
|
| 2014 |
Rembach A, Faux NG, Watt AD, Pertile KK, Rumble RL, Trounson BO, Fowler CJ, Roberts BR, Perez KA, Li QX, Laws SM, Taddei K, Rainey-Smith S, Robertson JS, Vandijck M, ... ... Martins RN, et al. Changes in plasma amyloid beta in a longitudinal study of aging and Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 10: 53-61. PMID 23491263 DOI: 10.1016/J.Jalz.2012.12.006 |
0.611 |
|
| 2014 |
Verdile G, Laws SM, Henley D, Ames D, Bush AI, Ellis KA, Faux NG, Gupta VB, Li QX, Masters CL, Pike KE, Rowe CC, Szoeke C, Taddei K, Villemagne VL, ... Martins RN, et al. Associations between gonadotropins, testosterone and β amyloid in men at risk of Alzheimer's disease. Molecular Psychiatry. 19: 69-75. PMID 23089633 DOI: 10.1038/Mp.2012.147 |
0.755 |
|
| 2014 |
Martins IJ, Creegan R, Lim W, Gupta V, Guanghou S, Martins R. The cholesterol-ceramide connection as a possible link between diabetes and Alzheimer?s disease Journal of Diabetes & Metabolism. DOI: 10.4172/2155-6156.S1.027 |
0.356 |
|
| 2014 |
Sharman M, Ong D, Verdile G, Munch G, Wenk M, Halliwell B, Martins R. Effect of nutritional supplement therapies in the prevention of Alzheimer’s disease in a transgenic mouse model Journal of Nutrition & Intermediary Metabolism. 1: 32. DOI: 10.1016/J.Jnim.2014.10.113 |
0.595 |
|
| 2014 |
Burnham S, Raghavan N, Wilson B, Baker D, Ropacki MT, Novak G, Ames D, Ellis KA, Martins R, Maruff P, Masters CL, Romano G, Rowe CC, Savage G, Twyman R, et al. Comparison Of Three Normative Data Correction Approaches: A Cross-Sectional Evaluation In The Aibl Study Alzheimers & Dementia. 10. DOI: 10.1016/J.Jalz.2014.07.064 |
0.345 |
|
| 2014 |
Burnham S, Raghavan N, Wilson B, Baker D, Ropacki MT, Novak G, Ames D, Ellis KA, Martins R, Maruff P, Masters CL, Romano G, Rowe CC, Savage G, Twyman R, et al. Novel Statistically-Derived Composite Measures For Assessing The Efficacy Of Disease-Modifying Therapies In Prodromal Ad Trials: An Aipl Study Alzheimers & Dementia. 10: 567. DOI: 10.1016/J.Jalz.2014.05.927 |
0.471 |
|
| 2014 |
Francois M, Fenech MF, Leifert W, Hecker J, Faunt J, Martins R, Thomas P. Nuclear Shape, Dna Ploidy, And Lipid Content As Measured By High Content Analysis Laser Scanning Cytometry Is Significantly Altered In Buccal Cells From Individuals With Mild Cognitive Impairment Or Alzheimer'S Disease Alzheimers & Dementia. 10: 520. DOI: 10.1016/J.Jalz.2014.05.809 |
0.349 |
|
| 2014 |
Buckley R, Saling M, Ames D, Rowe CC, Lautenschlager NT, Maruff P, Macaulay L, Martins R, Szoeke C, Masters C, Rainey-Smith SR, Rembach A, Savage G, Ellis KA. P4-164: QUALITATIVE THEMATIC ANALYSIS OF SUBJECTIVE MEMORY COMPLAINTS IN THE HEALTHY ELDERLY AND INDIVIDUALS WITH MCI Alzheimer's & Dementia. 10: P849-P850. DOI: 10.1016/J.Jalz.2014.05.1681 |
0.412 |
|
| 2014 |
Gupta VB, Pedrini S, Hone E, Deocke J, Obryant S, Masters CL, Martins R. Peripheral Biomarkers Differentiate Between Transitional And Non-Transitional Clinical Groups In The Longitudinal Australian Imaging Biomarkers And Lifestyle Study Of Aging Alzheimers & Dementia. 10: 807. DOI: 10.1016/J.Jalz.2014.05.1582 |
0.397 |
|
| 2014 |
Asih PR, Wahjoepramono EJ, Aniwiyanti V, Taddei K, Fuller S, Sohrabi HR, Dhaliwal S, Verdile G, Carruthers M, Martins RN. P3-389: PHYSIOLOGICAL EFFECTS AND SAFETY ASSESSMENT OF TESTOSTERONE REPLACEMENT THERAPY IN OLDER MALE SUBJECTIVE MEMORY COMPLAINERS Alzheimer's & Dementia. 10: P772-P772. DOI: 10.1016/J.Jalz.2014.05.1483 |
0.516 |
|
| 2014 |
Fowler CJ, Yevenes LF, Rembach A, Faux NG, Trounson B, Pertile K, Rumble R, Ellis KA, Ames D, Bush AI, Martins R, Masters CL. P3-114: ELEVATED BLOOD HDL AND HDL-ASSOCIATED LIPOPROTEINS IN HEALTHY CONTROLS WHO RAPIDLY CONVERT TO ALZHEIMER'S DISEASE IN THE AIBL COHORT Alzheimer's & Dementia. 10: P670-P670. DOI: 10.1016/J.Jalz.2014.05.1203 |
0.598 |
|
| 2014 |
Yates P, Villemagne VL, Bourgeat P, Ellis KA, Martins R, Szoeke C, Desmond P, Masters CL, Ames D, Rowe CC. Brain Beta-Amyloid, Vascular Factors, And Cognition: 54-Month Followup Results From The Aipl Study Alzheimers & Dementia. 10: 17. DOI: 10.1016/J.Jalz.2014.05.026 |
0.481 |
|
| 2014 |
Martins R, Hone E, Doecke J, Pedrini S, Gupta V. F5-02-03: PLASMA-BASED PROTEIN BIOMARKER PANEL FOR ALZHEIMER'S DISEASE: LONGITUDINAL DATA FROM AUSTRALIAN IMAGING BIOMARKERS AND LIFESTYLE STUDY OF AGING Alzheimer's & Dementia. 10: P283-P284. DOI: 10.1016/J.Jalz.2014.04.465 |
0.387 |
|
| 2014 |
Bourgeat P, Doré V, Zhou L, Fripp J, Martins R, Macaulay L, Masters CL, Ames D, Brown B, Rowe CC, Salvado O, Villemagne VL. Automated Reporting Of Amyloid Pet Quantification On Brain Surface Through A Web Interface Alzheimers & Dementia. 10. DOI: 10.1016/J.Jalz.2014.04.424 |
0.416 |
|
| 2014 |
Chatterjee P, Lim WLF, Gupta VB, Sohrabi HR, Taddei K, Brown B, Masters CL, Morris JC, Martins R. Altered Plasma Phospholipid Composition In Autosomal Dominant Alzheimer'S Disease: A Dian Study Alzheimers & Dementia. 10: 260. DOI: 10.1016/J.Jalz.2014.04.412 |
0.503 |
|
| 2014 |
Frost S, Kanagasingam Y, Macaulay L, Koronyo-Hamaoui M, Koronyo Y, Biggs D, Verdooner S, Black K, Taddei K, Shah T, Rainey-Smith S, Bourgeat P, Salvado O, Doecke J, Wilson B, ... ... Martins R, et al. Retinal Amyloid Fluorescence Imaging Predicts Cerebral Amyloid Burden And Alzheimer'S Disease Alzheimers & Dementia. 10. DOI: 10.1016/J.Jalz.2014.04.341 |
0.419 |
|
| 2014 |
Villemagne VL, Burnham S, Brown B, Bourgeat P, Ellis KA, Yates P, Veljanovski R, Martins R, Macaulay L, Salvado O, Ames D, Masters CL, Rowe CC. PRECLINICAL EFFECTS OF Aβ DEPOSITION ON EPISODIC MEMORY AND DISEASE PROGRESSION Alzheimers & Dementia. 10: 229. DOI: 10.1016/J.Jalz.2014.04.326 |
0.482 |
|
| 2014 |
Burnham SC, Ames D, Baker D, Bush AI, Cobiac L, Doecke J, Ellis KA, Faux NG, Head R, Kiiveri H, Laws SM, Martins R, Maruff P, Savage G, Wilson B, et al. Predicting Alzheimer'S Disease From A Blood-Based Biomarker Profile: Results From Aipl At 54 Months Alzheimers & Dementia. 10: 196. DOI: 10.1016/J.Jalz.2014.04.233 |
0.463 |
|
| 2014 |
Rainey-Smith SR, Brown B, Gardener S, Peiffer J, Bourgeat P, Laws SM, Barnes M, Taddei K, Sohrabi HR, Weinborn M, Rembach A, Burnham S, Villemagne VL, Ellis KA, Macaulay L, ... ... Martins R, et al. Apoe Genotype-Dependent Effects Of Diet And Physical Activity On Cognition And Alzheimer'S-Related Pathology: Data From The Aipl Study Of Ageing Alzheimers & Dementia. 10: 166. DOI: 10.1016/J.Jalz.2014.04.165 |
0.524 |
|
| 2014 |
Harrington K, Gould E, Lim YY, Ellis KA, Ames D, Martins R, Savage G, Szoeke C, Rowe CC, Villemagne VL, Masters CL, Maruff P. The Association Between Amyloid Burden And Sub-Clinical Depression In Healthy Older Adults Alzheimers & Dementia. 10: 139. DOI: 10.1016/J.Jalz.2014.04.086 |
0.418 |
|
| 2013 |
Rowe CC, Bourgeat P, Ellis KA, Brown B, Lim YY, Mulligan R, Jones G, Maruff P, Woodward M, Price R, Robins P, Tochon-Danguy H, O'Keefe G, Pike KE, Yates P, ... ... Martins R, et al. Predicting Alzheimer disease with β-amyloid imaging: results from the Australian imaging, biomarkers, and lifestyle study of ageing. Annals of Neurology. 74: 905-13. PMID 24448836 DOI: 10.1002/Ana.24040 |
0.51 |
|
| 2013 |
Bharadwaj PR, Bates KA, Porter T, Teimouri E, Perry G, Steele JW, Gandy S, Groth D, Martins RN, Verdile G. Latrepirdine: molecular mechanisms underlying potential therapeutic roles in Alzheimer's and other neurodegenerative diseases. Translational Psychiatry. 3: e332. PMID 24301650 DOI: 10.1038/Tp.2013.97 |
0.681 |
|
| 2013 |
Benzinger TL, Blazey T, Jack CR, Koeppe RA, Su Y, Xiong C, Raichle ME, Snyder AZ, Ances BM, Bateman RJ, Cairns NJ, Fagan AM, Goate A, Marcus DS, Aisen PS, ... ... Martins R, et al. Regional variability of imaging biomarkers in autosomal dominant Alzheimer's disease. Proceedings of the National Academy of Sciences of the United States of America. 110: E4502-9. PMID 24194552 DOI: 10.1073/Pnas.1317918110 |
0.495 |
|
| 2013 |
Gupta VB, Gupta VK, Martins R. Semagacestat for treatment of Alzheimer's disease. The New England Journal of Medicine. 369: 1660-1. PMID 24152268 DOI: 10.1056/Nejmc1310845 |
0.407 |
|
| 2013 |
Frost S, Kanagasingam Y, Sohrabi H, Bourgeat P, Villemagne V, Rowe CC, Macaulay SL, Szoeke C, Ellis KA, Ames D, Masters CL, Rainey-Smith S, Martins RN. Pupil response biomarkers for early detection and monitoring of Alzheimer's disease. Current Alzheimer Research. 10: 931-9. PMID 24117119 DOI: 10.2174/15672050113106660163 |
0.499 |
|
| 2013 |
Mills SM, Mallmann J, Santacruz AM, Fuqua A, Carril M, Aisen PS, Althage MC, Belyew S, Benzinger TL, Brooks WS, Buckles VD, Cairns NJ, Clifford D, Danek A, Fagan AM, ... ... Martins RN, et al. Preclinical trials in autosomal dominant AD: implementation of the DIAN-TU trial. Revue Neurologique. 169: 737-43. PMID 24016464 DOI: 10.1016/J.Neurol.2013.07.017 |
0.362 |
|
| 2013 |
Moore EM, Mander AG, Ames D, Kotowicz MA, Carne RP, Brodaty H, Woodward M, Boundy K, Ellis KA, Bush AI, Faux NG, Martins R, Szoeke C, Rowe C, Watters DA, et al. Increased risk of cognitive impairment in patients with diabetes is associated with metformin. Diabetes Care. 36: 2981-7. PMID 24009301 DOI: 10.2337/Dc13-0229 |
0.437 |
|
| 2013 |
Frost SM, Kanagasingam Y, Sohrabi HR, Taddei K, Bateman R, Morris J, Benzinger T, Goate A, Masters CL, Martins RN. Pupil response biomarkers distinguish amyloid precursor protein mutation carriers from non-carriers. Current Alzheimer Research. 10: 790-6. PMID 23919771 DOI: 10.2174/15672050113109990154 |
0.439 |
|
| 2013 |
Harrington KD, Lim YY, Ellis KA, Copolov C, Darby D, Weinborn M, Ames D, Martins RN, Savage G, Szoeke C, Rowe C, Villemagne VL, Masters CL, Maruff P. The association of Aβ amyloid and composite cognitive measures in healthy older adults and MCI. International Psychogeriatrics / Ipa. 25: 1667-77. PMID 23866942 DOI: 10.1017/S1041610213001087 |
0.516 |
|
| 2013 |
Sharman MJ, Moussavi Nik SH, Chen MM, Ong D, Wijaya L, Laws SM, Taddei K, Newman M, Lardelli M, Martins RN, Verdile G. The Guinea Pig as a Model for Sporadic Alzheimer's Disease (AD): The Impact of Cholesterol Intake on Expression of AD-Related Genes. Plos One. 8: e66235. PMID 23805206 DOI: 10.1371/Journal.Pone.0066235 |
0.624 |
|
| 2013 |
Lim YY, Villemagne VL, Laws SM, Ames D, Pietrzak RH, Ellis KA, Harrington KD, Bourgeat P, Salvado O, Darby D, Snyder PJ, Bush AI, Martins RN, Masters CL, Rowe CC, et al. BDNF Val66Met, Aβ amyloid, and cognitive decline in preclinical Alzheimer's disease. Neurobiology of Aging. 34: 2457-64. PMID 23769397 DOI: 10.1016/J.Neurobiolaging.2013.05.006 |
0.621 |
|
| 2013 |
Foster JK, Albrecht MA, Savage G, Lautenschlager NT, Ellis KA, Maruff P, Szoeke C, Taddei K, Martins R, Masters CL, Ames D. Lack of reliable evidence for a distinctive ε4-related cognitive phenotype that is independent from clinical diagnostic status: findings from the Australian Imaging, Biomarkers and Lifestyle Study. Brain : a Journal of Neurology. 136: 2201-16. PMID 23737466 DOI: 10.1093/Brain/Awt127 |
0.474 |
|
| 2013 |
Doré V, Villemagne VL, Bourgeat P, Fripp J, Acosta O, Chetélat G, Zhou L, Martins R, Ellis KA, Masters CL, Ames D, Salvado O, Rowe CC. Cross-sectional and longitudinal analysis of the relationship between Aβ deposition, cortical thickness, and memory in cognitively unimpaired individuals and in Alzheimer disease. Jama Neurology. 70: 903-11. PMID 23712469 DOI: 10.1001/Jamaneurol.2013.1062 |
0.531 |
|
| 2013 |
Buckley R, Saling MM, Ames D, Rowe CC, Lautenschlager NT, Macaulay SL, Martins RN, Masters CL, O'Meara T, Savage G, Szoeke C, Villemagne VL, Ellis KA. Factors affecting subjective memory complaints in the AIBL aging study: biomarkers, memory, affect, and age. International Psychogeriatrics / Ipa. 25: 1307-15. PMID 23693133 DOI: 10.1017/S1041610213000665 |
0.489 |
|
| 2013 |
Lim YY, Ellis KA, Harrington K, Kamer A, Pietrzak RH, Bush AI, Darby D, Martins RN, Masters CL, Rowe CC, Savage G, Szoeke C, Villemagne VL, Ames D, Maruff P. Cognitive consequences of high Aβ amyloid in mild cognitive impairment and healthy older adults: implications for early detection of Alzheimer's disease. Neuropsychology. 27: 322-32. PMID 23688214 DOI: 10.1037/A0032321 |
0.606 |
|
| 2013 |
Lim WL, Lam SM, Shui G, Mondal A, Ong D, Duan X, Creegan R, Martins IJ, Sharman MJ, Taddei K, Verdile G, Wenk MR, Martins RN. Effects of a high-fat, high-cholesterol diet on brain lipid profiles in apolipoprotein E ε3 and ε4 knock-in mice. Neurobiology of Aging. 34: 2217-24. PMID 23601809 DOI: 10.1016/J.Neurobiolaging.2013.03.012 |
0.54 |
|
| 2013 |
Lim YY, Jaeger J, Harrington K, Ashwood T, Ellis KA, Stöffler A, Szoeke C, Lachovitzki R, Martins RN, Villemagne VL, Bush A, Masters CL, Rowe CC, Ames D, Darby D, et al. Three-month stability of the CogState brief battery in healthy older adults, mild cognitive impairment, and Alzheimer's disease: results from the Australian Imaging, Biomarkers, and Lifestyle-rate of change substudy (AIBL-ROCS). Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists. 28: 320-30. PMID 23552802 DOI: 10.1093/Arclin/Act021 |
0.589 |
|
| 2013 |
Villemagne VL, Burnham S, Bourgeat P, Brown B, Ellis KA, Salvado O, Szoeke C, Macaulay SL, Martins R, Maruff P, Ames D, Rowe CC, Masters CL. Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study. The Lancet. Neurology. 12: 357-67. PMID 23477989 DOI: 10.1016/S1474-4422(13)70044-9 |
0.488 |
|
| 2013 |
Frost S, Kanagasingam Y, Sohrabi H, Vignarajan J, Bourgeat P, Salvado O, Villemagne V, Rowe CC, Macaulay SL, Szoeke C, Ellis KA, Ames D, Masters CL, Rainey-Smith S, Martins RN, et al. Retinal vascular biomarkers for early detection and monitoring of Alzheimer's disease. Translational Psychiatry. 3: e233. PMID 23443359 DOI: 10.1038/Tp.2012.150 |
0.493 |
|
| 2013 |
O'Bryant SE, Xiao G, Edwards M, Devous M, Gupta VB, Martins R, Zhang F, Barber R. Biomarkers of Alzheimer's disease among Mexican Americans. Journal of Alzheimer's Disease : Jad. 34: 841-9. PMID 23313927 DOI: 10.3233/Jad-122074 |
0.44 |
|
| 2013 |
Ellis KA, Lim YY, Harrington K, Ames D, Bush AI, Darby D, Martins RN, Masters CL, Rowe CC, Savage G, Szoeke C, Villemagne VL, Maruff P. Decline in cognitive function over 18 months in healthy older adults with high amyloid-β. Journal of Alzheimer's Disease : Jad. 34: 861-71. PMID 23302660 DOI: 10.3233/Jad-122170 |
0.544 |
|
| 2013 |
Carrillo MC, Rowe CC, Szoeke C, Masters CL, Ames D, O'Meara T, Macaulay SL, Milner A, Ellis KA, Maruff P, Rainey-Smith SR, Martins RN, Bain LJ, Head RJ. Research and standardization in Alzheimer's trials: reaching international consensus. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 9: 160-8. PMID 23266004 DOI: 10.1016/J.Jalz.2012.10.006 |
0.493 |
|
| 2013 |
Rembach A, Doecke JD, Roberts BR, Watt AD, Faux NG, Volitakis I, Pertile KK, Rumble RL, Trounson BO, Fowler CJ, Wilson W, Ellis KA, Martins RN, Rowe CC, Villemagne VL, et al. Longitudinal analysis of serum copper and ceruloplasmin in Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 34: 171-82. PMID 23168449 DOI: 10.3233/Jad-121474 |
0.613 |
|
| 2013 |
Brown BM, Peiffer JJ, Martins RN. Multiple effects of physical activity on molecular and cognitive signs of brain aging: can exercise slow neurodegeneration and delay Alzheimer's disease? Molecular Psychiatry. 18: 864-74. PMID 23164816 DOI: 10.1038/Mp.2012.162 |
0.433 |
|
| 2013 |
Lim YY, Ellis KA, Harrington K, Pietrzak RH, Gale J, Ames D, Bush AI, Darby D, Martins RN, Masters CL, Rowe CC, Savage G, Szoeke C, Villemagne VL, Maruff P. Cognitive decline in adults with amnestic mild cognitive impairment and high amyloid-β: prodromal Alzheimer's disease? Journal of Alzheimer's Disease : Jad. 33: 1167-76. PMID 23160011 DOI: 10.3233/Jad-121771 |
0.524 |
|
| 2013 |
Lim YY, Ellis KA, Ames D, Darby D, Harrington K, Martins RN, Masters CL, Rowe C, Savage G, Szoeke C, Villemagne VL, Maruff P. Aβ amyloid, cognition, and APOE genotype in healthy older adults. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 9: 538-45. PMID 23159043 DOI: 10.1016/J.Jalz.2012.07.004 |
0.46 |
|
| 2013 |
Lim YY, Pietrzak RH, Ellis KA, Jaeger J, Harrington K, Ashwood T, Szoeke C, Martins RN, Bush AI, Masters CL, Rowe CC, Villemagne VL, Ames D, Darby D, Maruff P. Rapid decline in episodic memory in healthy older adults with high amyloid-β. Journal of Alzheimer's Disease : Jad. 33: 675-9. PMID 23001710 DOI: 10.3233/Jad-2012-121516 |
0.5 |
|
| 2013 |
Brown BM, Peiffer JJ, Taddei K, Lui JK, Laws SM, Gupta VB, Taddei T, Ward VK, Rodrigues MA, Burnham S, Rainey-Smith SR, Villemagne VL, Bush A, Ellis KA, Masters CL, ... ... Martins RN, et al. Physical activity and amyloid-β plasma and brain levels: results from the Australian Imaging, Biomarkers and Lifestyle Study of Ageing. Molecular Psychiatry. 18: 875-81. PMID 22889922 DOI: 10.1038/Mp.2012.107 |
0.621 |
|
| 2013 |
Steele JW, Ju S, Lachenmayer ML, Liken J, Stock A, Kim SH, Delgado LM, Alfaro IE, Bernales S, Verdile G, Bharadwaj P, Gupta V, Barr R, Friss A, Dolios G, ... ... Martins RN, et al. Latrepirdine stimulates autophagy and reduces accumulation of α-synuclein in cells and in mouse brain. Molecular Psychiatry. 18: 882-8. PMID 22869031 DOI: 10.1038/Mp.2012.115 |
0.633 |
|
| 2013 |
Steele JW, Lachenmayer ML, Ju S, Stock A, Liken J, Kim SH, Delgado LM, Alfaro IE, Bernales S, Verdile G, Bharadwaj P, Gupta V, Barr R, Friss A, Dolios G, ... ... Martins RN, et al. Latrepirdine improves cognition and arrests progression of neuropathology in an Alzheimer's mouse model. Molecular Psychiatry. 18: 889-97. PMID 22850627 DOI: 10.1038/Mp.2012.106 |
0.675 |
|
| 2013 |
Copolov C, Harrington K, Dow B, Joosten M, Rainey-Smith S, Rodrigues M, Rembach A, Macaulay L, Rowe C, Martins R, Masters C, Ames D, Ellis K. The effect of rapid cognitive decline in MCI and Alzheimer's disease on level of dependence, resource utilization, carer satisfaction, burden and attitudes to aging Alzheimers & Dementia. 9. DOI: 10.1016/J.Jalz.2013.05.996 |
0.545 |
|
| 2013 |
Buckley R, Saling M, Irish M, Ames D, Rowe C, Lautenschlager N, Maruff P, Macaulay L, Martins R, Masters C, O'Meara T, Savage G, Szoeke C, Villemagne V, Ellis K. P2-267: Neuropsychological predictors of autobiographical memory impairment in mild cognitive impairment (MCI) Alzheimer's & Dementia. 9: P456-P456. DOI: 10.1016/J.Jalz.2013.05.914 |
0.463 |
|
| 2013 |
Johnson P, Graham P, Wilson B, Macaulay L, Maruff P, Savage G, Ellis K, Martins R, Rowe C, Masters C, Ames D, Zhang P. Genetic algorithm with logistic regression for Alzheimer's disease diagnosis and prognosis Alzheimers & Dementia. 9. DOI: 10.1016/J.Jalz.2013.05.913 |
0.463 |
|
| 2013 |
Restrepo C, Saling M, Ames D, Bush A, Faux N, Martins R, Maruff P, Masters C, Rowe C, Szoeke C, Villemagne V, Yates P, Ellis K. The effect of vascular risk factors on the rate of cognitive change in older adults: Data from the Australian Imaging Biomarkers and Lifestyle (AIBL) flagship study Alzheimers & Dementia. 9. DOI: 10.1016/J.Jalz.2013.05.911 |
0.559 |
|
| 2013 |
Lim YY, Villemagne V, Laws S, Ames D, Pietrzak R, Ellis K, Harrington K, Bourgeat P, Salvado O, Darby D, Snyder P, Bush A, Martins R, Masters C, Rowe C, et al. Modulation of beta-amyloid-related cognitive decline by brain-derived neurotrophic factor Val66Met polymorphism in preclinical Alzheimer's disease Alzheimers & Dementia. 9. DOI: 10.1016/J.Jalz.2013.05.893 |
0.643 |
|
| 2013 |
Lim YY, Ellis K, Harrington K, Kamer A, Pietrzak R, Bush A, Darby D, Martins R, Masters C, Rowe C, Savage G, Szoeke C, Villemagne V, Ames D, Maruff P. Cognitive consequences of high beta-amyloid levels in people with mild cognitive impairment and healthy older adults: Implications for early detection of Alzheimer's disease Alzheimers & Dementia. 9: 446. DOI: 10.1016/J.Jalz.2013.05.891 |
0.638 |
|
| 2013 |
Fernando W, Martins R. A novel way of thinking of a solution for Alzheimer's disease Alzheimers & Dementia. 9: 281. DOI: 10.1016/J.Jalz.2013.05.562 |
0.383 |
|
| 2013 |
Doré V, Bourgeat P, Zhou L, Fripp J, Martins R, Macaulay L, Masters C, Ames D, Brown B, Rowe C, Salvado O, Villemagne V. Cortical surface projection of PET images from 11C- and 18F-labeled radiotracers without magnetic resonance imaging Alzheimers & Dementia. 9. DOI: 10.1016/J.Jalz.2013.05.523 |
0.353 |
|
| 2013 |
Zhang P, Graham P, Savage G, Jones A, Macaulay L, Masters C, Martins R, Gupta VB, Bush A, Maruff P, Ellis K, Szoeke C, Rowe C, Ames D, Wilson B. Change in cognition over 36 months in relation to blood biomarkers Alzheimers & Dementia. 9: 204. DOI: 10.1016/J.Jalz.2013.05.372 |
0.559 |
|
| 2013 |
Rembach A, Wilson B, Ellis K, Ames D, Rowe C, Villemagne V, Bush A, Martins R, Masters C, Doecke J. Neutrophil-lymphocyte ratio in Alzheimer's disease: Data from the Australian Imaging Biomarker and Lifestyle study of ageing Alzheimers & Dementia. 9: 203. DOI: 10.1016/J.Jalz.2013.05.368 |
0.612 |
|
| 2013 |
Thomas J, Brier M, Bateman R, Snyder A, Benzinger T, Xiong C, Raichle M, Sperling R, Mayeux R, Ghetti B, Ringman J, Salloway S, McDade E, Rossor M, Schofield P, ... ... Martins R, et al. IC-P-184: Resting state functional connectivity in autosomal dominant and sporadic Alzheimer's disease Alzheimer's & Dementia. 9: P105-P105. DOI: 10.1016/J.Jalz.2013.05.181 |
0.466 |
|
| 2013 |
Zhang P, Macaulay L, Martins R, Maruff P, Savage G, Ellis K, Szoeke C, Masters C, Rowe C, Ames D, Riley M. P4-217: Association of BMI and change in BMI with cognitive function, change in cognitive function and conversion to Alzheimer's disease Alzheimer's & Dementia. 9: P785-P786. DOI: 10.1016/J.Jalz.2013.05.1609 |
0.502 |
|
| 2013 |
Maruff P, Lim YY, Ames D, Ellis K, Pietrzak R, Savage G, Harrington K, Bush A, Szoeke C, Martins R, Villemagne V, Rowe C, Darby D, Masters C. Clinical utility of the cogstate brief battery in Alzheimer's disease–related memory impairment Alzheimers & Dementia. 9. DOI: 10.1016/J.Jalz.2013.05.1296 |
0.587 |
|
| 2013 |
Cash D, Ridgway G, Modat M, Ryan N, Kinnunen K, Cardoso J, Benzinger T, Jack CR, Raichle M, Marcus D, Ringman J, Thompson P, Ghetti B, Salloway S, Sperling R, ... ... Martins R, et al. Dissociating volume and intensity differences in familial Alzheimer's disease Alzheimers & Dementia. 9: 603. DOI: 10.1016/J.Jalz.2013.05.075 |
0.482 |
|
| 2013 |
Doré V, Bourgeat P, Zhou L, Fripp J, Martins R, Macaulay L, Masters C, Ames D, Brown B, Rowe C, Salvado O, Villemagne V. MR-less cortical surface-projection of PET images from 11C- and 18F-labeled radiotracers Alzheimers & Dementia. 9. DOI: 10.1016/J.Jalz.2013.05.017 |
0.352 |
|
| 2013 |
Rowe C, Ames D, Ellis K, Bourgeat P, Brown B, Salvado O, Szoeke C, Woodward M, Macaulay L, Maruff P, Martins R, Masters C, Villemagne V. Biomarker-based prediction of cognitive decline in 270 nondemented older individuals: Three-year follow-up results from the Australian Imaging Biomarkers and Lifestyle Study of Aging (AIBL) Alzheimers & Dementia. 9: 12. DOI: 10.1016/J.Jalz.2013.05.005 |
0.467 |
|
| 2013 |
Bourgeat P, Villemagne V, Dore V, Fripp J, Martins R, Macaulay L, Masters C, Ames D, Ellis K, Rowe C, Salvado O. Automatic 11C PiB SUVR quantification Alzheimers & Dementia. 9: 597. DOI: 10.1016/J.Jalz.2013.05.004 |
0.34 |
|
| 2013 |
Rembach A, Wilson B, Villemagne V, Ellis K, Ames D, Rowe C, Bush A, Martins R, Masters C, Doecke J. Plasma beta-amyloid levels are significantly associated with a transition toward Alzheimer's disease as measured by cognitive decline and change in neocortical amyloid burden Alzheimers & Dementia. 9. DOI: 10.1016/J.Jalz.2013.04.341 |
0.659 |
|
| 2013 |
Villemagne V, Burnham S, Bourgeat P, Brown B, Ellis K, Salvado O, Szoeke C, Macaulay L, Martins R, Maruff P, Ames D, Rowe C, Masters C. The natural history of the dynamics of beta-amyloid deposition, neurodegeneration and cognitive decline in sporadic Alzheimer's disease Alzheimers & Dementia. 9. DOI: 10.1016/J.Jalz.2013.04.253 |
0.555 |
|
| 2013 |
Yates P, Villemagne V, Desmond P, Phal P, Steward C, Salvado O, Martins R, Masters C, Ames D, Ellis K, Szoeke C, Rowe C. Microbleeds and clinical trajectories: Results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging Alzheimers & Dementia. 9: 131. DOI: 10.1016/J.Jalz.2013.04.066 |
0.406 |
|
| 2013 |
Gupta VB, Rowe C, Szoeke C, Ames D, Cobiac L, Bush A, Ellis K, Macaulay L, Masters C, Martins R. Establishing apolipoprotein J as a potential candidate for Alzheimer's disease biomarker panel: Australian Imaging, Biomarker and Lifestyle (AIBL) flagship study of aging Alzheimers & Dementia. 9: 128. DOI: 10.1016/J.Jalz.2013.04.057 |
0.622 |
|
| 2013 |
Kinnunen K, Ryan N, Cash D, Leite AB, Finnegan S, Cardoso M, Leung K, Modat M, Benzinger T, Jack C, Marcus D, Raichle M, Thompson P, Ringman J, Ghetti B, ... ... Martins R, et al. Are early atrophy patterns in autosomal dominant familial Alzheimer's disease gene-dependent? Alzheimers & Dementia. 9. DOI: 10.1016/J.Jalz.2013.04.017 |
0.47 |
|
| 2012 |
Avdesh A, Chen M, Martin-Iverson MT, Mondal A, Ong D, Rainey-Smith S, Taddei K, Lardelli M, Groth DM, Verdile G, Martins RN. Regular care and maintenance of a zebrafish (Danio rerio) laboratory: an introduction. Journal of Visualized Experiments : Jove. e4196. PMID 23183629 DOI: 10.3791/4196 |
0.499 |
|
| 2012 |
Brown BM, Peiffer JJ, Sohrabi HR, Mondal A, Gupta VB, Rainey-Smith SR, Taddei K, Burnham S, Ellis KA, Szoeke C, Masters CL, Ames D, Rowe CC, Martins RN. Intense physical activity is associated with cognitive performance in the elderly. Translational Psychiatry. 2: e191. PMID 23168991 DOI: 10.1038/Tp.2012.118 |
0.334 |
|
| 2012 |
Morris JC, Aisen PS, Bateman RJ, Benzinger TL, Cairns NJ, Fagan AM, Ghetti B, Goate AM, Holtzman DM, Klunk WE, McDade E, Marcus DS, Martins RN, Masters CL, Mayeux R, et al. Developing an international network for Alzheimer research: The Dominantly Inherited Alzheimer Network. Clinical Investigation. 2: 975-984. PMID 23139856 DOI: 10.4155/Cli.12.93 |
0.478 |
|
| 2012 |
Lim YY, Ellis KA, Pietrzak RH, Ames D, Darby D, Harrington K, Martins RN, Masters CL, Rowe C, Savage G, Szoeke C, Villemagne VL, Maruff P. Stronger effect of amyloid load than APOE genotype on cognitive decline in healthy older adults. Neurology. 79: 1645-52. PMID 23071163 DOI: 10.1212/Wnl.0B013E31826E9Ae6 |
0.406 |
|
| 2012 |
Cyarto EV, Lautenschlager NT, Desmond PM, Ames D, Szoeke C, Salvado O, Sharman MJ, Ellis KA, Phal PM, Masters CL, Rowe CC, Martins RN, Cox KL. Protocol for a randomized controlled trial evaluating the effect of physical activity on delaying the progression of white matter changes on MRI in older adults with memory complaints and mild cognitive impairment: the AIBL Active trial. Bmc Psychiatry. 12: 167. PMID 23050829 DOI: 10.1186/1471-244X-12-167 |
0.433 |
|
| 2012 |
Gardener S, Gu Y, Rainey-Smith SR, Keogh JB, Clifton PM, Mathieson SL, Taddei K, Mondal A, Ward VK, Scarmeas N, Barnes M, Ellis KA, Head R, Masters CL, Ames D, ... ... Martins RN, et al. Adherence to a Mediterranean diet and Alzheimer's disease risk in an Australian population. Translational Psychiatry. 2: e164. PMID 23032941 DOI: 10.1038/Tp.2012.91 |
0.485 |
|
| 2012 |
Bharadwaj PR, Verdile G, Barr RK, Gupta V, Steele JW, Lachenmayer ML, Yue Z, Ehrlich ME, Petsko G, Ju S, Ringe D, Sankovich SE, Caine JM, Macreadie IG, Gandy S, ... Martins RN, et al. Latrepirdine (dimebon) enhances autophagy and reduces intracellular GFP-Aβ42 levels in yeast. Journal of Alzheimer's Disease : Jad. 32: 949-67. PMID 22903131 DOI: 10.3233/Jad-2012-120178 |
0.598 |
|
| 2012 |
Sohrabi HR, Bates KA, Weinborn MG, Johnston AN, Bahramian A, Taddei K, Laws SM, Rodrigues M, Morici M, Howard M, Martins G, Mackay-Sim A, Gandy SE, Martins RN. Olfactory discrimination predicts cognitive decline among community-dwelling older adults. Translational Psychiatry. 2: e118. PMID 22832962 DOI: 10.1038/Tp.2012.43 |
0.349 |
|
| 2012 |
Doecke JD, Laws SM, Faux NG, Wilson W, Burnham SC, Lam CP, Mondal A, Bedo J, Bush AI, Brown B, De Ruyck K, Ellis KA, Fowler C, Gupta VB, Head R, ... ... Martins RN, et al. Blood-based protein biomarkers for diagnosis of Alzheimer disease. Archives of Neurology. 69: 1318-25. PMID 22801742 DOI: 10.1001/Archneurol.2012.1282 |
0.607 |
|
| 2012 |
Bateman RJ, Xiong C, Benzinger TL, Fagan AM, Goate A, Fox NC, Marcus DS, Cairns NJ, Xie X, Blazey TM, Holtzman DM, Santacruz A, Buckles V, Oliver A, Moulder K, ... ... Martins RN, et al. Clinical and biomarker changes in dominantly inherited Alzheimer's disease. The New England Journal of Medicine. 367: 795-804. PMID 22784036 DOI: 10.1056/Nejmoa1202753 |
0.473 |
|
| 2012 |
Villain N, Chételat G, Grassiot B, Bourgeat P, Jones G, Ellis KA, Ames D, Martins RN, Eustache F, Salvado O, Masters CL, Rowe CC, Villemagne VL. Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: a voxelwise PiB-PET longitudinal study. Brain : a Journal of Neurology. 135: 2126-39. PMID 22628162 DOI: 10.1093/Brain/Aws125 |
0.429 |
|
| 2012 |
Barber B, Ames D, Ellis K, Martins R, Masters C, Szoeke C. Lifestyle and late life cognitive health: sufficient evidence to act now? International Psychogeriatrics / Ipa. 24: 683-8. PMID 22313892 DOI: 10.1017/S1041610211002912 |
0.415 |
|
| 2012 |
Chételat G, Villemagne VL, Villain N, Jones G, Ellis KA, Ames D, Martins RN, Masters CL, Rowe CC. Accelerated cortical atrophy in cognitively normal elderly with high β-amyloid deposition. Neurology. 78: 477-84. PMID 22302548 DOI: 10.1212/Wnl.0B013E318246D67A |
0.508 |
|
| 2012 |
Lim YY, Ellis KA, Harrington K, Ames D, Martins RN, Masters CL, Rowe C, Savage G, Szoeke C, Darby D, Maruff P, The Aibl Research Group. Use of the CogState Brief Battery in the assessment of Alzheimer's disease related cognitive impairment in the Australian Imaging, Biomarkers and Lifestyle (AIBL) study. Journal of Clinical and Experimental Neuropsychology. 34: 345-58. PMID 22248010 DOI: 10.1080/13803395.2011.643227 |
0.477 |
|
| 2012 |
Acosta O, Fripp J, Doré V, Bourgeat P, Favreau JM, Chételat G, Rueda A, Villemagne VL, Szoeke C, Ames D, Ellis KA, Martins RN, Masters CL, Rowe CC, Bonner E, et al. Cortical surface mapping using topology correction, partial flattening and 3D shape context-based non-rigid registration for use in quantifying atrophy in Alzheimer's disease. Journal of Neuroscience Methods. 205: 96-109. PMID 22226742 DOI: 10.1016/J.Jneumeth.2011.12.011 |
0.436 |
|
| 2012 |
Avdesh A, Martin-Iverson MT, Mondal A, Chen M, Askraba S, Morgan N, Lardelli M, Groth DM, Verdile G, Martins RN. Evaluation of color preference in zebrafish for learning and memory. Journal of Alzheimer's Disease : Jad. 28: 459-69. PMID 22008261 DOI: 10.3233/Jad-2011-110704 |
0.519 |
|
| 2012 |
Sona A, Zhang P, Ames D, Bush AI, Lautenschlager NT, Martins RN, Masters CL, Rowe CC, Szoeke C, Taddei K, Ellis KA. Predictors of rapid cognitive decline in Alzheimer's disease: results from the Australian imaging, biomarkers and lifestyle (AIBL) study of ageing. International Psychogeriatrics / Ipa. 24: 197-204. PMID 21749739 DOI: 10.1017/S1041610211001335 |
0.606 |
|
| 2012 |
Doré V, Bourgeat P, Fripp J, Acosta O, Chetelat G, Szoeke C, Ellis KA, Martins RN, Villemagne V, Masters CL, Ames D, Rowe CC, Salvado O. A surface based approach for cortical thickness comparison between PiB+ and PiB-healthy control subjects Progress in Biomedical Optics and Imaging - Proceedings of Spie. 8314. DOI: 10.1117/12.911752 |
0.46 |
|
| 2012 |
Laws SM, Verdile G, Doecke J, Martins RN. Diagnostic and therapeutic approaches to alzheimer’s disease Pathology. 44: S17. DOI: 10.1016/S0031-3025(16)32639-3 |
0.651 |
|
| 2012 |
Villemagne V, Ellis K, Bourgeat P, Brown B, Jones G, Fripp J, Martins R, Salvado O, Ames D, Masters C, Rowe C. Sigmoidal kinetics of BETA-AMYLOID deposition: Twenty-year interval between normality and fully developed Alzheimer's disease Alzheimers & Dementia. 8. DOI: 10.1016/J.Jalz.2013.08.148 |
0.526 |
|
| 2012 |
Appannah A, Szoeke C, Ellis K, Rowe C, Martins R, Masters C, Ames D, Bush A. Investigating cardiovascular risk factors on cognition: A two-cohort study Alzheimers & Dementia. 8. DOI: 10.1016/J.Jalz.2012.05.878 |
0.549 |
|
| 2012 |
Faux N, Burnham S, Wilson B, Jones G, Laws S, Bedo J, Ames D, Bush A, Doecke J, Ellis K, Head R, Kiiveri H, Macaulay L, Martins R, Masters C, et al. An update on an AIBL blood-based biomarker panel for the prediction of Aβ burden Alzheimers & Dementia. 8: 283. DOI: 10.1016/J.Jalz.2012.05.764 |
0.57 |
|
| 2012 |
Becker J, Koeppe R, Benzinger T, Jack C, Marcus D, Raichle M, Thompson P, Saykin A, Correia S, Schofield P, Rowe C, Fox N, Brickman A, Ghetti B, Masters C, ... ... Martins R, et al. FDG metabolism in the DIAN study of autosomal dominant Alzheimer's disease Alzheimers & Dementia. 8. DOI: 10.1016/J.Jalz.2012.05.655 |
0.498 |
|
| 2012 |
Chhatwal J, Schultz A, Johnson K, Benzinger T, Jack C, Salloway S, Ringman J, Koeppe R, Marcus D, Thompson P, Saykin A, Correia S, Schofield P, Rowe C, Fox N, ... ... Martins R, et al. O2-06-01: Disrupted functional connectivity in autosomal dominant Alzheimer's disease: Preliminary findings from the DIAN study Alzheimer's & Dementia. 8: P244-P245. DOI: 10.1016/J.Jalz.2012.05.654 |
0.486 |
|
| 2012 |
Shah T, Verdile G, Sohrabi H, Martins R. P1-129: Physical activity and cognitive stimulation improve cognition and alter levels of plasma beta-amyloid in healthy elderly Alzheimer's & Dementia. 8: P151-P151. DOI: 10.1016/J.Jalz.2012.05.406 |
0.641 |
|
| 2012 |
Burnham S, Graham P, Wilson B, Ames D, Macaulay L, Martins R, Masters C, Maruff P, Rowe C, Szoeke C, Ryan L, Ellis K. Intensity of dementia through latent variable modelling (I-DeLV) in the AIBL cohort Alzheimers & Dementia. 8: 131. DOI: 10.1016/J.Jalz.2012.05.347 |
0.53 |
|
| 2012 |
Burnham S, Wilson B, Graham P, Kiiveri H, Ames D, Macaulay L, Martins R, Masters C, Rowe C, Salvado O, Szoeke C, Villemagne V, Ellis K. Cognitive assessments as estimators of neocortical beta-amyloid burden in the AIBL cohort Alzheimers & Dementia. 8. DOI: 10.1016/J.Jalz.2012.05.346 |
0.48 |
|
| 2012 |
Villemagne V, Ellis K, Chetelat G, Brown B, Bourgeat P, Jones G, Martins R, Salvado O, Ames D, Masters C, Rowe C. Relation between rates of Aβ deposition, APOE genotype and cognition: Results from a 3- to 5-year longitudinal study Alzheimers & Dementia. 8: 113. DOI: 10.1016/J.Jalz.2012.05.293 |
0.51 |
|
| 2012 |
Gupta VB, Wilson A, Rainey-Smith S, Laws S, Bush A, Ellis K, Macaulay L, Rowe C, Szoeke C, Taddei K, Ames D, Masters C, Martins R. Establishing apolipoprotein E as a biomarker for Alzheimer's disease: Australian Imaging, Biomarker and Lifestyle (AIBL) Flagship Study of Ageing Alzheimers & Dementia. 8. DOI: 10.1016/J.Jalz.2012.05.285 |
0.618 |
|
| 2012 |
Shah T, Verdile G, Sohrabi H, Martins R. O1-08-03: Cross-training of auditory and visual brain training software program improves cognition and alters plasma BDNF levels in healthy older adults Alzheimer's & Dementia. 8: P99-P99. DOI: 10.1016/J.Jalz.2012.05.247 |
0.578 |
|
| 2012 |
Rainey-Smith S, Brown B, Ruyck KD, Laws S, Wilson A, Gupta VB, Ames D, Ellis K, Taddei K, Head R, Macaulay L, Masters C, Rowe C, Szoeke C, Martins R. Alzheimer's disease-related changes in plasma brain-derived neurotrophic factor levels: Data from the AIBL study Alzheimers & Dementia. 8. DOI: 10.1016/J.Jalz.2012.05.2035 |
0.492 |
|
| 2012 |
Laws S, Bender S, Rainey-Smith S, Wilson A, Gupta VB, Ruyck Kd, Bush A, Ellis K, Macaulay L, Rowe C, Szoeke C, Taddei K, Ames D, Masters C, Martins R. Alzheimer's disease–related changes in plasma cortisol levels and gene involvement in the AIBL study Alzheimers & Dementia. 8: 407. DOI: 10.1016/J.Jalz.2012.05.2034 |
0.601 |
|
| 2012 |
Benzinger T, Blazey T, Ances B, Raichle M, Ances B, Snyder A, Su Y, Marcus D, Ringman J, Thompson P, Ghetti B, Saykin A, Salloway S, Correia S, Johnson K, ... ... Martins R, et al. IC-P-128: Progressive white matter abnormalities in autosomal dominant Alzheimer's disease: Results of the DIAN study Alzheimer's & Dementia. 8: P68-P69. DOI: 10.1016/j.jalz.2012.05.1858 |
0.477 |
|
| 2012 |
Laws S, Lam C, Mondal A, Bush A, Ellis K, Macaulay L, Rowe C, Taddei K, Szoeke C, Ames D, Masters C, Martins R. Gene combination associations with Alzheimer's disease risk and quantitative traits in the AIBL study Alzheimers & Dementia. 8. DOI: 10.1016/J.Jalz.2012.05.1838 |
0.598 |
|
| 2012 |
Chen M, Tegg M, Avdesh A, Mondal A, Lardelli M, Verdile G, Martins R. P4-121: Analysis of insulin-degrading enzyme (IDE) expression and function in zebrafish embryos Alzheimer's & Dementia. 8: P674-P674. DOI: 10.1016/J.Jalz.2012.05.1824 |
0.539 |
|
| 2012 |
Kinnunen K, Cash D, Leung K, Liang Y, Cardoso M, Modat M, Malone I, Benzinger T, Koeppe R, Jack C, Raichle M, Marcus D, Ringman J, Thompson P, Saykin A, ... ... Martins R, et al. Brain and hippocampal rates of atrophy in familial Alzheimer's disease mutation carriers: Preliminary findings from the DIAN study Alzheimers & Dementia. 8. DOI: 10.1016/J.Jalz.2012.05.172 |
0.476 |
|
| 2012 |
Bharadwaj P, Verdile G, Caine J, Macreadie I, Martins R. A yeast model for studying intracellular clearance of beta-amyloid 42 Alzheimers & Dementia. 8: 642. DOI: 10.1016/J.Jalz.2012.05.1716 |
0.601 |
|
| 2012 |
Restrepo C, Saling M, Yates P, Villemagne V, Ames D, Bush A, Faux N, Martins R, Masters C, Rowe C, Szoeke C, Ellis K. The effect of vascular risk factors on cognition in older adults: Data from the AIBL study Alzheimers & Dementia. 8: 635. DOI: 10.1016/J.Jalz.2012.05.1693 |
0.546 |
|
| 2012 |
Yates P, Desmond P, Raniga P, Phal P, Steward C, Salvado O, Martins R, Salinas S, Ellis K, Szoeke C, Masters C, Ames D, Villemagne V, Rowe C. Incidence and Associations of Lobar Microbleeds: Results From the Australian Imaging, Biomarkers and Lifestyle Study of Ageing (Aibl) Alzheimers & Dementia. 8: 33-33. DOI: 10.1016/J.Jalz.2012.05.1642 |
0.416 |
|
| 2012 |
Lim YY, Harrington K, Ellis K, Ames D, Ashwood T, Jaeger J, Lachovitzki R, Martins R, Masters C, Rowe C, Savage G, Szoeke C, Villemagne V, Darby D, Maruff P. The Australian Imaging, Biomarkers and Lifestyle-Rate of Change sub-study (AIBL-ROCS): Rationale, design, acceptability and pilot data for the first three months of assessment Alzheimers & Dementia. 8: 557. DOI: 10.1016/J.Jalz.2012.05.1500 |
0.382 |
|
| 2012 |
Ellis K, Lim YY, Ames D, Darby D, Harrington K, Martins R, Masters C, Rowe C, Savage G, Szoeke C, Villemagne V, Maruff P. Aβ amyloid, cognition and APOE genotype in the preclinical stages of Alzheimer's disease Alzheimers & Dementia. 8. DOI: 10.1016/J.Jalz.2012.05.1499 |
0.592 |
|
| 2012 |
Kamer A, Ellis K, Kinsella G, Ames D, Martins R, Rowe C, Macaulay L, Szoeke C, Masters C. APOE and cognitive dysfunction in Alzheimer's dementia and mild cognitive impairment Alzheimers & Dementia. 8. DOI: 10.1016/J.Jalz.2012.05.1441 |
0.521 |
|
| 2012 |
Raffelt D, Tournier JD, Crozier S, Ellis K, Martins R, Villemagne V, Masters C, Ames D, Rowe C, Salvado O, Connelly A. Apparent fibre density: A novel MRI approach that identifies specific white matter tracts affected in Alzheimer's disease and MCI Alzheimers & Dementia. 8: 61-61. DOI: 10.1016/J.Jalz.2012.05.142 |
0.495 |
|
| 2012 |
Cyarto E, Cox K, Desmond P, Ames D, Szoeke C, Salvado O, Sharman M, Ellis K, Phal P, Masters C, Rowe C, Martins R, Lautenschlager N. AIBL ACTIVE: A randomized controlled trial of physical activity to delay the progression of white matter hyperintensities on MRI in older adults at risk of cognitive decline Alzheimers & Dementia. 8: 506. DOI: 10.1016/J.Jalz.2012.05.1377 |
0.501 |
|
| 2012 |
Gardener S, Rainey-Smith S, Gu Y, Taddei K, Laws S, Gupta VB, Ames D, Ellis K, Head R, Macaulay L, Masters C, Rowe C, Szoeke C, Clifton P, Keogh J, ... ... Martins R, et al. Diet, neuroimaging biomarkers and Alzheimer's disease: Data from the Australian Imaging, Biomarkers and Lifestyle Study of Ageing Alzheimers & Dementia. 8: 503. DOI: 10.1016/J.Jalz.2012.05.1365 |
0.514 |
|
| 2012 |
Brown B, Peiffer J, Gupta VB, Taddei K, Salvado O, Villemagne V, Rainey-Smith S, Ellis K, Ames D, Rowe C, Masters C, Szoeke C, Martins R. Level of physical activity is associated with hippocampal volume in a subgroup of the AIBL cohort Alzheimers & Dementia. 8: 494. DOI: 10.1016/J.Jalz.2012.05.1341 |
0.382 |
|
| 2012 |
Szoeke C, Ellis K, Zhang P, Rowe C, Martins R, Masters C, Ames D. A return to clinical skills in the early diagnosis of Alzheimer's disease Alzheimers & Dementia. 8: 491. DOI: 10.1016/J.Jalz.2012.05.1331 |
0.502 |
|
| 2012 |
Benzinger T, Blazey T, Koeppe R, Jack C, Raichle M, Su Y, Snyder A, Marcus D, Ringman J, Thompson P, Ghetti B, Saykin A, Salloway S, Correia S, Johnson K, ... ... Martins R, et al. Elevated PiB precedes dementia in autosomal dominant Alzheimer's disease: PiB, FDG and atrophy in the DIAN cohort Alzheimers & Dementia. 8. DOI: 10.1016/J.Jalz.2012.05.132 |
0.551 |
|
| 2012 |
Ellis K, Maruff P, Martins R, Masters C, McBride S, Macaulay L, Rowe C, Rainey-Smith S, Rembach A, Savage G, Szoeke C, Taddei K, Villemagne V, Zhang P, Ames D. Rates of conversion to MCI and Alzheimer's in the Australian Imaging, Biomarkers and Lifestyle (AIBL) cohort over 36 months Alzheimers & Dementia. 8. DOI: 10.1016/J.Jalz.2012.05.1312 |
0.502 |
|
| 2012 |
Verdile G, Sharman M, Chen M, Nik SM, Ong D, Wijaya L, Morgan N, Lardelli M, Martins R. P3-059: The impact of cholesterol intake on expression of Alzheimer's disease-related genes in the guinea pig brain Alzheimer's & Dementia. 8: P474-P475. DOI: 10.1016/J.Jalz.2012.05.1278 |
0.633 |
|
| 2012 |
Lim YY, Ellis K, Ames D, Harrington K, Martins R, Masters C, Rowe C, Savage G, Szoeke C, Villemagne V, Pietrzak R, Maruff P. Effect of Aβ burden and apolipoprotein E-ε4 on cognitive decline at 18 months in healthy older adults Alzheimers & Dementia. 8: 439. DOI: 10.1016/J.Jalz.2012.05.1168 |
0.488 |
|
| 2012 |
Rowe C, Ellis K, Brown B, Bourgeat P, Faux N, Martins R, Salvado O, Masters C, Ames D, Villemagne V. Cognition, hippocampal volume and fibrillar Aβ burden as predictors of cognitive decline: Three-year follow-up results from AIBL Alzheimers & Dementia. 8: 433. DOI: 10.1016/J.Jalz.2012.05.1154 |
0.492 |
|
| 2012 |
Dore V, Fripp J, Bourgeat P, Acosta O, Zhou L, Raniga P, Martins R, Macaulay L, Ellis K, Masters C, Ames D, Villemagne V, Rowe C, Salvado O. Longitudinal analysis of cortical thickness in PiB+ and PiB- healthy elderly controls Alzheimers & Dementia. 8: 34. DOI: 10.1016/J.Jalz.2012.05.088 |
0.395 |
|
| 2012 |
Bourgeat P, Fripp J, Raniga P, Dore V, Zhou L, Martins R, Macaulay L, Masters C, Ames D, Ellis K, Villemagne V, Rowe C, Salvado O. Longitudinal modeling of joint PiB/MRI changes in Alzheimer's disease Alzheimers & Dementia. 8: 29. DOI: 10.1016/J.Jalz.2012.05.075 |
0.498 |
|
| 2012 |
Bourgeat P, Salvado O, Raniga P, Dore V, Zhou L, Martins R, Macaulay L, Masters C, Ames D, Ellis K, Villemagne V, Rowe C, Fripp J. Classification of Alzheimer's subject based on PiB-MR manifold learning Alzheimers & Dementia. 8: 344. DOI: 10.1016/J.Jalz.2012.05.074 |
0.444 |
|
| 2012 |
Kinnunen K, Cash D, Liang Y, Leung K, Cardoso M, Modat M, Malone I, Yeatman T, Nicholas J, Benzinger T, Koeppe R, Jack C, Raichle M, Marcus D, Ringman J, ... ... Martins R, et al. Cross-sectional cerebral volumetric differences and associations with estimated time to age-at-onset in familial Alzheimer's disease: Findings from the DIAN study Alzheimers & Dementia. 8: 23. DOI: 10.1016/J.Jalz.2012.05.064 |
0.517 |
|
| 2012 |
Cash D, Ridgway G, Ryan N, Kinnunen K, Yeatman T, Malone I, Benzinger T, Koeppe R, Jack C, Raichle M, Marcus D, Ringman J, Thompson P, Saykin A, Salloway S, ... ... Martins R, et al. A voxel-based morphometry study of volumetric MRI in familial Alzheimer’s disease Alzheimers & Dementia. 8. DOI: 10.1016/J.Jalz.2012.05.052 |
0.459 |
|
| 2012 |
Bateman R, Benzinger T, Cairns N, Fagan A, Goate A, Marcus D, Storandt M, Xiong C, Buckles V, Holtzman D, Moulder K, Oliver A, Santacruz A, Fox N, Ghetti B, ... ... Martins R, et al. Presymptomatic Alzheimer's disease in the Dominantly Inherited Alzheimer's Network (DIAN) Alzheimers & Dementia. 8: 4. DOI: 10.1016/J.Jalz.2012.05.015 |
0.521 |
|
| 2011 |
Wahjoepramono EJ, Wijaya LK, Taddei K, Bates KA, Howard M, Martins G, deRuyck K, Matthews PM, Verdile G, Martins RN. Direct exposure of guinea pig CNS to human luteinizing hormone increases cerebrospinal fluid and cerebral beta amyloid levels. Neuroendocrinology. 94: 313-22. PMID 21985789 DOI: 10.1159/000330812 |
0.587 |
|
| 2011 |
Faux NG, Ellis KA, Porter L, Fowler CJ, Laws SM, Martins RN, Pertile KK, Rembach A, Rowe CC, Rumble RL, Szoeke C, Taddei K, Taddei T, Trounson BO, Villemagne VL, et al. Homocysteine, vitamin B12, and folic acid levels in Alzheimer's disease, mild cognitive impairment, and healthy elderly: baseline characteristics in subjects of the Australian Imaging Biomarker Lifestyle study. Journal of Alzheimer's Disease : Jad. 27: 909-22. PMID 21891867 DOI: 10.3233/Jad-2011-110752 |
0.61 |
|
| 2011 |
Mattsson N, Andreasson U, Persson S, Arai H, Batish SD, Bernardini S, Bocchio-Chiavetto L, Blankenstein MA, Carrillo MC, Chalbot S, Coart E, Chiasserini D, Cutler N, Dahlfors G, Duller S, ... ... Martins R, et al. The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 7: 386-395.e6. PMID 21784349 DOI: 10.1016/J.Jalz.2011.05.2243 |
0.507 |
|
| 2011 |
Kanyenda LJ, Verdile G, Boulos S, Krishnaswamy S, Taddei K, Meloni BP, Mastaglia FL, Martins RN. The dynamics of CD147 in Alzheimer's disease development and pathology. Journal of Alzheimer's Disease : Jad. 26: 593-605. PMID 21694447 DOI: 10.3233/Jad-2011-110584 |
0.582 |
|
| 2011 |
Hata S, Fujishige S, Araki Y, Taniguchi M, Urakami K, Peskind E, Akatsu H, Araseki M, Yamamoto K, Martins RN, Maeda M, Nishimura M, Levey A, Chung KA, Montine T, et al. Alternative processing of γ-secretase substrates in common forms of mild cognitive impairment and Alzheimer's disease: evidence for γ-secretase dysfunction. Annals of Neurology. 69: 1026-31. PMID 21681798 DOI: 10.1002/Ana.22343 |
0.313 |
|
| 2011 |
Pike KE, Ellis KA, Villemagne VL, Good N, Chételat G, Ames D, Szoeke C, Laws SM, Verdile G, Martins RN, Masters CL, Rowe CC. Cognition and beta-amyloid in preclinical Alzheimer's disease: data from the AIBL study. Neuropsychologia. 49: 2384-90. PMID 21529702 DOI: 10.1016/J.Neuropsychologia.2011.04.012 |
0.7 |
|
| 2011 |
Lambert JC, Dallongeville J, Ellis KA, Schraen-Maschke S, Lui J, Laws S, Dumont J, Richard F, Cottel D, Berr C, Ames D, Masters CL, Rowe CC, Szoeke C, Tzourio C, ... ... Martins R, et al. Association of plasma Aß peptides with blood pressure in the elderly. Plos One. 6: e18536. PMID 21525986 DOI: 10.1371/Journal.Pone.0018536 |
0.36 |
|
| 2011 |
Sohrabi HR, Weinborn M, Badcock J, Bates KA, Clarnette R, Trivedi D, Verdile G, Sutton T, Lenzo NP, Gandy SE, Martins RN. New lexicon and criteria for the diagnosis of Alzheimer's disease. The Lancet. Neurology. 10: 299-300; author repl. PMID 21435594 DOI: 10.1016/S1474-4422(11)70056-4 |
0.647 |
|
| 2011 |
Gupta VB, Laws SM, Villemagne VL, Ames D, Bush AI, Ellis KA, Lui JK, Masters C, Rowe CC, Szoeke C, Taddei K, Martins RN. Plasma apolipoprotein E and Alzheimer disease risk: the AIBL study of aging. Neurology. 76: 1091-8. PMID 21422459 DOI: 10.1212/Wnl.0B013E318211C352 |
0.607 |
|
| 2011 |
Ellis KA, Rowe CC, Szoeke CE, Villemagne VL, Ames D, Chételat G, Martins RN, Masters CL, Fripp J, Acosta O, Raniga P, Bourgeat PT, Salvado O. Advances in structural and molecular neuroimaging in Alzheimer's disease. The Medical Journal of Australia. 194: S20-3. PMID 21401483 DOI: 10.5694/J.1326-5377.2011.Tb02938.X |
0.516 |
|
| 2011 |
McBride SJ, Szoeke CE, Good NM, Ames D, Martins RN, Masters CL, Maruff PT, Rowe CC, Savage G, Ellis KA. A web-based normative data tool for assessing cognitive performance in healthy older Australians. The Medical Journal of Australia. 194: S12-4. PMID 21401481 DOI: 10.5694/J.1326-5377.2011.Tb02936.X |
0.384 |
|
| 2011 |
Sittironnarit G, Ames D, Bush AI, Faux N, Flicker L, Foster J, Hilmer S, Lautenschlager NT, Maruff P, Masters CL, Martins RN, Rowe C, Szoeke C, Ellis KA. Effects of anticholinergic drugs on cognitive function in older Australians: results from the AIBL study. Dementia and Geriatric Cognitive Disorders. 31: 173-8. PMID 21389718 DOI: 10.1159/000325171 |
0.582 |
|
| 2011 |
Chételat G, Villemagne VL, Pike KE, Ellis KA, Bourgeat P, Jones G, O'Keefe GJ, Salvado O, Szoeke C, Martins RN, Ames D, Masters CL, Rowe CC. Independent contribution of temporal beta-amyloid deposition to memory decline in the pre-dementia phase of Alzheimer's disease. Brain : a Journal of Neurology. 134: 798-807. PMID 21310725 DOI: 10.1093/Brain/Awq383 |
0.493 |
|
| 2011 |
Villemagne VL, Pike KE, Chételat G, Ellis KA, Mulligan RS, Bourgeat P, Ackermann U, Jones G, Szoeke C, Salvado O, Martins R, O'Keefe G, Mathis CA, Klunk WE, Ames D, et al. Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease. Annals of Neurology. 69: 181-92. PMID 21280088 DOI: 10.1002/Ana.22248 |
0.457 |
|
| 2011 |
Newman M, Verdile G, Martins RN, Lardelli M. Zebrafish as a tool in Alzheimer's disease research. Biochimica Et Biophysica Acta. 1812: 346-52. PMID 20920580 DOI: 10.1016/J.Bbadis.2010.09.012 |
0.608 |
|
| 2011 |
Szoeke C, Ellis K, Fahey M, Zhang P, Savage G, Sohrabi H, Rowe C, Martins R, Masters C, Ames D. Healthy older adults in the AIBL cohort at risk for cognitive decline Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.09.018 |
0.437 |
|
| 2011 |
Tegg M, Rainey-Smith S, Gupta VB, Martins R. Insulin-degrading enzyme as a potential blood biomarker for Alzheimer's disease Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.965 |
0.348 |
|
| 2011 |
Buckley R, Saling M, Ellis K, Lautenschlager N, Maruff P, Martins R, Masters C, Rowe C, Savage G, Szoeke C, Ames D. Cognitive and affective predictors of subjective memory complaints in the Australian Imaging Biomarkers and Lifestyle (AIBL) study of aging: A cross-sectional analysis Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.677 |
0.454 |
|
| 2011 |
Dore V, Bourgeat P, Fripp J, Acosta O, Chetelat G, Szoeke C, Ellis K, Martins R, Villemagne V, Masters C, Ames D, Rowe C, Salvado O. Cortical thickness comparison between PiB-positive and PiB-negative healthy control patients Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.591 |
0.364 |
|
| 2011 |
Ellis KA, Rowe C, Salvado O, Masters C, Martins R, Villemagne V, Bourgeat P, Ames D, Maruff P, Savage G, Macaulay L, Szoeke C, Yates P, Restrepo C. Normative neuropsychology datasets free from prodromal Alzheimer's disease (AD) cases may improve sensitivity for detecting early cognitive decline: Data from the AIBL study Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.427 |
0.571 |
|
| 2011 |
Ellis KA, Rowe C, Masters C, Szoeke C, Taddei K, Martins R, Villemagne V, Fahey M, Ames D, Maruff P, Zhang P, Savage G, Macaulay L. Predictors of cognitive decline at 18 month follow up among 1112 participants in the Australian imaging, biomarkers and lifestyle flagship study of ageing (AIBL) Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.426 |
0.512 |
|
| 2011 |
Rembach A, Rowe C, Ellis K, Doecke J, Masters C, Martins R, Faux N, Duce J, Ames D, Volitakis I, Bush A, Roberts B, Trounson B, Fowler C, Pertile K, et al. Plasma copper and ceruloplasmin are not altered in Alzheimer's disease: Baseline data in the Australian Imaging Biomarker Lifestyle (AIBL) study of Ageing Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.386 |
0.613 |
|
| 2011 |
Frost S, Martins R, Bourgeat P, Kanagasingam Y, Rowe C. Retinal vascular parameters as biomarkers for Alzheimer's disease Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.361 |
0.358 |
|
| 2011 |
Drummond E, Martins R, Harvey A. P1-037: Development of an Alzheimer's disease mouse model using viral vectors to cause localized over-expression of beta amyloid Alzheimer's & Dementia. 7: S122-S122. DOI: 10.1016/J.Jalz.2011.05.317 |
0.401 |
|
| 2011 |
Bates KA, Harvey A, Martins R, Vink R. Closed head injury in the guinea pig, a new animal model for Alzheimer's disease? Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.313 |
0.331 |
|
| 2011 |
Avdesh A, Martin-Iverson M, Chen M, Groth D, Mondal A, Morgan N, Lardelli M, Martins R, Verdile G. Evaluation of color preference in zebrafish: A possible potential model for learning and memory disorders Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.311 |
0.544 |
|
| 2011 |
Morici M, Martins I, Taddei K, Martins R, Verdile G, Wijaya L, Sharman M, Berger T. O1-03-06: Peripheral clearance of intravenously injected Aß42 is APOE genotype-specific in chow-fed mice but not cholesterol-fed mice Alzheimer's & Dementia. 7: S99-S99. DOI: 10.1016/J.Jalz.2011.05.244 |
0.549 |
|
| 2011 |
Rowe C, Ellis K, Brown B, Bourgeat P, Head R, Salvado O, Martins R, Masters C, Ames D, Villemagne V. The consequences of Aβ deposition in aging and Alzheimer's disease: Results from 366 elderly subjects Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.2016 |
0.546 |
|
| 2011 |
Fagan A, Xiong C, Bateman R, Goate A, Holtzman D, Ghetti B, Martins R, Masters C, Mayeux R, Ringman J, Rossor M, Salloway S, Schofield P, Sperling R, Morris J. Plasma and Cerebrospinal Fluid Markers in the DIAN Study of Autosomal-Dominant Alzheimer’s Disease Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.1960 |
0.425 |
|
| 2011 |
Martins R, Gupta VB, Sohrabi H, Clarnette R, Zentner A, Paton A, Taddei K, Lenzo N, Salvado O, Morris J. Androgen intervention therapy in a patient with familial Alzheimer's disease Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.1735 |
0.322 |
|
| 2011 |
Villemagne V, Ellis K, Chetelat G, Bourgeat P, Jones G, Martins R, Salvado O, Ames D, Masters C, Rowe C. Aβ accumulation correlates with cognitive decline: results from the longitudinal AIBL study Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.142 |
0.523 |
|
| 2011 |
Singh S, Sharman M, Martins R. Protective effects of curcuminoids against beta amyloid toxicity Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.1373 |
0.31 |
|
| 2011 |
Ellis K, Walker S, Robertson J, Mucha L, Bobula J, Martins R, Masters C, Rowe C, Szoeke C, Ames D. Dependence and resource utilization in MCI and Alzheimer’s patients participating in the AIBL study Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.1273 |
0.396 |
|
| 2011 |
Macreadie I, Verdile G, Martins R. P2-300: Targets of Aβ-induced activation of mTOR pathway in yeast model Alzheimer's & Dementia. 7: S406-S407. DOI: 10.1016/J.Jalz.2011.05.1178 |
0.587 |
|
| 2011 |
Chetelat G, Villain N, Villemagne V, Ames D, Ellis K, Head R, Martins R, Masters C, Rowe C. The effects of APOE4 on the rate of atrophy and Aβ deposition in asymptomatic elderly Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.106 |
0.477 |
|
| 2011 |
Lambert J, Dallongeville J, Ellis K, Schraen-Maschke S, Lui J, Laws S, Dumont J, Richard F, Cottel D, Berr C, Ames D, Masters C, Rowe C, Szoeke C, Tzourio C, ... ... Martins R, et al. Association of plasma Amyloid Beta peptides with blood pressure in the elderly Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.1027 |
0.429 |
|
| 2011 |
Chételat G, Villemagne V, Villain N, Jones G, Ellis K, Ames D, Martins R, Head R, Masters C, Rowe C. Greater rate of atrophy in elderly with high versus low Aβ deposition Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.051 |
0.453 |
|
| 2010 |
Frost S, Martins RN, Kanagasingam Y. Ocular biomarkers for early detection of Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 22: 1-16. PMID 20847434 DOI: 10.3233/JAD-2010-100819 |
0.374 |
|
| 2010 |
Barron AM, Verdile G, Taddei K, Bates KA, Martins RN. Effect of chronic hCG administration on Alzheimer's-related cognition and A beta accumulation in PS1KI mice. Endocrinology. 151: 5380-8. PMID 20844010 DOI: 10.1210/En.2009-1168 |
0.657 |
|
| 2010 |
Chételat G, Villemagne VL, Pike KE, Baron JC, Bourgeat P, Jones G, Faux NG, Ellis KA, Salvado O, Szoeke C, Martins RN, Ames D, Masters CL, Rowe CC. Larger temporal volume in elderly with high versus low beta-amyloid deposition. Brain : a Journal of Neurology. 133: 3349-58. PMID 20739349 DOI: 10.1093/Brain/Awq187 |
0.417 |
|
| 2010 |
Bharadwaj P, Martins R, Macreadie I. Yeast as a model for studying Alzheimer's disease. Fems Yeast Research. 10: 961-9. PMID 20618869 DOI: 10.1111/J.1567-1364.2010.00658.X |
0.481 |
|
| 2010 |
Newman M, Wilson L, Camp E, Verdile G, Martins R, Lardelli M. A zebrafish melanophore model of amyloid beta toxicity. Zebrafish. 7: 155-9. PMID 20515319 DOI: 10.1089/Zeb.2009.0628 |
0.618 |
|
| 2010 |
Rowe CC, Ellis KA, Rimajova M, Bourgeat P, Pike KE, Jones G, Fripp J, Tochon-Danguy H, Morandeau L, O'Keefe G, Price R, Raniga P, Robins P, Acosta O, Lenzo N, ... ... Martins R, et al. Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging. Neurobiology of Aging. 31: 1275-83. PMID 20472326 DOI: 10.1016/J.Neurobiolaging.2010.04.007 |
0.589 |
|
| 2010 |
Ellis KA, Rowe CC, Villemagne VL, Martins RN, Masters CL, Salvado O, Szoeke C, Ames D. Addressing population aging and Alzheimer's disease through the Australian imaging biomarkers and lifestyle study: collaboration with the Alzheimer's Disease Neuroimaging Initiative. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 6: 291-6. PMID 20451879 DOI: 10.1016/J.Jalz.2010.03.009 |
0.504 |
|
| 2010 |
Lui JK, Laws SM, Li QX, Villemagne VL, Ames D, Brown B, Bush AI, De Ruyck K, Dromey J, Ellis KA, Faux NG, Foster J, Fowler C, Gupta V, Hudson P, ... ... Martins RN, et al. Plasma amyloid-beta as a biomarker in Alzheimer's disease: the AIBL study of aging. Journal of Alzheimer's Disease : Jad. 20: 1233-42. PMID 20413897 DOI: 10.3233/Jad-2010-090249 |
0.603 |
|
| 2010 |
Chételat G, Villemagne VL, Bourgeat P, Pike KE, Jones G, Ames D, Ellis KA, Szoeke C, Martins RN, O'Keefe GJ, Salvado O, Masters CL, Rowe CC. Relationship between atrophy and beta-amyloid deposition in Alzheimer disease. Annals of Neurology. 67: 317-24. PMID 20373343 DOI: 10.1002/Ana.21955 |
0.491 |
|
| 2010 |
Bourgeat P, Chételat G, Villemagne VL, Fripp J, Raniga P, Pike K, Acosta O, Szoeke C, Ourselin S, Ames D, Ellis KA, Martins RN, Masters CL, Rowe CC, Salvado O, et al. Beta-amyloid burden in the temporal neocortex is related to hippocampal atrophy in elderly subjects without dementia. Neurology. 74: 121-7. PMID 20065247 DOI: 10.1212/Wnl.0B013E3181C918B5 |
0.524 |
|
| 2010 |
Rodrigues MA, Foster JK, Verdile G, Joesbury K, Prince R, Devine A, Mehta P, Beilby J, Martins RN. Predicting memory decline as a risk factor for Alzheimer's disease in older post-menopausal women: quod erat demonstrandum? International Psychogeriatrics / Ipa. 22: 332-5. PMID 19814842 DOI: 10.1017/S1041610209991190 |
0.58 |
|
| 2010 |
Taddei K, Laws SM, Verdile G, Munns S, D'Costa K, Harvey AR, Martins IJ, Hill F, Levy E, Shaw JE, Martins RN. Novel phage peptides attenuate beta amyloid-42 catalysed hydrogen peroxide production and associated neurotoxicity. Neurobiology of Aging. 31: 203-14. PMID 18472186 DOI: 10.1016/J.Neurobiolaging.2008.03.023 |
0.599 |
|
| 2010 |
Macreadie I, Bharadwaj P, Martins R. Biodiscovery of chemo preventatives of Alzheimer’s disease using yeast Microbiology Australia. 31: 84-85. DOI: 10.1071/Ma10084 |
0.422 |
|
| 2010 |
Bennett LE, Bharadwaj P, Waddington L, Sudharmarajan S, Xu X, Szoeke C, Martins R, RH. Modulation of Amyloid Beta (Aβ) Structure and Toxicity by a Dairy-derived Peptide Product Alzheimers & Dementia. 6. DOI: 10.1016/J.Jalz.2010.08.064 |
0.326 |
|
| 2010 |
Brown BM, Peiffer JJ, Taddei K, Foster JK, Ward VK, Lachovitzki RM, Rodrigues MA, Taddei T, Lui J, Gupta V, Laws SM, Rimajova MR, Ellis KA, Szoeke C, Masters CL, ... ... Martins RN, et al. O4-07-02: Monitored physical activity is associated with better cognitive performance in the elderly: A study from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study Alzheimer's & Dementia. 6: S162-S163. DOI: 10.1016/J.Jalz.2010.05.505 |
0.358 |
|
| 2010 |
Villemagne VL, Chetelat G, Pike K, Jones G, Ellis K, Li Q, Mulligan R, Ackermann U, O'Keefe G, Martins R, Ames D, Masters CL, Rowe C. Comparison of biomarkers for the prediction of cognitive decline Alzheimers & Dementia. 6. DOI: 10.1016/J.Jalz.2010.05.431 |
0.452 |
|
| 2010 |
Rowe CC, Ellis K, Chetelat G, Pike K, Rimajova M, Szoeke C, Bourgeat P, Salvado O, Martins R, Masters CL, Ames D, Villemagne VL. Baseline and follow-up neuroimaging results from the Australian imaging, biomarker, and lifestyle flagship study of aging (AIBL) Alzheimers & Dementia. 6. DOI: 10.1016/J.Jalz.2010.05.430 |
0.419 |
|
| 2010 |
Doecke J, Buckley M, Good N, Laws S, Faux N, Dunne R, Wilson W, Bush A, Ames D, Ellis K, Rowe C, Szoeke C, Martins R, Masters C. Identifying protein biomarkers for early diagnosis of Alzheimer's disease Alzheimers & Dementia. 6. DOI: 10.1016/J.Jalz.2010.05.407 |
0.615 |
|
| 2010 |
Foster J, Jha U, Brown B, Savage G, Ellis K, Darby D, Lautenschlager N, Maruff P, Szoeke C, Taddei K, Ward V, Rodrigues M, Lachovitzki R, Rimajova M, Lenzo N, ... ... Martins R, et al. Subjective memory complainers in the AIBL cohort: Hypervigilance amongst the worried well, or individuals at increased risk of Alzheimer's disease? Alzheimers & Dementia. 6. DOI: 10.1016/J.Jalz.2010.05.397 |
0.487 |
|
| 2010 |
Ellis KA, Clifford D, Villemagne VL, Ames D, Chetelat G, Foster J, Martins R, Maruff P, Masters CL, Szoeke C, Rowe CC. In an amnestic MCI population, those with high PIB binding perform more poorly on memory tests than those with low binding Alzheimers & Dementia. 6. DOI: 10.1016/J.Jalz.2010.05.309 |
0.379 |
|
| 2010 |
Martins RN, Gandy SE, Gupta V, Steele JW, Kim SH, Cirrito J, Lachenmayer L, Ehrlich M, Yue Z, Bharadwaj P, Barr R, Martins I, Morici M, Taddei K, Verdile G. P3-409: Effects of latrepirdine on Aβ clearance, neurotoxicity and aggregation Alzheimer's & Dementia. 6: S572-S573. DOI: 10.1016/J.Jalz.2010.05.1952 |
0.581 |
|
| 2010 |
Bharadwaj PR, Barr R, Lachenmayer L, Steele JW, Ehrlich ME, Yue Z, Gandy S, Verdile G, Martins R. P3-377: Latrepirdine enhances Aβ degradation in yeast via an autophagic pathway Alzheimer's & Dementia. 6: S562-S563. DOI: 10.1016/J.Jalz.2010.05.1919 |
0.61 |
|
| 2010 |
Gupta VB, Bhardawaj P, Steele J, Taddei K, Morici M, Gandy S, Verdile G, Martins R. P3-324: Latrepirdine modulates Aβ oligomer formation and attenuates oligomer-associated toxicity Alzheimer's & Dementia. 6: S547-S547. DOI: 10.1016/J.Jalz.2010.05.1825 |
0.622 |
|
| 2010 |
Faux NG, Ellis KA, Fowler CJ, Martins R, Pertile KK, Rowe C, Rumble RL, Szoeke C, Porter L, Rembach A, Trounson B, Masters C, Ames D, Bush AI. Plasma levels of homocysteine and red cell folate correlate with neurological composite z-scores in Alzheimer's disease and healthy subjects: The Australian Imaging Biomarker Lifestyle (AIBL) study of aging Alzheimers & Dementia. 6. DOI: 10.1016/J.Jalz.2010.05.1726 |
0.606 |
|
| 2010 |
Kotsopoulos EJ, Good N, Ames DA, Fazio DD, Forster J, Maruff P, Masters C, Martins R, O'Halloran C, Rowe C, Savage G, Szoeke C, Ellis KA. Normative data from the AIBL study: Language, visuoconstruction, and executive functioning in a large healthy elderly cohort Alzheimers & Dementia. 6. DOI: 10.1016/J.Jalz.2010.05.1631 |
0.368 |
|
| 2010 |
Chetelat G, Villemagne V, Bourgeat P, Pike K, Jones G, Ames D, Ellis K, Szoeke C, Martins R, O'Keefe G, Salvado O, Masters C, Rowe C. Relationship between Atrophy and Beta-Amyloid Deposition in Normal Elderly, Mild Cognitive Impairment and Alzheimer's Disease Alzheimers & Dementia. 6. DOI: 10.1016/J.Jalz.2010.05.129 |
0.568 |
|
| 2010 |
Ellis KA, Bush AI, Foster J, Martins RN, Maruff P, Masters CL, Rowe CC, Savage G, Szoeke C, Ames D. P2-178: Findings from the first 18-month follow up of the Australian Imaging Biomarkers and Lifestyle (AIBL) cohort Alzheimer's & Dementia. 6: S365-S366. DOI: 10.1016/J.Jalz.2010.05.1226 |
0.471 |
|
| 2010 |
Kaldi A, Ellis KA, Darby D, Ames D, Martins R, Masters CL, Rowe C, Szoeke C, Maruff P. Determining rate of decline in pre-AD and AD AIBL participants using a brief computerized battery Alzheimers & Dementia. 6. DOI: 10.1016/J.Jalz.2010.05.1143 |
0.512 |
|
| 2010 |
Chetelat G, Villemagne V, Pike K, Baron J, Bourgeat P, Jones G, Ellis K, Salvado O, Szoeke C, Martins R, Ames D, Masters C, Rowe C. Larger temporal volume in asymptomatic elderly with high versus low beta-amyloid deposition Alzheimers & Dementia. 6. DOI: 10.1016/J.Jalz.2010.05.009 |
0.444 |
|
| 2009 |
Martins IJ, Berger T, Sharman MJ, Verdile G, Fuller SJ, Martins RN. Cholesterol metabolism and transport in the pathogenesis of Alzheimer's disease. Journal of Neurochemistry. 111: 1275-308. PMID 20050287 DOI: 10.1111/J.1471-4159.2009.06408.X |
0.632 |
|
| 2009 |
Krishnaswamy S, Verdile G, Groth D, Kanyenda L, Martins RN. The structure and function of Alzheimer's gamma secretase enzyme complex. Critical Reviews in Clinical Laboratory Sciences. 46: 282-301. PMID 19958215 DOI: 10.3109/10408360903335821 |
0.592 |
|
| 2009 |
Pedrini S, Thomas C, Brautigam H, Schmeidler J, Ho L, Fraser P, Westaway D, Hyslop PS, Martins RN, Buxbaum JD, Pasinetti GM, Dickstein DL, Hof PR, Ehrlich ME, Gandy S. Dietary composition modulates brain mass and solubilizable Abeta levels in a mouse model of aggressive Alzheimer's amyloid pathology. Molecular Neurodegeneration. 4: 40. PMID 19845940 DOI: 10.1186/1750-1326-4-40 |
0.344 |
|
| 2009 |
Nornes S, Newman M, Wells S, Verdile G, Martins RN, Lardelli M. Independent and cooperative action of Psen2 with Psen1 in zebrafish embryos. Experimental Cell Research. 315: 2791-801. PMID 19563801 DOI: 10.1016/J.Yexcr.2009.06.023 |
0.526 |
|
| 2009 |
Ellis KA, Bush AI, Darby D, De Fazio D, Foster J, Hudson P, Lautenschlager NT, Lenzo N, Martins RN, Maruff P, Masters C, Milner A, Pike K, Rowe C, Savage G, et al. The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease. International Psychogeriatrics / Ipa. 21: 672-87. PMID 19470201 DOI: 10.1017/S1041610209009405 |
0.617 |
|
| 2009 |
Bharadwaj PR, Dubey AK, Masters CL, Martins RN, Macreadie IG. Abeta aggregation and possible implications in Alzheimer's disease pathogenesis. Journal of Cellular and Molecular Medicine. 13: 412-21. PMID 19374683 DOI: 10.1111/J.1582-4934.2009.00609.X |
0.49 |
|
| 2009 |
Drummond ES, Harvey AR, Martins RN. Androgens and Alzheimer's disease. Current Opinion in Endocrinology, Diabetes, and Obesity. 16: 254-9. PMID 19373081 DOI: 10.1097/MED.0b013e32832b101f |
0.35 |
|
| 2009 |
Bates KA, Sohrabi HR, Rodrigues M, Beilby J, Dhaliwal SS, Taddei K, Criddle A, Wraith M, Howard M, Martins G, Paton A, Mehta P, Foster JK, Martins IJ, Lautenschlager NT, ... ... Martins RN, et al. Association of cardiovascular factors and Alzheimer's disease plasma amyloid-beta protein in subjective memory complainers. Journal of Alzheimer's Disease : Jad. 17: 305-18. PMID 19363264 DOI: 10.3233/Jad-2009-1050 |
0.371 |
|
| 2009 |
Barron AM, Cake M, Verdile G, Martins RN. Ovariectomy and 17beta-estradiol replacement do not alter beta-amyloid levels in sheep brain. Endocrinology. 150: 3228-36. PMID 19282379 DOI: 10.1210/En.2008-1252 |
0.635 |
|
| 2009 |
Foster JK, Verdile G, Bates KA, Martins RN. Immunization in Alzheimer's disease: naïve hope or realistic clinical potential? Molecular Psychiatry. 14: 239-51. PMID 18957942 DOI: 10.1038/Mp.2008.115 |
0.652 |
|
| 2009 |
Bates KA, Verdile G, Li QX, Ames D, Hudson P, Masters CL, Martins RN. Clearance mechanisms of Alzheimer's amyloid-beta peptide: implications for therapeutic design and diagnostic tests. Molecular Psychiatry. 14: 469-86. PMID 18794889 DOI: 10.1038/Mp.2008.96 |
0.713 |
|
| 2009 |
Bates KA, Verdile G, Li Q, Ames D, Hudson P, Masters CL, Martins RN. Erratum: Clearance mechanisms of Alzheimer's amyloid-β peptide: implications for therapeutic design and diagnostic tests Molecular Psychiatry. 14: 1144-1144. DOI: 10.1038/Mp.2008.123 |
0.637 |
|
| 2009 |
Foster JK, Ellis K, Savage G, Darby D, Lautenschlager N, Maruff P, Taddei K, Ward V, Rodrigues M, Brown B, Rimajova M, Taddei T, Lui J, Masters C, Martins R, et al. O4-05-06: Neuropsychological performance and the e4 and e2 alleles: Findings from the first phase of the australian imaging, biomarker and lifestyle (AIBL) flagship study of ageing Alzheimer's & Dementia. 5: P160-P161. DOI: 10.1016/J.Jalz.2009.05.554 |
0.392 |
|
| 2009 |
Ellis K, Rowe C, Masters C, Martins R, Hudson P, Milner A, Bevege L, Ames D. Baseline data from the Australian Imaging Biomarkers and Lifestyle Flagship Study of Ageing Alzheimer's & Dementia. 5: e4-e4. DOI: 10.1016/J.Jalz.2009.05.265 |
0.314 |
|
| 2009 |
Ames DJ, Maruff P, Savage G, Foster J, Darby D, Pike K, Kotsopoulos E, De Fazio D, Rowe C, Szoeke C, Masters C, Martins R, Hudson P, Milner A, Ellis KA. IC-P-022: The bimodality of healthy ageing: How do the differing profiles of healthy controls compare to patients with mild cognitive impairment? Alzheimer's & Dementia. 5: P14-P14. DOI: 10.1016/J.Jalz.2009.05.042 |
0.447 |
|
| 2009 |
Szoeke C, Ellis KA, Bush A, Darby D, Fazio DD, Foster J, Hudson P, Lautenschlager N, Lenzo N, Martins R, Maruff P, Masters C, Milner A, Pike K, Rowe C, et al. The AIBL study: Baseline data from a multicenter, prospective longitudinal study of ageing in 1,100 volunteers Alzheimers & Dementia. 5: 10. DOI: 10.1016/J.Jalz.2009.05.033 |
0.52 |
|
| 2009 |
Martins R. Exploring the association between plasma apoE levels and Alzheimer's disease: Australian Imaging, Biomarker and Lifestyle (AIBL) flagship study of ageing Alzheimers & Dementia. 5. DOI: 10.1016/J.Jalz.2009.04.473 |
0.428 |
|
| 2009 |
Lui J, Ruyck KD, Gupta V, Li Q, Taddei K, Foster J, Taddei T, Brown B, Ward V, Rodrigues M, Ellis K, Rowe C, Villemagne V, Hudson P, Masters C, ... Martins R, et al. Amyloid-β and its relevance to the detection of Alzheimer's disease in blood plasma: Findings from the first phase of the Australian Imaging, Biomarker and Lifestyle (AIBL) flagship study of ageing Alzheimers & Dementia. 5. DOI: 10.1016/J.Jalz.2009.04.1196 |
0.522 |
|
| 2009 |
Wijaya LK, Wahjoepramono EJ, Taddei K, Martins G, Howard M, Bates K, Dhaliwal S, Verdile G, Martins R. P1-029: Effect of cortical placement of luteinizing hormone on Aβ metabolism in guinea pigs Alzheimer's & Dementia. 5: P180-P180. DOI: 10.1016/J.Jalz.2009.04.032 |
0.593 |
|
| 2008 |
Chan HW, Liu T, Verdile G, Bishop G, Haasl RJ, Smith MA, Perry G, Martins RN, Atwood CS. Copper Induces Apoptosis of Neuroblastoma Cells Via Post-translational Regulation of the Expression of Bcl-2-family Proteins and the tx Mouse is a Better Model of Hepatic than Brain Cu Toxicity. International Journal of Clinical and Experimental Medicine. 1: 76-88. PMID 19079689 |
0.573 |
|
| 2008 |
Wahjoepramono EJ, Wijaya LK, Taddei K, Martins G, Howard M, de Ruyck K, Bates K, Dhaliwal SS, Verdile G, Carruthers M, Martins RN. Distinct effects of testosterone on plasma and cerebrospinal fluid amyloid-beta levels. Journal of Alzheimer's Disease : Jad. 15: 129-37. PMID 18780973 DOI: 10.3233/Jad-2008-15111 |
0.593 |
|
| 2008 |
Gnjec A, D'Costa KJ, Laws SM, Hedley R, Balakrishnan K, Taddei K, Martins G, Paton A, Verdile G, Gandy SE, Broe GA, Brooks WS, Bennett H, Piguet O, Price P, ... ... Martins RN, et al. Association of alleles carried at TNFA -850 and BAT1 -22 with Alzheimer's disease. Journal of Neuroinflammation. 5: 36. PMID 18715507 DOI: 10.1186/1742-2094-5-36 |
0.631 |
|
| 2008 |
Maczurek A, Hager K, Kenklies M, Sharman M, Martins R, Engel J, Carlson DA, Münch G. Lipoic acid as an anti-inflammatory and neuroprotective treatment for Alzheimer's disease. Advanced Drug Delivery Reviews. 60: 1463-70. PMID 18655815 DOI: 10.1016/J.Addr.2008.04.015 |
0.425 |
|
| 2008 |
Verdile G, Yeap BB, Clarnette RM, Dhaliwal S, Burkhardt MS, Chubb SA, De Ruyck K, Rodrigues M, Mehta PD, Foster JK, Bruce DG, Martins RN. Luteinizing hormone levels are positively correlated with plasma amyloid-beta protein levels in elderly men. Journal of Alzheimer's Disease : Jad. 14: 201-8. PMID 18560131 DOI: 10.3233/Jad-2008-14208 |
0.626 |
|
| 2008 |
Rodrigues MA, Verdile G, Foster JK, Hogervorst E, Joesbury K, Dhaliwal S, Corder EH, Laws SM, Hone E, Prince R, Devine A, Mehta P, Beilby J, Atwood CS, Martins RN. Gonadotropins and cognition in older women. Journal of Alzheimer's Disease : Jad. 13: 267-74. PMID 18430994 DOI: 10.3233/Jad-2008-13304 |
0.585 |
|
| 2008 |
Foster J, Sohrabi H, Verdile G, Martins R. Research criteria for the diagnosis of Alzheimer's disease: genetic risk factors, blood biomarkers and olfactory dysfunction. International Psychogeriatrics / Ipa. 20: 853-5. PMID 18416874 DOI: 10.1017/S1041610208006807 |
0.604 |
|
| 2008 |
Nornes S, Newman M, Verdile G, Wells S, Stoick-Cooper CL, Tucker B, Frederich-Sleptsova I, Martins R, Lardelli M. Interference with splicing of Presenilin transcripts has potent dominant negative effects on Presenilin activity. Human Molecular Genetics. 17: 402-12. PMID 17981814 DOI: 10.1093/Hmg/Ddm317 |
0.596 |
|
| 2008 |
Bates KA, Sohrabi HR, Rodrigues M, De Ruyck K, Beilby J, Dhaliwal SS, Criddle A, Wraith M, Howard M, Martins G, Paton A, Mehta P, Foster JK, Martins IJ, Lautenschlager NT, ... ... Martins RN, et al. P1-342: Relationship between cardiovascular disease risk factors and Alzheimer's disease Aβ protein in subjective memory complainers Alzheimer's & Dementia. 4: T319-T319. DOI: 10.1016/J.Jalz.2008.05.923 |
0.381 |
|
| 2008 |
Barron AM, Taddei K, DeRuyck K, Croft KD, Mori TA, Verdile G, Martins RN. P1-436: Time- and dose-dependent effects of ovariectomy and human chorionic gonadotropin treatment on beta amyloid and isoprostane levels in the PS1M146V mouse model of Alzheimer's disease Alzheimer's & Dementia. 4: T347-T347. DOI: 10.1016/J.Jalz.2008.05.1018 |
0.611 |
|
| 2008 |
Ellis KA, Villemagne VL, Ames D, Lenzo N, Pike KE, O'Keefe G, Tochon-Danguy H, Price R, Jones G, Rimajova M, Bourgeat P, Raniga P, Fripp J, Acosta O, Salvado O, ... Martins R, et al. IC-03-03: The Australian Biomarker, Imaging and Lifestyle Study: Preliminary PIB results Alzheimers & Dementia. 4. DOI: 10.1016/J.Jalz.2008.05.008 |
0.358 |
|
| 2007 |
Fuller SJ, Tan RS, Martins RN. Androgens in the etiology of Alzheimer's disease in aging men and possible therapeutic interventions. Journal of Alzheimer's Disease : Jad. 12: 129-42. PMID 17917157 DOI: 10.3233/JAD-2007-12202 |
0.344 |
|
| 2007 |
McRae A, Martins RN, Fonte J, Kraftsik R, Hirt L, Miklossy J. Cerebrospinal fluid antimicroglial antibodies in Alzheimer disease: a putative marker of an ongoing inflammatory process. Experimental Gerontology. 42: 355-63. PMID 17140756 DOI: 10.1016/j.exger.2006.10.015 |
0.323 |
|
| 2007 |
Verdile G, Gandy SE, Martins RN. The role of presenilin and its interacting proteins in the biogenesis of Alzheimer's beta amyloid. Neurochemical Research. 32: 609-23. PMID 16944319 DOI: 10.1007/S11064-006-9131-X |
0.583 |
|
| 2006 |
Ellis K, Ames D, Martins R, Hudson P, Masters C. The Australian Biomarkers Lifestyle and Imaging flagship study of ageing. Acta Neuropsychiatrica. 18: 285. PMID 27397271 DOI: 10.1017/S0924270800031136 |
0.31 |
|
| 2006 |
Barron AM, Fuller SJ, Verdile G, Martins RN. Reproductive hormones modulate oxidative stress in Alzheimer's disease. Antioxidants & Redox Signaling. 8: 2047-59. PMID 17034349 DOI: 10.1089/Ars.2006.8.2047 |
0.628 |
|
| 2006 |
Martins IJ, Hone E, Foster JK, Sünram-Lea SI, Gnjec A, Fuller SJ, Nolan D, Gandy SE, Martins RN. Apolipoprotein E, cholesterol metabolism, diabetes, and the convergence of risk factors for Alzheimer's disease and cardiovascular disease. Molecular Psychiatry. 11: 721-36. PMID 16786033 DOI: 10.1038/Sj.Mp.4001854 |
0.431 |
|
| 2006 |
Barron AM, Verdile G, Martins RN. The role of gonadotropins in Alzheimer's disease: potential neurodegenerative mechanisms. Endocrine. 29: 257-69. PMID 16785601 DOI: 10.1385/Endo:29:2:257 |
0.661 |
|
| 2006 |
Miklossy J, Kis A, Radenovic A, Miller L, Forro L, Martins R, Reiss K, Darbinian N, Darekar P, Mihaly L, Khalili K. Beta-amyloid deposition and Alzheimer's type changes induced by Borrelia spirochetes. Neurobiology of Aging. 27: 228-36. PMID 15894409 DOI: 10.1016/J.Neurobiolaging.2005.01.018 |
0.433 |
|
| 2006 |
Martins RN, Balakrishnan K, Verdile G, Bates K, Mehta PD, Beilby J, Nolan D, Galvao D, Gandy SE. P1-167: Plasma Aβ42 correlates positively with increased body fat Alzheimer's & Dementia. 2: S144-S145. DOI: 10.1016/J.Jalz.2006.05.543 |
0.549 |
|
| 2005 |
Balakrishnan K, Verdile G, Mehta PD, Beilby J, Nolan D, Galvão DA, Newton R, Gandy SE, Martins RN. Plasma Abeta42 correlates positively with increased body fat in healthy individuals. Journal of Alzheimer's Disease : Jad. 8: 269-82. PMID 16340084 DOI: 10.3233/Jad-2005-8305 |
0.618 |
|
| 2005 |
Lautenschlager NT, Wu JS, Laws SM, Almeida OP, Clarnette RM, Joesbury K, Wagenpfeil S, Martins G, Paton A, Gandy SE, Förstl H, Martins RN. Neurological soft signs are associated with APOE genotype, age and cognitive performance. Journal of Alzheimer's Disease : Jad. 7: 325-30. PMID 16131735 DOI: 10.3233/Jad-2005-7409 |
0.372 |
|
| 2005 |
Hone E, Martins IJ, Jeoung M, Ji TH, Gandy SE, Martins RN. Alzheimer's disease amyloid-beta peptide modulates apolipoprotein E isoform specific receptor binding. Journal of Alzheimer's Disease : Jad. 7: 303-14. PMID 16131732 DOI: 10.3233/Jad-2005-7406 |
0.42 |
|
| 2005 |
Bates KA, Harvey AR, Carruthers M, Martins RN. Androgens, andropause and neurodegeneration: Exploring the link between steroidogenesis, androgens and Alzheimer's disease Cellular and Molecular Life Sciences. 62: 281-292. PMID 15723164 DOI: 10.1007/S00018-004-4383-1 |
0.397 |
|
| 2005 |
Bowen RL, Martins RN, Gregory CW, Smith MA, Atwood CS. Dementia and testosterone levels in men. Jama. 293: 551; author reply 55. PMID 15687304 DOI: 10.1001/Jama.293.5.551-B |
0.354 |
|
| 2005 |
James VJ, Richardson JC, Robertson TA, Papadimitriou JM, Dutton NS, Maley MA, Berstein LM, Lantseva OE, Martins RN. Fibre diffraction of hair can provide a screening test for Alzheimer's disease: a human and animal model study. Medical Science Monitor : International Medical Journal of Experimental and Clinical Research. 11: CR53-7. PMID 15668631 |
0.326 |
|
| 2004 |
Carter TL, Verdile G, Groth D, Bogush A, Thomas S, Shen P, Fraser PE, Mathews P, Nixon RA, Ehrlich ME, Kwok JB, St George-Hyslop P, Schofield P, Li Y, Yang A, ... Martins RN, et al. Alzheimer amyloid precursor aspartyl proteinase activity in CHAPSO homogenates of Spodoptera frugiperda cells. Alzheimer Disease and Associated Disorders. 18: 261-3. PMID 15592142 |
0.581 |
|
| 2004 |
Verdile G, Gnjec A, Miklossy J, Fonte J, Veurink G, Bates K, Kakulas B, Mehta PD, Milward EA, Tan N, Lareu R, Lim D, Dharmarajan A, Martins RN. Protein markers for Alzheimer disease in the frontal cortex and cerebellum. Neurology. 63: 1385-92. PMID 15505153 DOI: 10.1212/01.Wnl.0000141848.45315.A6 |
0.669 |
|
| 2004 |
Sweeney D, Martins R, LeVine H, Smith JD, Gandy S. Similar promotion of Abeta1-42 fibrillogenesis by native apolipoprotein E epsilon3 and epsilon4 isoforms. Journal of Neuroinflammation. 1: 15. PMID 15312232 DOI: 10.1186/1742-2094-1-15 |
0.327 |
|
| 2004 |
Verdile G, Fuller S, Atwood CS, Laws SM, Gandy SE, Martins RN. The role of beta amyloid in Alzheimer's disease: still a cause of everything or the only one who got caught? Pharmacological Research : the Official Journal of the Italian Pharmacological Society. 50: 397-409. PMID 15304237 DOI: 10.1016/J.Phrs.2003.12.028 |
0.625 |
|
| 2004 |
Flicker L, Martins RN, Thomas J, Acres J, Taddei K, Norman P, Jamrozik K, Almeida OP. Homocysteine, Alzheimer genes and proteins, and measures of cognition and depression in older men. Journal of Alzheimer's Disease : Jad. 6: 329-36. PMID 15201487 DOI: 10.3233/Jad-2004-6313 |
0.406 |
|
| 2004 |
Burkhardt MS, Foster JK, Laws SM, Baker LD, Craft S, Gandy SE, Stuckey BG, Clarnette R, Nolan D, Hewson-Bower B, Martins RN. Oestrogen replacement therapy may improve memory functioning in the absence of APOE epsilon4. Journal of Alzheimer's Disease : Jad. 6: 221-8. PMID 15201477 DOI: 10.3233/Jad-2004-6302 |
0.376 |
|
| 2004 |
Martins R, Hallmayer J. Age at onset: important marker of genetic heterogeneity in Alzheimer's disease Pharmacogenomics Journal. 4: 138-140. PMID 15024381 DOI: 10.1038/Sj.Tpj.6500239 |
0.384 |
|
| 2004 |
Bowen RL, Verdile G, Liu T, Parlow AF, Perry G, Smith MA, Martins RN, Atwood CS. Luteinizing hormone, a reproductive regulator that modulates the processing of amyloid-beta precursor protein and amyloid-beta deposition. The Journal of Biological Chemistry. 279: 20539-45. PMID 14871891 DOI: 10.1074/Jbc.M311993200 |
0.662 |
|
| 2004 |
Liu T, Perry G, Chan HW, Verdile G, Martins RN, Smith MA, Atwood CS. Amyloid-beta-induced toxicity of primary neurons is dependent upon differentiation-associated increases in tau and cyclin-dependent kinase 5 expression. Journal of Neurochemistry. 88: 554-63. PMID 14720205 DOI: 10.1046/J.1471-4159.2003.02196.X |
0.627 |
|
| 2004 |
Lim D, Flicker L, Dharamarajan A, Martins RN. Can testosterone replacement decrease the memory problem of old age? Medical Hypotheses. 60: 893-6. PMID 12699720 DOI: 10.1016/S0306-9877(03)00072-0 |
0.365 |
|
| 2004 |
Verdile G, Groth D, Mathews P, George-Hyslop PS, Fraser P, Ramabhadran T, Kwok J, Schofield P, Carter T, Gandy S, Martins R. P4-265 Baculoviral expressionof the presenilin mutation lacking exon 9 increase levels of an amyloid beta — like protein in SF9insect cells Neurobiology of Aging. 25: S550-S551. DOI: 10.1016/S0197-4580(04)81823-2 |
0.601 |
|
| 2004 |
Atwood CS, Liu T, Smith MA, Martins RN, Bowen RL, Verdile G. O2-04-06 17β-Estradiol and luteinizing hormone modulate the expression of luteinizing hormone receptors in neuroblastoma cells Neurobiology of Aging. 25: S40. DOI: 10.1016/S0197-4580(04)80132-5 |
0.555 |
|
| 2003 |
Veurink G, Fuller SJ, Atwood CS, Martins RN. Genetics, lifestyle and the roles of amyloid beta and oxidative stress in Alzheimer's disease. Annals of Human Biology. 30: 639-67. PMID 14675907 DOI: 10.1080/03014460310001620144 |
0.368 |
|
| 2003 |
Atwood CS, Obrenovich ME, Liu T, Chan H, Perry G, Smith MA, Martins RN. Amyloid-beta: a chameleon walking in two worlds: a review of the trophic and toxic properties of amyloid-beta. Brain Research. Brain Research Reviews. 43: 1-16. PMID 14499458 DOI: 10.1016/S0165-0173(03)00174-7 |
0.409 |
|
| 2003 |
Dean B, Laws SM, Hone E, Taddei K, Scarr E, Thomas EA, Harper C, McClean C, Masters C, Lautenschlager N, Gandy SE, Martins RN. Increased levels of apolipoprotein E in the frontal cortex of subjects with schizophrenia. Biological Psychiatry. 54: 616-22. PMID 13129656 DOI: 10.1016/S0006-3223(03)00075-1 |
0.332 |
|
| 2003 |
Miklossy J, Taddei K, Suva D, Verdile G, Fonte J, Fisher C, Gnjec A, Ghika J, Suard F, Mehta PD, McLean CA, Masters CL, Brooks WS, Martins RN. Two novel presenilin-1 mutations (Y256S and Q222H) are associated with early-onset Alzheimer's disease. Neurobiology of Aging. 24: 655-62. PMID 12885573 DOI: 10.1016/S0197-4580(02)00192-6 |
0.648 |
|
| 2003 |
Thomas EA, Laws SM, Sutcliffe JG, Harper C, Dean B, McClean C, Masters C, Lautenschlager N, Gandy SE, Martins RN. Apolipoprotein D levels are elevated in prefrontal cortex of subjects with Alzheimer's disease: no relation to apolipoprotein E expression or genotype. Biological Psychiatry. 54: 136-41. PMID 12873803 DOI: 10.1016/S0006-3223(02)01976-5 |
0.499 |
|
| Show low-probability matches. |
